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ENHANCED MENTAL REINSTATEMENT OF EXPOSURE TREATMENT TO 
IMPROVE THE GENERALIZATION OF LEARNING IN CLAUSTROPHOBIA 
JOSEPH K. CARPENTER 
Boston University Graduate School of Arts and Sciences, 2020 




Exposure therapy is the gold standard treatment for anxiety disorders, but 
reductions in fear following exposure often do not generalize well outside the context in 
which they took place. This study tested a strategy for increasing generalization that 
involved revisiting the memory of a prior exposure experience in order to enhance the 
retrieval of the learning that occurred. Forty-five participants (29 females, 16 males) with 
claustrophobia received exposure training consisting of repeated 5-minute trials lying 
inside a narrow cabinet laid on its back. One week later, they were randomly assigned to 
either enhanced mental reinstatement (EMR) or control procedures.  
Results of the exposure training showed significant decreases in subjective fear, 
heart rate and avoidance in the training context, as well as reduced claustrophobia 
symptoms. As expected, fear levels in the mock MRI scanner one week later increased 
relative to the exposure training context post-treatment. Compared to the control 
condition, the EMR intervention led to significantly reduced heart rate reactivity in the 
mock MRI scanner, but not to reduced self-reported fear or avoidance of the mock 
scanner, nor to differences in claustrophobia symptoms at one-month follow-up. 
Expectancy violations about coping self-efficacy, measured via participants’ surprise 
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about their ability to effectively cope during exposure, predicted lower fear in the mock 
MRI regardless of condition. Fear-related expectancy violations, reflecting greater 
discrepancy in expected vs. actual fear levels during exposure, predicted greater fear in 
the mock MRI. Results highlight the potential for mental reinstatement of exposure to 
improve generalization of learning in claustrophobia, though effects may be limited. The 
impact of expectancy violations on exposure outcomes may depend on the type of 
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Cognitive-behavioral therapy consisting of exposure therapy has been shown to 
be the gold-standard treatment for anxiety disorders, yet treatment outcomes remain 
suboptimal (Carpenter et al., 2018; Hofmann & Smits, 2008). One hypothesized reason 
for this is that the learning that occurs from the nonoccurrence of anticipated negative 
outcomes during exposure, known as extinction learning, is somewhat fragile. Basic 
experimental research has shown that when a fear response is extinguished, the original 
fear memory has not been erased, but rather a new memory of safety has formed that 
inhibits its activation (Bouton, 2002). As a result, the retrieval of such learning appears to 
be highly dependent on context, such that the presentation of an extinguished stimulus 
outside of the context in which extinction occurs can lead to the renewal of the original 
fear response (Vervliet, Baeyens, Van den Bergh, & Hermans, 2013).   
An important consequence of such contextual fear renewal effects is that the 
learning that occurs during exposure therapy often does not completely generalize to new 
situations. For example, spider phobics who undergo successful exposure therapy to a 
spider in one context demonstrate a return of fear to the same spider when it is presented 
in another context, (Mineka, Mystkowski, Hladek, & Rodriguez, 1999), with studies 
showing between 30% and 50% of the fear reduction seen during treatment in one 
context returning after a context change (Dibbets, Moor, & Voncken, 2013; Mystkowski, 
Craske, & Echiverri, 2002). Similarly, changes in elements of the feared stimulus itself 
can lead to a return of fear after successful extinction (Vervliet, Vansteenwegen, 
Baeyens, Hermans, & Eelen, 2005; Vervliet, Vansteenwegen, & Eelen, 2006; Rowe & 
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Craske, 1998). The consequences of such a failure to generalize safety learning can be 
significant for exposure therapy outcomes, as successful exposures conducted with a 
therapist may not translate to reduced anxiety outside of the treatment context, or 
improvements may be restricted to the specific feared situation confronted in the 
exposure. Individuals with anxiety disorders tend to experience anxiety in a wide variety 
of scenarios, but it is usually not feasible to conduct exposures to all possible feared 
stimuli in all contexts. Therefore, some amount of generalization is needed for successful 
treatment outcome. In addition, enhancing generalization could result in a need for fewer 
in-session exposures, and could increase the likelihood of patients confronting feared 
situations outside of session, which would contribute to further improvements. 
Extinction Generalization Techniques  
A number of different techniques designed to enhance the generalization of 
extinction learning have been tested in both laboratory and clinical research. For instance, 
conducting training in multiple contexts has been shown to attenuate renewal in 
experimental studies (Bandarian-Balooch, Neumann, & Boschen, 2012; Krisch, 
Bandarian-Balooch, & Neumann, 2018) and lead to reduced fear to a novel feared 
stimulus in clinical studies (Bandarian-Balooch et al., 2015; Shiban, Pauli, & 
Mühlberger, 2013; Shiban, Schelhorn, Pauli, & Mühlberger, 2015). Other methods of 
reducing contextual renewal that have shown promise in laboratory research, include 
extinguishing the original conditioned stimulus (CS; Vervliet, Vansteenwegen, & Eelen, 
2004), directing attention to shared elements of an extinction stimulus and the original CS 
(Barry, Verliet & Hermans, 2017), increasing the number of extinction trials (Krisch et 
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al., 2018), and post-extinction sleep (Pace-Schott et al., 2009; Pace-Schott, Verga, 
Bennett, & Spencer, 2012). In addition, several different methods of decreasing the 
perceived aversiveness of an unconditioned stimulus in experimental extinction 
paradigms have also been shown to attenuate renewal (Dibbets, Poort, & Arntz, 2012; 
Haesen & Vervliet, 2015; Leer, Haesen, & Vervliet, 2018). 
The techniques used in the studies above largely focus on manipulations of the 
extinction or exposure training itself, rather than procedures that occur in the context of a 
test of renewal. Identifying techniques that can help patients to apply prior learning to 
novel exposure situations as they come up, however, could be particularly helpful for 
fostering long-term treatment gains. One technique that fits with this approach is the use 
of a retrieval cue, which is a neutral stimulus present during extinction training that 
becomes associated with the learning that occurred during training. The presence of such 
a cue across different contexts can then help to retrieve the extinction memory and 
attenuate renewal of fear. Despite promising results seen in the laboratory (Dibbets, 
Havermans, & Artnz, 2008; Dibbets & Maes, 2011), only one of four trials has shown 
meaningful benefits of a retrieval cue for reducing return of fear (Culver, Stoyanova, & 
Craske, 2011; Dibbets, Moor, & Voncken, 2013; Laborda et al., 2016). The exception 
was a study by Shin and Newman (2018), which found reduced recovery of behavioral 
and physiological indicators of anxiety (though not subjective fear) when using a scented, 
neon-green puffer ball as a retrieval cue during public speaking exposure. Notably, this 
study differed from prior retrieval cue manipulations by increasing the sensory modalities 
the cue targeted (i.e. smell, touch, sight, and sound), suggesting that increasing the 
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salience of safety cue may be important for seeing beneficial effects.  
One potential risk of a retrieval cue is that safety during exposure becomes 
attributed to the presence of the cue rather than the actual exposure situation (Dibbets & 
Maes, 2011; Salkovskis, 1991). If non-occurrence of feared outcomes only occurs in the 
context of a particular physical cue, then the retrieval of safety learning may depend on 
the presence of that cue, and fear is likely to return in the cue’s absence. Therefore, the 
development of generalized safety learning about a feared situation could theoretically be 
impaired by the retrieval cue (i.e. protection from extinction; Lovibond, Davis, & 
O’Flaherty, 2000), similar to the way reliance of safety behaviors can maintain anxiety 
and slow progress during exposure therapy (see Blakey & Abramowitz, 2016 for a 
review). 
Mental Reinstatement 
Another generalization technique that attempts to enhance retrieval of the safety 
memory formed during extinction is mental reinstatement. Rather than using an arbitrary 
cue, however, participants are instructed to mentally revisit what happened during 
exposure training, as well as the context in which it occurred. Mental reinstatement of the 
context in which information was encoded has been shown to reduce the decrement in 
memory seen after a context change (Smith & Vela, 2001), and could plausibly bolster 
the retrievability of memories formed during extinction learning after a context change as 
well. While physical cues of a learning context may not necessarily be sufficient to 
counteract context-dependent memory effects, mental imagery of the learning 
environment and what occurred in it has been should to have more significant impact 
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(Smith, 1979). Furthermore, such a technique would appear less susceptible to protection 
from extinction than a retrieval cue given that it explicitly involves recall of prior safety 
learning memory rather than introducing a new contextual stimulus to which safety may 
be attributed.   
Similar to the clinical findings on retrieval cues, mental reinstatement procedures 
show promise for enhancing generalization, but effects are somewhat inconsistent and are 
limited to particular outcomes. In the most successful application to date, Mystkowski, 
Craske, Echiverri, and Labus (2006) showed that in spider phobics, mental reinstatement 
of exposure treatment led to reduced recovery of subjective fear after a context change 
compared to reinstatement of a neutral memory, though they elected not to test effects on 
heart rate or behavioral avoidance given that no return of fear was seen in those 
measures. Elsesser and colleagues (2013) found that mental reinstatement led to shorter 
approach latencies to one of three phobic stimuli a week after exposure treatment for 
dental phobia, but no effects on subjective fear or heart rate to the phobic stimuli, or 
likelihood of going through with a dental procedure (Elsesser, Wannemüller, Lohrmann, 
Jöhren, & Sartory, 2013). Finally, in a study by Laborda and colleagues (2016) on public 
speaking anxiety, there was no effect of mental reinstatement on renewal of subjective 
fear ratings.  
 One limitation of the techniques used to enhance generalization to date is that 
they neglect to fully harness the benefits that could be seen by explicitly engaging top-
down cognitive processes, and often rely on implicit methods of increasing the likelihood 
of extinction memory retrieval across different contexts. Participants undergoing 
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manipulations like training in multiple contexts (e.g., Bandarian-Balooch et al., 2015), 
attentional manipulations (Barry et al., 2017), or the use of retrieval cues (e.g. Shin & 
Newman, 2017) are largely passive recipients of training manipulations designed to 
enhance the likelihood of retrieving a memory of safety. Absent from these techniques is 
any explicit encouragement of reasoning processes or the generation of propositional 
beliefs about how such a safety memory might be relevant to a feared situation they are 
about to encounter. For example, although associating the scented neon green puffer ball 
used as a retrieval cue in Shin and Newman (2017) with a memory of safety may increase 
the likelihood of retrieving that safety memory when the puffer ball is present, its effects 
could be limited if its presence does not provide a clear reason for an individual to feel 
more safe.  
The meaning of such a cue is relevant because feared stimuli are embedded with 
meaning that goes beyond their associative strength with an aversive experience 
(DeHouwer, 2009; Lovibond, 2004), and top-down cognitive processes can influence 
associative learning processes such as extinction (Delgado, Nearing, LeDoux, & Phelps, 
2008; Hofmann, 2008). For example, extinction learning with a stimulus that is believed 
to be highly typical of a category has been shown to generalize to other members of that 
category more than an atypical member (Scheveneels, Boddez, Bennett, & Hermans, 
2017), showing that the appraisal of an extinction experience impacts the extent to which 
extinction generalization occurs. Furthermore, reappraisal of conditioned stimuli has been 
shown to reduce conditioned fear responses when applied during extinction training 
(Blechert et al., 2015) as well as without it (Shurick et al., 2012). Accordingly, targeting 
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top-down reappraisal processes in order to strengthen beliefs about the relevance of prior 
learning to diverse contexts offers a promising direction for enhancing generalization. 
The mental reinstatement technique offers some potential in this regard, as 
revisiting the outcome of prior exposure training in one’s mind could provide a 
meaningful reason to feel safe in a new exposure context at the propositional level, as 
well as enhance the automatic retrieval of the safety memory developed during 
extinction. The instructions used in the studies employing mental reinstatement, however, 
provided minimal guidance for what exactly participants should recall. Specifically, 
participants in the different studies were told to: “Remember what happened and what 
you learned last time, and where all of that took place” (Mystkowski et al., 2006; p. 52), 
“mentally retrieve the treatment session” (Elsesser et al., 2013, p. 7), or “carefully re-
imagine the sequence of events that took place last time, including what you learned and 
where all of that took place (Laborda et al., 2016, p. 906). Given such instructions, it is 
possible that participants widely varied in what exactly they recalled (no such 
information was reported in the studies), ranging from how anxious they were during the 
exposures to how accomplished they felt afterward for overcoming their fear. Such 
varying responses could have led to dramatically different expectations, anxiety levels, 
and avoidance behavior in the subsequent exposure, thereby altering effects of the 
manipulation. In addition, participants were not explicitly encouraged to reflect on or 
articulate the extent to which the learning they recalled applies to the exposure situation 
they are about to encounter. If participants were to reason about or focus their attention 
on similarities between the new and old exposure contexts, that may influence their level 
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of fear and willingness to approach the new exposure situation.  
One illustration of how a memory of an exposure experience can be shaped to 
target beliefs about future feared situations, and consequently improve outcomes, comes 
from a recent study by Raeder and colleagues (2019). Immediately after virtual reality 
exposure for height phobia, participants were instructed to reactivate the memory of 
exposure treatment, identify how the exposure experience could help them take on other 
challenges, and identify prior mastery experiences from their life that they could relate to 
the exposure treatment process. Relative to control conditions, this memory reactivation 
manipulation led to reduced subjective fear and behavioral avoidance two to three days 
later and at one-month follow-up. Although the tests of fear in this study did not involve 
a change in context or feared stimuli, thereby not speaking directly to generalization, the 
results do show how the meaning of an exposure memory can be targeted in order to 
influence return of fear. Accordingly, shaping what participants recall from a prior 
exposure and guiding them to reason about what that learning means for an exposure in a 
new context could be a meaningful way to use reinstatement techniques in order to 
maximize generalization of learning.   
Enhancing Mental Reinstatement 
Following from the above discussion, the present study sought to test an enhanced 
version of mental reinstatement procedures which involved the following modifications. 
First, while recalling their exposure memory participants were explicitly instructed to 
recall the extent to which feared levels changed and feared outcomes did not occur during 
the course of exposure training. This was done to more tightly control what participants 
 
9 
were recalling, and specifically to have them identify the aspects of prior learning that are 
theorized to be most important for long-term gains resulting from exposure therapy. 
Inhibitory learning theory posits that a mismatch between expectancies and outcome 
drives the development and retention of new non-fearful associations during exposure 
therapy (Craske et al., 2008; Craske, Treanor, Conway, Zbozinek, & Verlivet, 2014), and 
evidence suggests that altering the delivery of treatment to maximize such expectancy 
violations leads to improved outcomes (Deacon et al., 2013). Therefore, highlighting the 
extent to which expectancies were violated in a prior exposure could help to more 
effectively recall the non-threat associations previously developed, thereby decreasing 
expectations of danger and increasing confidence in coping ability in a new exposure 
situation.  
A second modification was to have participants revisit the memory of their 
exposure training while listening to audio recording of themselves (created immediately 
after training) articulating what happened during the exposure and what they learned. 
This was done firstly to further control what participants were recalling from exposure 
and to ensure they would recall the memory in an accurate and detailed manner. 
Furthermore, the audio-recording was used to enhance the believability of what 
participants learned at an affective level. Hearing their own words and expressions about 
what they took away from the training and how they felt about it, while simultaneously 
replaying that experience in their imagination, could help to more effectively reinstate the 
emotional learning associated with the training, thereby enhancing the extent to which the 
intervention targets both bottom-up and top-down processes.  
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The final modification was to have participants articulate how the learning 
recalled from the prior exposure is relevant to a subsequent exposure. This was done to 
more effectively harness top-down cognitive processes by fostering the generation of 
propositional beliefs about the likelihood of safety and one’s ability to cope. Threat 
expectancies and coping beliefs have been shown to impact acute anxiety levels during 
singular exposures (Valentiner, Telch, Petruzzi, Bolte, 1996) and throughout exposure-
based therapy (Fentz et al., 2013; Gallagher et al., 2013). Therefore, being encouraged to 
reason how prior learning about the absence of expected danger applies to a novel feared 
situation was expected to help participants to realize that feared consequences related to 
the new exposure situation are unlikely to occur.  
It should be noted that the purpose of these procedures was to maximize the effect 
that could be achieved through mental reinstatement in order to better understand this 
method’s potential for improving generalization after exposure. Including several 
different elements to this procedure necessarily reduces the level of mechanistic 
specificity that could be achieved if the intervention were to have an effect. However, 
research on exposure augmentation techniques frequently is unable to detect improved 
outcomes, and when improved outcomes are seen effects tend to be relatively modest 
(Weisman & Rodebaugh, 2018). Accordingly, this design was used based on the idea that 
it is more fruitful to focus on identifying specific mechanisms of augmentation 
techniques when it has been more firmly established that they work.  
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Application to Claustrophobia 
A wide body of research has utilized samples with specific phobias or analogue 
clinical samples with discrete fears (e.g., public speaking) to investigate augmentation 
strategies of exposure therapy such as the one currently proposed. Such clinical research 
paradigms are particularly useful from a translational perspective, enabling findings from 
basic research paradigms (e.g. fear conditioning and extinction) to be tested in a fairly 
controlled setting with relatively straightforward clinical fears that typically respond 
quickly to exposure  (Carpenter, Pinaire, & Hofmann, 2019; Scheveneels, Boddez, 
Vervliet, & Hermans, 2016).  
Claustrophobia is one of the more common specific phobias, with prevalence 
rates around 4% (Curtis, Magee, Eaton, Wittchen, & Kessler, 1998). It is defined by a 
fear of being trapped or suffocated in enclosed spaces, and has been shown to be highly 
responsive to exposure treatment in a single session (Öst, Alm, Brandberg, & Breitholtz, 
2001). Claustrophobia offers a particularly well-suited model to exposure treatment-
related processes given the ease of creating highly controlled exposure contexts and the 
existence of established single-session exposure protocols that have been widely used in 
clinical research (Deacon, Su, Lickel, & Nelson, 2010; Sy, Dixon, Lickel, Nelson, & 
Deacon, 2011; Telch et al., 2014; Telch, Valentiner, Ilai, Petruzzi, & Hehmsoth, 2000). 
Furthermore, unlike other phobias often tested in exposure analogue studies (e.g., spider 
phobia, contamination fears), it does not involve a significant disgust component, which 
is influenced more by evaluative conditioning processes and responds more slowly to 
exposure (Olatunji et al., 2009). A common claustrophobic situation that has significant 
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public health relevance is the fear of magnetic resonance imaging (MRI scans). 
Approximately 1% of patients in need of an MRI refuse or prematurely terminate a scan 
due to claustrophobia, posing a significant problem for accurate detection of many 
serious medical issues (Munn, Moola, Lisy, Ritano & Murphy, 2015). Although exposure 
therapy has major potential for helping to alleviate this problem, poor generalization from 
exposure training in a separate context to an actual MRI could limit its utility. 
Accordingly, MRI-related claustrophobia offers a target for investigating generalization 
that both has ecologically validity and relates to an important public health issue.    
Study Aims 
Primary Aim 
The primary aim of the this study was to conduct a randomized control trial 
comparing  the effect of an enhanced mental reinstatement (EMR) procedure with 
standard exposure (SE) on recovery of subjective, behavioral and physiological indices of 
claustrophobic fear during exposure to a novel feared situation one week after exposure 
training for claustrophobia. Exposure training involved repeated exposure trials lying 
inside a metal cabinet laid on the ground, and then fear-related outcomes were measured 
one week later in a mock MRI scanner following EMR or SE procedures. EMR consisted 
of 1) mentally retrieving the memory of prior exposure training, including the extent to 
which feared outcomes did not occur; 2) listening to an audio recording made by 
participants after exposure training that includes them discussing their expectancy 
violations and biggest “take-away” from the exposure training; 3) identifying the 
similarities between the two feared situations and the relevance of what they learned from 
 
13 
the prior training for the exposure they were about to undergo. EMR was compared to a 
standard exposure (SE) condition, which included equivalent exposure training 
procedures. Prior to approaching the novel claustrophobia exposure, however, SE 
participants 1) recalled a neutral memory, 2) listened to an audio recording of themselves 
narrating this memory, and 3) answered a filler question connecting the memory to events 
that happened earlier that day. It was hypothesized that EMR would lead to reduced 
subjective fear, behavioral avoidance, and heart rate reactivity during exposure  
Secondary Aims  
Aim 2A. A number of secondary outcomes were investigated in this study. For 
one, the effect of EMR vs SE on self-reported claustrophobia symptoms was examined at 
one-month follow-up. Although self-reported ratings provide less specificity for 
measuring intervention effects, symptom measures of claustrophobia can assess 
anticipated anxiety and avoidance to a wider number of situations, thereby offering an 
alternative assessment of generalization. In addition, given that claustrophobia prevents 
many patients from receiving medically indicated MRI scans, participant ratings of 
expected anxiety and likelihood of getting a real MRI scan at Visit 2 and follow-up was 
examined across conditions. It was hypothesized that the benefits of EMR compared to 
SE would extend to improved claustrophobia symptoms, expected anxiety, and likelihood 
of getting an MRI. 
   Aim 2B. This study also sought to compare the effect of EMR and SE on the 
strength of feared outcomes reported immediately prior to the novel exposure context one 
week post-training. Given that participants in the EMR condition listened to an audio-
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recording of themselves describing the extent to which their feared outcomes did not 
occur during exposure training, and were explicitly instructed to identify how their prior 
experience applied to the novel feared situation, it was expected that EMR would 
specifically decrease negative outcome expectancies regarding that novel feared situation. 
Furthermore, it was hypothesized that increased reductions in feared outcomes resulting 
from the EMR manipulation would mediate intervention effects. In addition, this study 
investigated the effect of condition on participants’ feared outcomes if they were to 
receive a real MRI scan, assessed at the end of Visit 2 and at one-month follow-up, to 
assess the durability of intervention effects.  
Aim 3A. Building on research showing the influence that top-down cognitive 
processes can have on extinction learning (Blechert et al., 2015; DeHouwer, 2009; 
Hofmann, 2008), another aim of this study was to investigate how participants’ beliefs 
about what they learned from exposure training (i.e. their biggest “takeaway”) impacted 
generalization to a novel feared situation. Investigating the relationship between the 
learning participants articulate about exposure training and subsequent outcomes can 
provide valuable information about the mechanisms driving change in exposure. In 
addition, understanding what participants take away from their exposure experience is 
particularly important for understanding the effects of any technique that attempts to 
enhance retrieval of an exposure memory, given that the effects of such retrieval may 
vary depending on the meaning associated with that memory. For instance, the retrieval 
cue study by Shin & Newman (2017) mentioned earlier found that participants who 
viewed the cue as a reminder of their anxiety during the exposure exhibited the least 
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return of fear, possibly because it reminded them that they were able to tolerate the 
anxiety that occurred in a prior exposure.  
 Research on mechanisms of change in exposure therapy offers several different 
possibilities for the types of learning that can drive symptom improvement. These include 
changes in threat appraisals (Smits, Julian, Rosenfield, & Powers, 2012), improved fear 
tolerance (Deacon et al., 2013), improved coping self-efficacy (Fentz et al., 2013; 
Gallagher et al., 2013) and fear reductions between exposures (de Kleine et al., 2017). 
This study examined the extent to which themes related to such exposure mechanisms 
were present when participants verbalized what they learned from exposure training, as 
well as when they recalled what occurred during exposure a week later during EMR 
procedures. Exploratory analyses were conducted to examine the presence of each of 
these themes as a predictor of generalization to a novel feared situation. Treatment 
condition was then examined as a moderator of the relationship between post-exposure 
takeaway and fear outcomes, since listening to such takeaways via audio-recording right 
before entering a feared situation could enhance their impact.  
Aim 3B. To further investigate the types of fear-related beliefs that impact 
generalization, this study also examined the impact of changes in different types of feared 
outcomes over the course of exposure training. Although changes in the threat appraisals, 
fear tolerance, and coping self-efficacy have each been shown to function as mediators or 
predictors of symptom improvement over the course of treatment (Smits, Julian, 
Rosenfield, & Powers, 2012; Deacon et al., 2013; Fentz et al., 2013; Gallagher et al., 
2013), such analyses provide less specificity about the aspects of a single exposure most 
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important for subsequent gains. In a study examining fear-related outcomes in a single 
claustrophobia exposure, greater coping self-efficacy, but not threat expectancies related 
to suffocation and entrapment concerns, predicted lower subjective fear and heart rate 
(Valentiner et al., 1996), but this study did not examine belief change. To examine the 
specific belief changes that are the most impactful for maintaining and generalizing 
reduced fear outcomes, the present study explored the relative effects of changes in threat 
expectancies, coping self-efficacy and fear tolerance during exposure training on 
subsequent fear-related outcomes.  
Aim 3C. A final aim of this study was to examine whether the strength of 
expectancy violations (i.e. prediction error; Rescorla & Wagner, 1972) during exposure 
training predicts fear-related outcomes in novel and familiar exposure contexts one week 
post-training, as well as self-reported outcomes at one-month follow-up. Although 
changes in threat expectancies are widely thought to be a fundamental mechanism of 
learning during exposure (Craske et al., 2008; Hofmann, 2008), and modifying treatment 
to maximize expectancy violations has been shown to fruitful (Deacon et al., 2013), 
explicit tests of the impact of expectancy violation strength on subsequent outcomes have 
only begun to emerge and have not consistently shown predicted effects. For instance, a 
study by de Kleine and colleagues (2017) found that the extent to which specific harm 
expectancies were violated during imaginal exposures was not related to PTSD symptom 
change, though measures of fear habituation were significant predictors. Two studies in 
pediatric OCD investigated discrepancy between expected and actual fear ratings during 
exposure, with one showing that fear being less than expected predicted (i.e. over-
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predictions) worse outcomes at mid-treatment, though not post-treatment (Kircanski & 
Peris, 2015), and a second showing that more variability in expected vs. actual fear, as 
well as a higher proportion of over-predictions, were associated with  predicted superior 
outcomes (Guzick, Reid, Balkhi, Geffken & McNamara., 2018). To help further clarify 
the role of expectancy violations in exposure outcomes, the present study measured 
expected vs. actual fear, discrepancy between likelihood of greatest feared outcomes and 
their occurrence, and surprise about feared outcome occurrence throughout exposure 
training, and these variable were examined as predictors of fear-related outcomes in a 
novel exposure context.   
Methods 
Experimental Design 
 A schematic of the experimental design can be seen in Figure 2. During the initial 
visit participants in both conditions completed a pre-training behavioral approach test 
(BAT; which also served as the final assessment of eligibility), exposure training, and a 
post-training BAT all in context 1 (a horizontal metal cabinet). Prior to the pre-training 
BAT (BAT 1A), baseline heart rate data and state anxiety were measured. Following 
BAT 1A, participants completed a battery of self-report questionnaires and audio 
recorded a neutral memory. After exposure training, an audio recording was made of 
participants orally reviewing their change in fear and feared outcomes and verbalizing 
their biggest “takeaway” from the training. At Visit 2, one week after exposure training, 
baseline heart rate, state anxiety and self-reported claustrophobia symptoms were 
measured again. Participants were then block-randomized to either Standard Exposure 
 
18 
(SE) or Enhanced Mental Reinstatement (EMR), and underwent condition-specific 
procedures prior to a BAT conducted in a mock MRI scanner (BAT 2) in a different 
location from Visit 1. Randomization was done in blocks of 4 and 6 and stratified by 
participant type (university student vs. community) using the web-based service Sealed 
Envelope, with condition revealed only when participants arrived at Visit 2. Primary 
outcomes included subjective fear, behavioral approach (i.e. time spent in mock MRI) 
and heart rate during BAT 2. Secondary outcomes included self-reported claustrophobia 
symptoms, feared outcomes, and expected fear of a real MRI scan at Visit 2 and one-
month follow-up. 
Participants 
Participants consisted of adults (n = 45) recruited through postings on university 
student job sites, Craigslist and email list-serves of local hospitals. In addition, patients at 
BU’s Center for Anxiety and Related Disorders who received a diagnostic assessment 
indicating clinical levels of claustrophobia and reported interest in research were 
contacted about the study. Participants received $75 for their participation. The 
CONSORT diagram outline participant screening, randomization and study completion 
can be seen in Figure 1.  
Inclusion criteria included: 1) being 18–75 years of age; 2) self-reported fear of 
enclosed spaces at a moderate or greater level (≥2 on a 0–4 Likert scale); 3) expected fear 
of being in an MRI machine at a moderate or greater level (≥2 on a 0–4 Likert scale); 4) 
peak self-reported fear during a behavioral approach test (BAT) in a claustrophobia 
chamber (i.e. a horizontal metal cabinet) of ≥50 of 100. Participants with peak fear <50 
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who exited the cabinet before for the end of the two-minute BAT for fear-related reasons 
were also deemed eligible. See the Procedure section for further details on the screening 
process.  
Exclusion criteria included: 1) presence of a medical condition (i.e., pregnancy, 
cerebrovascular disease, cardiovascular disease) that contraindicated participation in 
claustrophobia exposures; 2) physical condition preventing individuals from being able to 
safely enter the claustrophobia chamber, including individuals weighing >350 lbs (the 
weight limit for the mock MRI used in this study), and 6’4” (the length of the inside of 
the claustrophobia chamber); 3) prior exposure therapy for claustrophobia-related 
concerns; 4) presence of bipolar disorder, psychotic disorder, or cognitive dysfunction 
likely to impair participation in study activities; 5) refusal to enter the claustrophobia 
chamber during the initial BAT. In addition, participants who took as-needed medication 
(e.g. benzodiazepines, beta blockers) for anxiety were asked to refrain from taking 
medication the day of the study visit until after study procedures had been completed.  
The sample was racially/ethnically diverse, with 40% identifying as Asian, 36% 
White/Caucasian, 18% Black/African-American, 4% Latinx and 2 % multiracial. Females 
made up 64% of the sample, mean age was 29.2 (SD = 12.3), and 58% of participants 
were students (graduates or undergraduates). Demographics for each study condition can 
be seen in Table 1, and baseline clinical variables are in Table 2. Thirteen percent of the 
sample was taking psychiatric medication and 84% met DSM-5 diagnostic criteria for 




Screening Process. The screening procedure in this study was based on that of 
previous studies examining exposure training for claustrophobia (Kamphuis & Telch, 
2000; Powers et al., 2008; Sloan & Telch, 2002; Telch et al., 2004; Telch et al., 2014). 
Potential participants were first screened on the phone for eligibility, which included 
being asked to rate on their overall fear of enclosed spaces on a 5-point Likert scale (0 = 
no fear, 1 = mild fear, 2 = moderate fear, 3 = severe fear, 4 = extreme fear). They also 
were provided a description of the mock MRI scanner used during BAT 2 and asked how 
much fear they would experience if they were to enter the scanner using the same scale. 
Those who reported a 2 or above on both questions and did not meet any exclusion 
criteria were invited in to the laboratory. Following the consent process, state anxiety was 
measured so ratings would not be affected by having entered the cabinet during BAT 1. 
Next, participants were outfitted with a heart rate monitor and baseline heart rate data 
was collected while resting in seated position for a five-minute period. Participants were 
then instructed to complete BAT 1. Those who experienced a peak fear level of 50 or 
greater (out of 100) were eligible to participate in the rest of the study. In addition, 
participants who requested to leave the cabinet prior to the 2-minute time limit for any 
fear-related reason (e.g., couldn’t tolerate their anxiety, felt like they couldn’t breathe, 
etc.) were also deemed eligible.  
Behavioral Approach Test 1 (BAT 1). For BAT 1, participants were first shown 
the claustrophobia chamber, which consists of a metal cabinet measuring 6.5’ x 4’ x 1.5’ 
laid on the ground (see Figure 2). The surface participants laid on was lined with foam 
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padding, and one side of the cabinet was lined with boxes so that the open space was 
three feet wide.  Participants were told they would be asked to lie down inside the cabinet 
on their backs, at which point the experimenter would shut the cabinet doors. They were 
also instructed that the goal of the task was to remain inside the cabinet for as long as 
they could, but if they wanted to leave they could tell the experimenter, who would 
remain in the room, and would be let out immediately. Participants were made aware that 
when the task was over the experimenter would open the doors and let them out, but were 
not told the maximum length of the task, which was 2 minutes. After these instructions 
were given, participants completed a series of questions about their fears and 
expectations for the task, and then instructions were reiterated prior to entering the 
cabinet. BAT 1 was conducted prior to exposure training (BAT 1A) and after the training 
was completed (BAT 1B).  
Pre-Exposure Procedures. Following BAT 1A, participants underwent a 
diagnostic interview assessing DSM-5 criteria for specific phobia of claustrophobia, and 
completed the remainder of the self-report questionnaires, and then created an audio 
recording of a neutral memory. Specifically they were asked to recall what they did for 
the first 30 minutes when they got out of bed that morning, and rate the degree of 
negative and positive emotion associated with this memory on a 5-point Likert scale (0 = 
none, 1 = a little , 2 = moderate, 3 = quite a bit, 4 = extreme). Participants with a rating of 
0 or 1 for both emotions were then asked to recount the memory out loud step by step 
while being audio-recorded. Participants whose memory elicited a rating of  >1 for either 
negative or positive emotion were then instructed to identify a different memory from the 
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previous 24 hours that met the positive and negative emotion criteria, and was also 
something they did on a daily basis (e.g. what they did before going to bed). An audio-
recording was made while they recited the detail of this memory.  
Exposure Training. Participants first viewed an eight-minute video of a clinician 
who was not an experimenter for the study describing the rationale for exposure as a 
method for overcoming claustrophobia (see Appendix A for text of rationale). The video 
began with psychoeducation about the role of avoidance and threat-related beliefs in the 
maintenance of claustrophobia, and how phobias act like a false alarm, making a person 
feel like there is danger present when in fact they are safe. It was then explained how 
repeatedly remaining in the situation for an extended period of time provides the 
opportunity to see that the situation is safe and tolerable, that one’s expectations of 
danger are exaggerated, and that anxiety tends to go down over time. The video also 
explained the procedures of exposure training conducted in this study, emphasizing the 
importance of remaining in claustrophobia chamber for the duration specified by the 
experimenter in order to successfully overcome one’s fear.  
Following the procedures by Telch and colleagues (Kamphuis & Telch, 2000; 
Powers et al., 2008; Sloan & Telch, 2002; Telch et al., 2004; Telch et al., 2014), the 
exposure training itself consisted of six 5-minute exposure trials. During these trials, 
participants lay on their backs in the cabinet with the doors closed in the same manner as 
during BAT 1, except they were asked to stay in the cabinet for 5-minute intervals. They 
were also instructed to not engage in any avoidance behaviors like closing their eyes or 
pretending they were somewhere else, and instead try to simply observe the situation 
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around them and attend to whether their feared outcomes were actually occurring. If 
participants were unwilling to stay in the cabinet for the full 5-minute period initially, the 
time during later exposures when participants were more comfortable was increased so 
that each participant spent a full 30 minutes in the closet. This occurred for just three 
participants.  
Prior to each trial, participants rated their degree of concern about various feared 
outcomes, as well as the predicted likelihood that their three greatest feared outcomes 
will occur (see details in Measures section). They also rated their current and expected 
fear levels. After each trial, participants rated their peak and end fear levels, as well as the 
extent to which their feared outcomes occurred and how surprised they were about each 
outcome. The experimenter also checked in about any avoidance behaviors the 
participant may have been engaging in, and provided coaching on how to act counter to 
such urges to avoid. Participants then rated their feared outcomes and expected fear levels 
for the next exposure trial.  
Post-Exposure Training. After the final exposure trial, the experimenter helped 
the participant complete the Post-Exposure Review form (see Appendix C), in which they 
reviewed 1) what happened during the exposure training, including how their fear levels 
and concern and expectancy ratings for their three most feared outcomes changed, and 2) 
their biggest “take-away” from the training (i.e. the most important thing they learned). 
Then, participants made an audio recording of themselves verbalizing what they had just 
reviewed on the form. After this exercise, participants entered the cabinet one final time 
for BAT 1B.    
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 Visit 2 Procedures. Visit 2 occurred one week after the first visit, plus or minus 
one day, at the Boston University Medical Campus’s Center for Biomedical Imaging, 
which was in a different campus compared to Visit 1. Participants completed measures of 
state anxiety and claustrophobia symptoms, and baseline heartrate data were recorded 
while seated over the same 5-minute period as Visit 1. The experimenter then showed 
participants the mock MRI scanner they would be entering, explained the nature of BAT 
2, and then took participants to a separate room for condition-specific procedures. After 
BAT 2, participants answered a final set of questionnaires.  
 Enhanced Mental Reinstatement (EMR). Following the introduction of the 
BAT 2, EMR participants were be taken to another room and asked to close their eyes 
and re-imagine what took place during their exposure training one week before. 
Specifically they were told to recall out loud 1) where they were, 2) how their fear levels 
and feared outcomes changed and why, and 3) what they learned from the training. Next, 
participants were instructed to continue to keep their eyes closed and keep the memory of 
the training in mind while listening to the audio recording they made the prior week 
about what happened and what they learned through exposure training at the first visit. 
Following this, participants completed vividness, perspective, affect ratings. Finally, the 
experimenter assisted participants in completing a worksheet in which they write down 
all the ways in which the situation they just recalled in their memory was similar to the 
mock MRI scanner they were about to enter, including similarities about the space itself 
as well as the types of fears elicited. They were explicitly instructed to focus only 
similarities. Next, participants were instructed to identify how what they learned in the 
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prior exposure training was relevant to the situation they were about to enter. They then 
spoke out loud what they had written on the worksheet. All participant responses during 
this time were audio-recorded for further analysis.  
Standard Exposure (SE). The pre-BAT 2 procedures of the SE group were 
designed to mimic those of the EMR group as much as possible. After the introduction of 
the BAT 2 procedures, participants in the SE condition were taken to another room and 
reminded of the neutral memory they recorded at Visit 1. They were asked to close their 
eyes and imagine what took place during that memory in as much detail as possible, 
saying out loud exactly what they remembered. Next, they listened to the audio recording 
made the week before of them recalling this event while continuing to hold their memory 
in mind, and afterward completed the same vividness and affect questions as the EMR 
group. Following this, participants wrote down and then verbalized all the ways in which 
what happened the morning of the experiment (or whatever neutral memory had been 
recalled) was similar to what had happened the morning of Visit 2 (or equivalent, if a 
different memory). As in EMR, participant responses during SE procedures were audio-
recorded.  
Behavioral Approach Test 2 (BAT 2). BAT 2 took place in a decommissioned 
3T MRI scanner used to accustom individuals to an MRI machine prior to a real scan (see 
Figure 2). Participants lay on a stretcher with their head held in place by plastic siding, 
and the experimenter slid the stretcher in to the tube of the mock scanner until the 
participant’s entire upper body was inside enclosed. The opening of the scanner had a 
diameter of 60 cm, and the back side was covered with opaque plastic so the only light 
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coming in to the tube was from the direction of the participants’ feet. Following the same 
procedures as BAT 1, participants answered questions about their feared outcomes and 
current fear levels prior to entering the scanner. They were given the same instructions as 
BAT 1A and BAT 1B about remaining in the tube for as long as they were willing, but if 
they became too uncomfortable, the experimenter would remove them from the scanner 
immediately. In order to reduce the likelihood of ceiling effects for time spent in the 
mock scanner, the maximum time before participants were removed was increased to 10 
minutes (compared to two minutes during BAT 1). In addition, every two minutes 
participants were asked their current fear level, and then told that if they remained in the 
willing to stay they will be moved another 6 inches in to the scanner. After participants 
exited the tube, they completed a rating of their maximum and end fear levels.  
One-month Follow-up. One month after visit 2, participants were sent a series of 
questionnaires via email that assessed claustrophobia symptoms, severity of feared 
outcomes if they were to undergo an MRI scan, and likelihood and expected fear of 
receiving an MRI scan.  
Outcome Measures 
Subjective Fear. Participants rated their subjective fear on a scale from 0 to 100, 
with anchors of 0 (no fear), 25 (mild fear), 50 (moderate fear), 75 (strong fear), and 100 
(extreme fear/panic). Immediately upon exiting the claustrophobia chamber during BATs 
and exposure trials, participants rated their maximum level of fear while in the chamber, 
and their fear at the end of the trial (before knowing they were about to exit). Peak and 
end fear were highly correlated and initial analyses examining the two measures 
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separately were consistently similar, so analyses focused on peak fear. Prior to each BAT 
and exposure trial, participants also rated their current fear and expected fear for entering 
the enclosed space. 
Behavioral Avoidance. Time until each participant requested to exit each of the 
BAT tasks, if relevant, was also recorded an indicator of behavioral avoidance.  
Heart Rate Reactivity. Heart rate was measured continuously throughout the 
experiment via the Zephyr BioModuleTM (Zephyr Technology Corp, Annapolis, MD, 
US), an ambulatory heart rate monitor that attaches to the chest via skin conductive 
electrodes. The device measures heart rate via electrocardiography (ECG) and has been 
shown to produce reliable and valid measurements of heart rate across a variety of 
contexts (Nazari et al., 2018). Sampling rate for ECG data was 1000 Hz. Artifact 
detection was conducted automatically using Kubios Version 3.1 Premium (Tarvainen, 
Niskanen, Lipponen, Ranta-Aho, & Karjalainen, 2014), and then was inspected manually 
and any additional corrections necessary were made. Mean heart rate data were extracted 
for baseline and BAT periods from Visits 1 and 2. Heart rate during BATs was adjusted 
for baseline by calculating the difference between mean heart rate during each BAT and 
the corresponding baseline period, and then adding that value to the mean baseline heart 
rate for the sample. This baseline-adjusted heart rate variable was used in analyses.  
The Claustrophobia Questionnaire (CLQ). The CLQ (Radomsky, Rachman, 
Thordarson, McIsaac, & Teachman,, 2001) is a 26-item assessment of claustrophobia 
symptoms. Participants are asked to rate how anxious they would feel on a 5-point Likert 
scale (0 = not at all anxious, 4 = extremely anxious) in situations eliciting concerns about 
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suffocation (e.g. “Using an oxygen mask”) and restriction (e.g. “Locked in a small dark 
room without windows for 15 minutes”), the two components of fear thought to underlie 
claustrophobia (Rachman & Taylor, 1993). The CLQ has demonstrated strong predictive 
and discriminant validity, along with good internal consistency and test-retest reliability 
(Radomsky et al., 2001). Given the importance of avoidance of feared situations in 
anxiety psychopathology, participants were also asked how much they would want to 
avoid each of the 26 situations listed in the CLQ from 0 (no desire to avoid) to 4 (avoid at 
all costs). The CLQ was administered at after eligibility screening, the beginning of Visit 
2 prior to randomization, and at one-month follow-up. Internal consistency in the present 
study was excellent at all three time points, both for fear and avoidance subscales 
separately and combined (α = .92 – .96). 
Claustrophobic Expectancies Questionnaire (CLEQ). The CLEQ (see 
Appendix B) is a measure adapted for this study assessing respondents concern about 20 
possible feared outcomes for a claustrophobic situation. It consisted of four items 
regarding concerns about suffocation (e.g. “I might start to choke”), four items regarding 
entrapment concerns (e.g. “I might not be able to escape if I had to”), and four items 
regarding coping self-efficacy (e.g. “I won’t be able to tolerate to my fear”), all of which 
were adapted from the Claustrophobic Concerns Questionnaire (Valentiner, Telch, 
Petruzzie, & Bolte, 1996). Also included were four items regarding loss of control (e.g. “I 
might lose control”) adapted from the Claustrophobia General Cognitions Questionnaire 
(Febbraro & Clum, 1995), and four items regarding fear tolerance (e.g. “The feelings of 
fear might be unbearable to me”) adapted from the Distress Tolerance Scale (Simons & 
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Gaher, 2005). The intent in creating this questionnaire was to generate a wide variety of 
possible feared outcomes for individuals with claustrophobia in order to increase the 
likelihood of accurately capturing participants’ greatest specific concerns, and enable 
them to be tracked throughout the exposure training. From this scale, three subscale 
scores were created based on item averages: 1) threat expectancies (based on suffocation, 
entrapment, and loss of control items), 2) coping self-efficacy, and 3) fear tolerance.  
Items were rated on a scale from 0 (no concern) to 100 (extreme concern). In 
addition, the highest-rated feared outcome from each CLEQ subscale was selected, and 
participants indicated how likely they believed each outcome was to occur (0% to 100% 
likelihood). The CLEQ was administered prior to all BATs and prior to the first and last 
trials of exposure training. Also before exposure trials 2 through 5, participants tracked 
their top-rated feared outcomes from the initial exposure by continuing to complete 
concern and likelihood ratings with regards to the next exposure. Internal consistency for 
the full scale was excellent across time points (α = .92 – .96), with subscale reliability 
being strong as well: Threat Expectancies: (α = .86 – .91), Coping Self-Efficacy, (α = .78 
– .90), and Fear Tolerance (α = .83 – .94). 
MRI Expectancies, Fear and Likelihood. After BAT 2 and at one-month 
follow-up, participants were asked how likely they would be to get a medically indicated 
MRI from 0 (definitely would NOT get it) to 100 (definitely WOULD get it). They were 
then asked to imagine they were to undergo a real MRI scan. They were told this would 
involve being in the same type of scanner they were in during the study, but that it would 
last 30–40 minutes and there would be no one in the room with them, though they could 
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press a button to tell the MRI technician they wanted to leave. Participants then rated 
their maximum expected fear while in the scanner with the same 0–100 scale used during 
BATs, as well as the feared outcome items from the CLEQ (CLEQ-MRI). Participants 
also rated fear and likelihood of getting a medically indicated MRI scan at baseline.  
Claustrophobic Expectancy Violations. After each exposure, participants rated 
the extent to which their top feared outcomes occurred on a scale from 0 (not at all) to 
100 (completely), and how surprised they were at the extent to which it occurred from 0 
(not at all surprised) to 100 (completely surprised) (see Appendix B). For surprise ratings, 
the experimenter asked participants whether they were surprised that their feared 
outcome occurred more or less than expected, and if participants reported it happened 
more than expected, ratings were given a negative value. Surprise ratings, the difference 
between likelihood and occurrence scores, and the difference between concern and 
occurrence scores (see De Kleine, et al., 2017) were initially investigated as indicators of 
expectancy violations. In addition, the difference between expected and actual fear was 
examined as an additional possible indicator, as has been done in previous literature 
(Guzick et al., 2018; Kircanski & Paris, 2015). Because correlations between likelihood 
and concern rating at each exposure were quite high (r > .60), however, concern-
occurrence discrepancies were not included in the analysis. Values for each feared 
outcome from the CLEQ (Threat Expectancies, Coping Self-Efficacy, and Fear 
Tolerance) over the course of six exposure trials were averaged in an attempt to capture 
the total  expectancy violation throughout training. Because the exposure scenarios were 
identical throughout training and the potential for surprise at the outcome of repeated 
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exposures was likely to decline, expectancy violations during the first exposure were also 
examined. Expectancy violations for each type of feared outcome were not combined for 
analysis in order to comparatively examine violation of different beliefs, and also because 
internal consistency for discrepancy scores was in the questionable range (α = .62–.63).  
Additional Measures  
Composite International Diagnostic Interview (CIDI). The CIDI is a structured 
clinical interview commonly used in clinical and research settings to efficiently assess 
diagnostic criteria of psychological disorders (World Health Organization, 1997). The 
experimenter administered only the specific phobia module in this study to assess 
claustrophobia. Although designed for assessment of DSM-IV criteria, criteria for 
specific phobia in DSM-5 were essentially unchanged, and responses were evaluated with 
regard to DSM-5 criteria. The anxiety disorder module of the CIDI has demonstrated 
good psychometric properties, including good sensitivity (.86) and acceptable specificity 
(.52) (World Health Organization, 1997). 
State-Trait Anxiety Inventory (STAI). The 6-item version of the STAI-state 
(Marteau & Bekker, 1992) was used as a brief measure of state anxiety at the beginning 
of Visits 1 and 2, whereas the 20-item version of the STAI-trait (Spielberger, Gorsuch, & 
Lushene, 1970) was used to characterize the degree of trait anxiety present in the sample. 
Internal consistency in this study was strong for the STAI-trait (α = 0.92), as well as for 
the STAI-state at Visit 1 (α = 0.83) and Visit 2 (α = 0.86).  
Anxiety Sensitivity Inventory-3 (ASI-3). The ASI-3 (Taylor et al., 2007) 
measures the extent to which respondents are afraid of anxiety-related sensations, and 
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contains three subscales: physical concerns, social concerns, and cognitive concerns. The 
ASI-3 was administered at baseline only. Internal consistency in this sample was high (α 
= 0.89). 
Distress Tolerance Scale (DTS). The DTS (Simons & Gaher, 2005) is a 15-item 
scale measuring respondents’ perceived ability to tolerate emotional distress, 
administered at baseline in this study. Internal consistency in this study high (α = 0.90).  
Vividness of Visual Imagery Questionnaire (VVIQ). The VVIQ (Marks, 1973) 
measures the strength of respondents’ mental imagery. Respondents are asked to close 
their eyes and form an image of sixteen different scenes, and then rate the vividness of 
the mental image on a scale from 0 (no image at all, you only “know” that you are 
thinking of the object) to 4 (perfectly clear and as vivid as normal vision). Internal 
consistency in this study was high (α = 0.89). This same scale was used for participant 
ratings of vividness of the exposure or neutral memory recalled during EMR or SE. 
Memory Perspective Rating. After revisiting either the neutral or exposure 
memory, participants were asked to rate the extent to which they recalled the memory 
from an ‘observer’ perspective (i.e. viewing from the outside) or ‘field’ perspective (i.e. 
viewing through one’s own eyes) on a Likert scale from -3 (strong field perspective) to 3 
(strong observer perspective) (Wells, Clark, & Ahmad, 1998).   
Credibility and Expectancy Questionnaire (CEQ). The CEQ (Devilly & 
Borkovec, 2000) is a 6-item instrument designed to assess respondent’s assessment of the 
credibility of a treatment they are about to receive, as well as their expectations for 
success. Participants completed the CEQ after watching the video explaining the rationale 
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for exposure treatment, before the first exposure. Internal consistency in this study was 
high (α = 0.91). 
Positive and Negative Affect Scale – Short Form (PANAS-SF). The PANAS-
SF (Kercher, 1992) is a commonly used scale consisting of five items measuring positive 
affect and five items assessing negative affect. The scale was administered immediately 
after the participants went through EMR or SE procedures to determine whether the 
memory recall procedures led to any immediate differences in affect across condition. 
Internal consistency was adequate for both the positive (α = 0.76) and negative scales (α 
= 0.80). 
Exposure Training Thinking. After participants completed BAT 2, they 
answered questions about how much they thought about the exposure training when 
approaching the mock MRI and when inside on a scale from 0 (not at all) to 100 (the 
entire time). If they answered a response other than 0, they were prompted to write a 
sentence or two about what specifically they thought about. Responses were coded yes/no 
for whether the participant described either something they learned from the exposure 
training or reported using the memory to help them feel less anxious.   
Coding of Audio-recordings 
 Audio-recordings made after exposure training and during EMR procedures were 
transcribed and then coded for the presence of statements related to possible mechanisms 
driving change in exposure therapy. Specifically, transcriptions from both post-exposure 
audio-recordings and the portion of EMR audio-recordings in which they recalled prior 
exposure training (i.e. exposure recall) were coded for statements pertaining to: 1) 
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Coping Self-Efficacy, 2) Fear Tolerance, 3) Threat Reappraisal/Safety, 4) Fear 
Reduction, and 5) Generalization. For EMR audio-recordings only, a dimensional Fear 
Recall rating was also made, which assessed the amount of attention paid to experience 
of fear during recounting of exposure experience. This was done given evidence that 
mental rehearsal of feared stimuli can lead to sustained fear responses (Dadds, Bovbjerg, 
Redd & Cutmore, 1997; Joos, Vansteenwegen, & Hermans 2012), which could negate the 
effects of the EMR manipulation in this study. Definitions, example statements and 
interrater reliability ratings for the coding categories can be seen in Table 3, with full 
coding guidelines in Appendix D. Two independent raters were trained on the coding 
procedures using five transcriptions, and then the remaining transcriptions were rated 
separately. Discrepancies were resolved by consensus of the two raters. 
Data Analytic Approach 
 Data were analyzed using SPSS 26.0. Prior to running the primary analyses, EMR 
and SE groups were compared on baseline clinical and demographic variables using Chi-
Square for categorical variables and independent-samples t-test for continuous measures. 
A series of 2 x 2 mixed effects ANOVAs with time as a within-subject factor and 
condition as a between-subject factor were then used to examine equivalence of treatment 
effects across condition (pre-randomization) on subjective fear, behavioral avoidance, 
and heart rate during pre- and post-exposure training BATs, as well as Visit 1 and Visit 2 
CLQ scores. One-way ANOVAs were also used to test for differences in main outcome 
variables between BATs (collapsing across condition), in order to test for return of fear 
after exposure training. Partial-eta squared (ηp2), which represents the portion of variance 
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explained by the predictor after excluding other predictors, was reported as an effect size 
for ANOVAs.  
 For the study’s primary aim, the effect of condition (EMR vs. SE) on peak fear 
and heart rate during BAT 2 was tested using hierarchical linear regression, entering each 
at outcome at BAT 1B and Visit 2 STAI-S as predictors in the first step, and condition at 
the second step (SE coded as 0, EMR coded as 1). For behavioral avoidance, a survival 
analysis was performed using Cox regression to predict the relatively likelihood of exit 
from the mock MRI scanner for EMR vs. SE (i.e. the hazard ratio [HR]) over the course 
of the 10 minutes of the BAT, while controlling for relevant covariates. Because no 
participants exited early from BAT 1B, a categorical variable was created to indicate 
whether a participant exited early from BAT 1A, and was used to control for baseline 
behavioral avoidance.  
For secondary outcomes (Aims 2A and 2B), linear regression was used to 
examine the effect of condition on CLQ scores at one-month follow-up, controlling for 
CLQ at Visit 2 (pre-randomization). The effect of condition was also examined on Visit 2 
(post-BAT 2) and one-month follow-up CLEQ-MRI scores, controlling for CLEQ at 
BAT 1B (as CLEQ-MRI was not administered pre-randomization), and MRI fear and 
likelihood ratings, controlling for at baseline (as these ratings were not made post-
exposure training). Furthermore, the effect of EMR vs. SE was investigated on CLEQ 
scores (concern and likelihood ratings) prior to BAT 2, controlling for CLEQ at BAT 1B.  
A number of exploratory analyses were conducted in this study as part of Aims 
3A–3C, so the analytic approach for these aims attempted to balance the Type I error 
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risks inherent to running a large number of tests, while still thoroughly examining 
possible relationships impacting exposure outcomes. To do so, predictions of BAT 2 
outcomes by exposure takeaways and their interaction with treatment condition (Aim 3A) 
as well as expectancy violation variables (Aim 3C) were entered in to a stepwise linear 
regression set to retain all predictors at p < .05 and exclude predictors at p > .10. 
Stepwise regression uses an automatic model-building process that adds predictors one at 
a time based on the amount of additional variance explained, and thus offers an efficient 
method of balancing parsimony and model fit. Given that such an approach has received 
some criticism for producing findings that are generalizable across samples (Mundry & 
Nunn, 2009; Thompson, 1995), simultaneous regression was used as a secondary 
approach, with results presented in the text when they substantially differed, or footnoted 
when they were similar. For the stepwise regression, moderator analyses for post-
exposure takeaways were run with all main effects entered first, and then all interactions 
with treatment condition were added in a stepwise manner. Because using so many 
predictors compromises degrees of freedom, interaction terms with p < .10 were re-run in 
a model without the other main effects to get a more accurate assessment of effect size 
and significance. For expectancy violation variables (Aim 3C), predictors were grouped 
and entered into stepwise regression based on measure time-point (i.e., initial exposure or 
all exposures). Significant predictors of BAT 2 fear outcomes were then tested in a 
separate model to examine whether effects extended to CLQ scores at Visit 2 and one-
month follow-up.  
When analyzing exposure recall themes among participants randomized to EMR, 
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point bi-serial partial correlations accounting for BAT 1B variables were used to 
preliminarily examine relations with fear outcomes. For simplicity of presentation, 
relationships between change in CLEQ scores and fear outcomes at Visit 2 (Aim 3B) 
were also analyzed using partial correlations, controlling for outcomes at BAT 1B.  
Throughout analysis assumptions of linear regression were tested, including 
normality, homoscedasticity and independence of residuals, absence of multicollinearity, 
and the presence of outliers. Data were consistently suitable for linear regression. The 
squared semi-partial correlation coefficient (sr2), which represents the unique portion of 
variance explained by the predictor, was used as an indicator of effect size for regression 
analyses. 
Missing data. No data were missing for self-report or behavioral variables. Due 
to equipment failure, heart rate data was not collected for two participants (one SE, one 
EMR), and 10 participants had one or two baseline or BAT periods with unusable data 
resulting from a poor-quality ECG signal. Across participants with any heart rate data, 
9.7% of values were missing. To address this, first Little’s missing completely at random 
test (Little, 1988) was used to determine whether missingness of data was related to any 
variables being examined in the study. Although this test was not significant, χ2 (24) = 
23.65, p = .48, indicating that were missing completely at random, multiple imputation 
was used to generate plausible values for the missing heart rate data and preserve power. 
The model used to generate such values included the mean, maximum and standard 
deviation of heart rate at each BAT and baseline period, as well as several additional 
periods of heart rate data not directly analyzed in this study, specifically the first and last 
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exposure in the closet and a two-minute period for and after each BAT. In addition, fear 
ratings and duration of BATs, state anxiety and experimental condition were included as 
predictors given their potential relationships with heart rate during a BAT. Fully 
conditional specification (van Buunen, 2007) was used to handle instances of multiple 
missing variables, and twenty iterations of complete data sets were generated and 
analyzed, with effects pooled to create a single set of results. As recommended by Sterne 
et al., (2009), we conducted sensitivity analyses to compare results of the imputed data 
set with the original data, and report results in a footnote below.  
 Power Analyses: The mental reinstatement procedure by Mystkowski and 
colleagues (2006), which led to significantly reduced subjective fear levels after a context 
change compared to a control condition, resulted in a partial eta squared of 0.15, 
indicative of a large effect (Cohen, 1988). Conservatively assuming a medium-to-large 
effect size (f2 = 0.25) and power = 0.80, a power analysis conducted with G*Power 
indicated that a sample size of 34 would be sufficient to detect a significant effect. A 
minimum sample size of 40 was planned for in order to increase power to detect a smaller 
effect and investigate potential moderators, and data collection was continued until no 
longer feasible. A post-hoc sensitivity analysis indicated that with the current sample 
size, controlling for an additional covariate (STAI-S), the study had power = .80 to detect 




Baseline Characteristics and Overall Response to Exposure Training 
 Demographics across condition can be seen in Table 1, with baseline clinical 
characteristics seen in Table 2. No baseline differences were found for any demographic 
or clinical variables.  
With regard to effects of exposure training, means and standard errors of BAT 
Fear across Time and Condition can be seen in Figure 3. A 2 x 2 mixed-effects ANOVA 
showed a main effect of Time on BAT Fear during Visit 1, F(1,43) = 598.78, p < .001, 
ηp2 = .93, such that fear at BAT 1B (M = 8.18, SE = 1.78) was significantly reduced 
compared to BAT 1A (M = 73.59, SE = 2.18), with no significant effect of Condition, 
F(1,43) = 2.94, p = 0.10, ηp2 = .06, or Time by Condition interaction, F(1,43) = 0.35, p = 
0.85, ηp2 = .00. Similarly, there was a significant main effect of Time on heart rate, 
F(1,41) = 55.23, p < .001, ηp2 = .57, showing a decrease from BAT 1A (M = 77.01, SE = 
1.36) to BAT 1B (M = 68.80, SE = 1.29), but no significant effect of Condition, F(1,41) = 
1.17, p = .29, ηp2 = .02, or Time by Condition interaction, F(1,41) = 1.52, p = .22, ηp2 = 
.04. For behavioral avoidance, all participants remained in the closet for the full two 
minutes at BAT 1B, in contrast to BAT 1A in which eight SE participants (35%) and 
three EMR participants (14%) exited early (not significantly different, Fisher’s Exact 
Test, p = 0.17). There was a significant main effect of Time on BAT duration, F(1,43) = 
8.72, p = .005, ηp2 = .17, but again no effect of Condition, F(1,43) = 0.21, p = .89, ηp2 = 
.00, or Time by Condition interaction, F(1,43) = 0.21, p = .89, ηp2 = .00. In sum, exposure 
training led to significant and large improvements in subjective fear, heart rate and 
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behavioral avoidance, with no differences in response to exposure across conditions.  
 At Visit 2, CLQ scores (M = 95.18, SE = 5.60) from prior to randomization 
showed a similarly large and significant reduction compared to scores pre-exposure 
training from Visit 1 (M = 120.33, SE = 5.23; F[1,43] = 23.06, p < .001, ηp2 = .35). No 
main effect of Condition, F(1,43) = 0.02, p = .89, ηp2 = .00, or Time by Condition 
interaction, F(1,43) = 0.93, p = .34, ηp2 = .02, was found. However, there was a 
significant difference in state on the STAI-S at the beginning of Visit 2, t(43) = -2.11, p = 
.04, d = 0.63, indicating that at the beginning of Visit 2 (prior to all other Visit 2 
procedures other than baseline heart rate measurement), EMR participants (M = 42.58, 
SE = 2.75) endorsed greater levels of state anxiety than SE participants (M = 34.93, SE = 
2.36). Accordingly, STAI-S was controlled for in subsequent analyses examining the 
effect of condition.1 There was no significant difference in baseline heart rate at visit 2, 
t(41) = 1.82, p = .55, d = 0.05. 
 Return of Fear. To examine the extent to which the change in context from BAT 
1 to BAT 2 led to a return of fear across conditions, one-way ANOVAs were conducted 
on fear ratings and heart rate across all three BATs. Results showed significant 
differences across time-points in fear, F(1.54, 67.78) = 140.69, p = <.001, ηp2 = .76, and 
heart rate F(1.51, 66.20) = 27.68, p = <.001, ηp2 = .40. Paired-samples t-tests indicated 
 
1 Although controlling for baseline differences in randomized trials is a common practice (Austin, 
Manca, Zwarenstein, Juurlinnk, & Stanbrook), it is not without its critics (e.g., de Boer et al., 2015). 
Given the relatively limited power in this study and the potential for an additional covariate to reduce 
significance by removing degrees of freedom, analyses were also run without controlling for STAI-S 
at Visit 2. Except as noted in the text, results did not differ in statistical significance, and in most 




fear rating at BAT 2 (M = 44.04, SE = 4.29) was significantly greater than at BAT 1B, 
t(44) = 8.35, p < .001, d = 1.25, and significantly lesser than at BAT 1A, t(44) = 8.35, p < 
.001, d = 0.98. Similarly, heart rate at BAT 2 (M =72.21, SE = 1.27) was significantly 
greater than BAT 1B (M = 68.80, SE = 0.92; t(42) = 2.21, p = .03, d = 0.34), and 
significantly lower than BAT 1A (M = 77.01, SE =0.97; t(42) = 3.96, p < .001, d = 0.61).  
Primary Aim: Effects of Treatment Condition on Fear Outcomes at BAT 2 
 Results of the full regression models predicting fear rating and heart rate can be 
seen in Table 4. Controlling for BAT 1B Fear2 and STAI-S, the effect of treatment 
condition (EMR vs. SE) on Fear at BAT 2 was not significant, B = -9.79, SE = 8.41, p = 
.25, sr2 = .03. 
For heart rate data, after controlling for STAI-S and heart rate at BAT 1B, the 
effect of condition was significant, B = -6.73, SE = 2.64, p = .01, sr2 = .14, indicating that 
EMR participants had a lower heart rate during BAT 2 relative to baseline than 
participants in SE. To ensure that such an effect was not confounded by the variable 
length of time participants spent in BAT 2, heart rate data during the first minute of BAT 
2 was compared to the full duration of the BAT (among participants who stayed more 
than one minute, 95% of the sample), and a paired t-test showed no significant difference, 
t(40) = -0.44, p = .66, d = .07. Nonetheless, the effect of condition was also examined on 
 
2 Because fear ratings at BAT 1B were so consistently low (≤ 10 of 100 for 78% of the sample) and 
were unrelated to fear ratings at BAT 2, variability among ratings may not have been the most 
meaningful indicator of claustrophobic fear following exposure training. In an attempt to better 
capture claustrophobia levels prior to randomization, the analysis was also run with post-exposure 
CLQ scores as a predictor at Step 1. Although CLQ significantly predicted BAT 2 fear, B = 0.55, SE = 
0.18, p = .004, sr2 = .19, the effect of condition was still not significant, B = -9.81, SE = 7.67, p = .21, 
sr2 = .04, so the original planned analysis was retained.    
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heart rate during the first minute of BAT 2. Results again show a significant effect of 
condition, B = -5.35, SE = 2.67, p = .04, sr2 = .09, with lower heart rate relative to 
baseline in EMR vs. SE.3  
Regarding behavioral avoidance, Figure 5 graphically depicts the portion of 
participants in EMR vs. SE groups exiting early across the 10 minutes of BAT 2, 
including when they exited. One participant asked to exit the scanner before entering 
entirely, so time was recorded as 0. When entered together in a Cox regression, exiting 
BAT 1A early was a significant predictor of exiting early during BAT 2, Hazard Ratio 
(HR) = 5.79, 95% CI [1.45, 37.10],  p = .02, but treatment condition, HR = 0.60, 95% CI 
[0.12, 3.38], p = .60, and STAI-S, HR = 1.05, 95% CI [0.99, 1.12], p = .13) were not. 
Given that only seven of 45 participants (16%) exited the MRI scanner early (n = 4 in SE, 
n = 3 in EMR), results should be interpreted in the context of possible ceiling effects. 
Accordingly, BAT 2 duration was not used as a dependent variable in subsequent 
analyses.  
Exposure Thinking Manipulation Check. When asked after BAT 2, all but 3 
participants endorsed thinking about the prior exposure training while in the mock MRI 
scanner. EMR participants’ ratings of how much they thought about the prior exposure 
training while in the scanner (M = 63.73, SD = 27.17) were not significantly different 
from SE participants (M = 50.91, SD = 30.52; t(43) = 1.49, p = .15, d = 0.44), though 
 
3 Following recommendations by Sterne et al., (2009), a sensitivity analysis was conducted examining 
only participants with complete data and compared to the analysis using multiple imputation. The 
significant effect of condition remained, and effect sizes were slightly larger when examining heart 
rate during the full duration of BAT 2, B = -8.89, SE = 3.30, p = .01, sr2 = .20, and the first minute 
only, B = -7.42, SE = 3.53, p = .04, sr2 = .14. 
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means were in the expected direction. When comparing the portion of participants from 
each group who described thinking about what they learned from exposure training or 
used the memory to help them feel less anxious (i.e. safety retrieval), the difference 
approached significance, (EMR = 81%; SE = 56%; χ2 = 3.02, p = .08). After controlling 
for BAT 1B outcomes and STAI-S, safety retrieval did not significantly predict BAT 2 
fear, B = -9.04, SE = 9.66, p = .36, sr2 = .02, or heart rate, B = -1.38, SE = 2.99, p = .65, 
sr2 = .01, nor did it its interaction with treatment condition, (fear: B = 13.74, SE = 21.66, 
p = .53, sr2 = .01; heart rate: B = 5.49, SE = 5.72, p = .34, sr2 = .02).  
When asked at the conclusion of Visit 2 whether they thought revisiting the 
memory of prior training was helpful, 14 of 18 (78%) EMR participants (4 missing 
responses) responded affirmatively, with 2 participants being unsure and 2 participants 
saying it was not. A partial point bi-serial correlation with BAT 2 fear outcomes, 
controlling for outcomes at BAT 1B, showed responding yes was associated with lower 
fear ratings (r = -.43, p = .07) and heart rate (r = -.54, p = .04). 
Aim 2: Effects of Treatment Condition on Secondary Outcomes 
 Visit 2. There was no significant effect of condition on pre-BAT 2 outcome 
expectancies (i.e. CLEQ scores) as measured by concern ratings, B = -3.06, SE = 5.79, p 
= .60, sr2 = .01, and likelihood ratings, B = -10.00, SE = 6.91, p = .16, sr2 = .05, nor on 
expected fear, B = -8.84, SE = 7.21, p = .23, sr2 = .04, controlling for each variable at 
BAT 1B as well as STAI-S at the beginning of Visit 2. Accordingly, planned analyses of 
claustrophobic expectancies as a mediator of the effect of EMR vs. SE were not 
conducted. There was also no significant difference between conditions on MRI-related 
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variables at the end of Visit 2, including negative outcome expectancies (i.e. CLEQ-MRI 
score) as measured by concern ratings, B = -2.00, SE = 5.92, p = .74, sr2 = .003, and 
likelihood ratings, B = 1.99, SE = 8.19, p = .81, sr2 = .002, expected fear, B = 5.21, SE = 
8.23, p = .53, sr2 = .01, or likelihood of getting a medically indicated MRI scan, B = 7.37, 
SE = 5.07, p = .15, sr2 = .05, controlling for baseline ratings, or in the case of the CLEQ-
MRI, controlling for BAT 1B CLEQ scores. 
Follow-up. Effects at follow-up mirrored those at Visit 2. Controlling for CLQ 
scores at Visit 2 (pre-randomization), there was no significant effect of treatment 
condition on CLQ at one-month follow-up, B = -11.71, SE = 9.25, p = .21, sr2 = .04. 
Similarly, there was no significant effect of condition on MRI fear, B = -2.20, SE = 9.25, 
p = .81, sr2 = .001, MRI likelihood, B = 8.75, SE = 5.63, p = .13, sr2 = .05, or CLEQ-MRI 
concern, B = -2.92, SE = 7.61, p = .70, sr2 = .01, or likelihood, B = -3.86, SE = 6.05, p = 
.53, sr2 = .004, controlling for baseline ratings, or in the case of the CLEQ-MRI, 
controlling for BAT 1B CLEQ. 
Table 5 shows means of the CLQ and MRI-related variables across study time-
points, along with the results of one-way ANOVAs examining differences in each 
variable across time when collapsing across condition. Significant decreases in CLQ 
scores, MRI fear, and MRI outcome expectancies were seen between all time-points, as 
were significant increases in likelihood of getting an MRI (all ps < .001).  
Aim 3A: Exposure Takeaways  
 The frequency of post-exposure audio-recording themes can be seen in Table 3. 
The most frequent theme was Threat Reappraisal/Safety, present in 56% of the 
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recordings, whereas Fear Tolerance was relatively infrequent, present in just 18% of 
recordings. When entering each exposure takeaway variable in to stepwise regression, 
controlling for BAT 1B fear, condition, and STAI-S, only Generalized emerged as a 
significant predictor of BAT 2 fear, B = 16.51, SE = 7.93, p = .04, sr2 = .10.4 The 
direction of this effect indicated that participants who described their takeaway from 
exposure training in generalized terms had higher fear ratings at BAT 2 compared to than 
those who did not. When entering the interaction terms for each exposure takeaway with 
treatment condition in to the model (after re-entering each main effect), the Generalized 
variable approached significance as a moderator (p  = .08), though when examined 
without the other exposure takeaway main effects, this effect fell outside of even 
marginal significance, B = -25.04, SE = 15.18, p = .11, sr2 = .07. Nonetheless, graphical 
inspection of the results (see Figure 6) split by condition showed that those with 
Generalized takeaways in SE appeared to have greater fear during at BAT 2 compared to 
EMR participants, which may have been driving the main effect.   
 When examining heart rate as the dependent variable, a stepwise regression with 
all exposure takeaway predictors, controlling for BAT 1B heart rate and STAI-S, did not 
produce any significant effects (ps > 0.10). When examining exposure takeaways as 
moderators, however, both the interaction for Fear Reduction × Condition, B = 12.80, SE 
 
4 Results when entering predictors simultaneously showed similar patterns. Although Generalized was 
not initially significant with all other predictors present, B = 14.75, SE = 9.06, p = .11, sr2 = .07, it was 
associated with a similar small to medium effect size, and became significant when other predictors 
were removed B = 16.51, SE = 7.93, p = .04, sr2 = .10. Also similar to the stepwise results, the 
Generalized x Condition interaction was marginally significant when entered with other predictors, B 
= 39.74, SE = 20.35, p = .06, sr2 = .10. (p = .06), but not significant with other predictors removed, B 
= 16.51, SE = 7.93, p = .04, sr2 = .10.  
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= 6.12, p = .04, sr2 = .12, and Generalized × Condition , B = -8.22, SE = 3.98, p = .03, sr2 
= .12, were significant. After removing other exposure takeaway variables, Fear 
Reduction remained a significant moderator, B = 14.36, SE = 6.40, p = .02, sr2 = .12, 
whereas Generalized did not, B = 5.74, SE = 5.03, p = .25, sr2 = .03, though the direction 
of moderation effect for Generalized was the same that it had been when predicting fear 
rating.5 Figure 7 illustrates that the effect of EMR on reduced heart rate compared to SE 
appears to be driven by participants who did not have a fear reduction takeaway from 
their exposure. The effect of condition appears to be in the opposite direction for those 
with a Fear Reduction takeaway, but there were only three participants in SE with fear 
reduction takeaways, so this pattern may be spurious. A post-hoc examination of the 
EMR sample found there was a trend toward the presence of a Fear Reduction takeaway 
predicting greater heart rate reactivity, controlling for post-exposure training levels, B = 
4.83, SE = 2.87, p = .09, sr2 = .14. 
Effects of Mental Reinstatement Variables. Table 3 shows the frequency by 
which different exposure takeaway themes were recalled during EMR procedures at Visit 
2, when participants revisited the memory of exposure training. Notably, only one 
participant recalled a Fear Tolerance takeaway, whereas all but two participants recalled 
a Fear Reduction takeaway. In Table 6, partial point bi-serial correlations of the presence 
of each exposure recall theme with BAT 2 fear ratings and heart rate reactivity, 
 
5 Again, results of a simultaneous regression analysis were highly similar as the stepwise approach. 
There were no significant main effects, but the Fear Reduction x Condition interaction was significant 
both when entered with other interactions terms as predictors, B = 19.97, SE = 7.70, p = .009, sr2 = 
.18, and without, B = 14.36, SE = 6.40, p = .02, sr2 = .12.  
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controlling for each variable at BAT 1B, are reported. Given that these correlations were 
conducted on just half the sample, results should be interpreted with caution. 
Table 6 also presents partial correlations between outcome variables and several 
ratings made immediately after recalling their exposure training and listening to their 
audio-recording. Post-reinstatement negative affect demonstrated a positive association 
with BAT 2 fear that approached significance, though in a separate analysis this did not 
hold when also controlling for STAI-S rated at the beginning of Visit 2 (r(18) = .33, p = 
.15). Positive affect, however, remained significantly negatively associated with BAT 2 
fear rating when controlling for STAI-S and BAT 1B fear (r(18) = -.45, p = .047). Since 
affect ratings were also made after the memory recall procedure in the SE condition, 
positive affect and its interaction with condition were then examined as predictor in the 
full sample. After controlling for STAI-S and Post BAT 1B fear, neither the main effect, 
B = -.325, SE = 1.06, p = .76, sr2 = .002, nor the interaction term with condition were 
significant, B = -3.71, SE = 2.29, p = .11, sr2 = .06. When removing STAI-S as a 
covariate, however, the interaction effect was significant, B = -5.07, SE = 2.34, p = .04, 
sr2 = .10, indicating that EMR was more predictive of reduced fear levels during BAT 2 
for those who reported greater positive affect after reinstatement of the exposure 
memory.  
Although vividness of the exposure memory was not significantly associated with 
BAT 2 outcomes, greater imagery ability as assessed by the VVIQ was a strong predictor 
of increased fear, so VVIQ and their interaction with condition were examined in the 
whole sample to determine whether this relationship was specific to EMR. Controlling 
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for STAI-S and Post BAT 1B fear, VVIQ had a significant main effect on BAT 2 fear, B 
= 1.36, SE = 0.38, p = .001, sr2 = .11, and the VVIQ × Condition interaction approached 
significance, B = 1.31, SE = 0.73, p = .08, sr2 = .06, with the direction of this effect 
trending toward a stronger relationship for participants in EMR. However, when 
removing STAI-S as a covariate, the effect weakened, B = 1.04, SE = 0.86, p = .23, sr2 = 
.04.  
Exploratory Moderator Analysis. Given that a sizable portion of the sample 
experienced only mild fear levels during BAT 2 (median peak fear = 40, median end fear 
= 20) and may have experienced minimal benefit from additional intervention to help 
generalize learning, exploratory moderator analyses were run to investigate whether an 
effect of treatment condition on subjective fear may emerge for those more likely to be 
fearful in the mock scanner. Specifically, post-exposure CLQ scores and their interaction 
with treatment condition were entered in to the regression model. However, the effect of 
the interaction term was not significant, B = -0.19, SE = 0.21, p = .38, sr2 = .02. The same 
test of moderation was run with the STAI-S to explore whether those with greater state 
anxiety at the beginning of Visit 2 may have benefited more from MRE. Again, the effect 
of the interaction term was non-significant, B = -1.03, SE = 0.66, p = .13, sr2 = .06, 
though the direction of both of these effects were such that EMR was associated with 
lower fear ratings relative to SE among those with higher CLQ and STAI-S scores at the 
beginning of Visit 2. The same non-significance was seen when examining heart rate as 
the dependent variable (CLQ by condition interaction: B = 0.04, SE = 0.07, p = .54, sr2 = 
.001; STAI-S by condition interaction, B = -0.11, SE = 0.21, p = .60, sr2 = .001). 
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Aim 3B: Changes in Feared Outcomes  
Following planned analysis, the relative effects of changes in feared outcomes 
related to threat expectancies, fear tolerance, and coping self-efficacy on the CLEQ 
during exposure training were examined as predictors of outcomes at BAT 2. Means and 
SDs of CLEQ subscales across BATs are reported in Table 7. Partial correlations 
controlling for BAT 1B outcomes showed that neither the CLEQ subscales or total scale 
were associated with fear ratings or heart rate at BAT 2 (Table 7). CLEQ changes from 
BAT 1B to BAT 2 showed strong positive correlations with fear and small positive 
correlations (approaching significance) with heart rate at BAT 2, controlling for 
outcomes at BAT 1B, though the magnitude of these associations did not meaningfully 
differ across CLEQ subscales. 
One-way ANOVAs were examined to evaluate differences across changes scores 
in CLEQ subscales. Significant differences emerges across subscales from BAT 1A to 
BAT 1B, F(2,88) = 9.28, p < .001, ηp2 = .17, with greater reduction in fear tolerance than 
threat expectancies, t(44) = 3.50, p = .001, and coping self-efficacy, t(44) = 3.77, p < 
.001. Change scores for the CLEQ from BAT 1B to BAT 2 also varied significantly, 
F(2,88) = 14.27, p < .001, ηp2 = .25, with smaller increases in threat expectancies 
compared to fear tolerance, t(44) = -4.38, p < .001, and coping self-efficacy, t(44) =         
-3.81, p < .001.  
Aim 3C: Expectancy Violations 
 Means and standard deviations of expectancy violation variables during the initial  
exposure and across all exposures are reported in Table 8. Values reflecting surprise 
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regarding feared outcome occurrence were consistently higher than likelihood-occurrence 
discrepancies, though standard deviations reflect significant variability across participants 
for both measures. Values were also greater during the initial exposure than when 
averaged across all six exposures. For prediction analyses, expectancy violation variables 
were grouped according to time-point (initial exposure vs. mean across all six exposures), 
and then each type of expectancy violation (threat expectancy, coping self-efficacy, fear 
tolerance, and fear level) as measured by both surprise ratings and likelihood-occurrence 
discrepancy was entered in a stepwise regression model predicting BAT 2 fear and heart 
rate reactivity, controlling for condition and the relevant outcome at BAT 1B.  
Prediction of BAT 2 Fear. When examining initial exposure predictors of fear at 
BAT 2, surprise ratings regarding coping self-efficacy, B = -0.33, SE = 0.14, p = .02, sr2 
= .10, and discrepancy between expected vs. actual fear levels, B = 0.45, SE = 0.21, p = 
.04, sr2 = .10, emerged as significant, though effects were in opposite directions. Whereas 
greater coping self-efficacy surprise predicted lower fear, expecting greater fear than 
actually occurred (i.e., over-predicting fear) during the first exposure was associated with 
higher fear ratings at BAT 2. Of note, likelihood-occurrence discrepancy for coping self-
efficacy approached significance, B = -0.38, SE = 0.20, p = .06, sr2 = .09, with its effect 
in same direction as coping self-efficacy surprise (i.e., greater expectancy violation 
predicting reduced fear). Expectancy violations related to threat expectancies and fear 
tolerance from the initial exposure were not significant predictors of BAT 2 fear, 
regardless of whether they were measured by surprise ratings or likelihood-occurrence 
discrepancies (all ps > .22). When examining expectancy violation variables averaged 
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across all exposure trials, no individual predictor showed significant effects on BAT 2 
fear (all ps > .11).6 
 Prediction of BAT 2 Heart Rate. When examining heart rate at BAT 2, the only 
initial exposure predictor that emerged as significant in the stepwise regression was fear 
level expectancy violations, with greater over-predictions of fear associated with greater 
BAT 2 heart rate, B = -0.38, SE = 0.20, p = .06, sr2 = .09 (all other ps > .15). No 
expectancy violation measure averaged across all exposures significantly predicted BAT 
2 heart rate (all ps > .11).  
Unlike BAT 2 fear, testing predictors of heart rate reactivity simultaneously led to 
substantially different results, which can be seen in Appendix E, Table E.2. Regardless of 
whether ratings were from the initial exposure or averaged across all six exposures, 
greater self-efficacy expectancy violations (measured by likelihood-occurrence 
discrepancies) predicted lower heart rate at BAT 2, whereas greater discrepancy between 
predicted vs. actual fear levels during the initial exposure was associated with higher 
heart rate at BAT 2. Greater fear tolerance expectancy violations through all six 
exposures, measured by likelihood-occurrence discrepancies, also predicted higher heart 
rate at BAT 2. The emergence of a larger number of significant predictors in the 
simultaneous regression could suggest the presence of suppressor effects. Specifically, if 
 
6 Results from a separate analysis regressing BAT 2 fear on expectancy violation variables 
simultaneously, which can be seen in Appendix E, Table E.1, showed a similar pattern to stepwise 
analysis. Coping self-efficacy surprise and fear level expectancy violations again emerged as 
significant predictors, with the one difference being that the effect of the other coping self-efficacy 
expectancy violation measure from the initial exposure, likelihood-occurrence discrepancy, reached 
significance. Of note, predictors in the simultaneous regression were also grouped by expectancy 
violation measurement type (i.e. surprise ratings vs. likelihood-occurrence discrepancy), with separate 
tests for each group of variables.  
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shared variance in a group of predictors is uncorrelated with the dependent variable, 
entering the predictors simultaneously will lead that portion of the variance to be 
partialled out. In turn, this can cause the unique variance in each predictor to be more 
likely to account for variance in the dependent variable, thereby emerging as significant 
when no effect of the predictor was evident when tested by itself (Ludlow & Klein, 
2014). Expectancy violation predictors were modestly correlated (most rs between 0.3 
and 0.4), making such an explanation plausible. However, the lack of consistency in the 
relation between expectancy violations and BAT 2 heart rate changes across analytic 
approaches suggests significant caution with interpretation is warranted.    
Prediction of Claustrophobia Symptoms. Based on results from the stepwise 
approach, a separate regression model was then tested that included just the significant 
predictors from the previous analyses, coping self-efficacy surprise and fear level 
expectancy violation during the initial exposure, and examined effects on CLQ scores at 
Visit 2 and follow-up, controlling for Visit 1 CLQ scores and treatment condition. No 
significant effects were seen for CLQ at Visit 2 (coping self-efficacy: B = -0.23, SE = 
0.16, p = .17, sr2 = .05; fear level: B = 0.34, SE = 0.17, p = .22, sr2 = .03), but coping 
self-efficacy surprise significantly predicted CLQ scores at follow-up, B = -0.40, SE = 
0.19, p = .04, sr2 = .10, with greater surprise about coping self-efficacy during the initial 
exposure being associated with reduced claustrophobia symptoms on the CLQ. For initial 
exposure fear level expectancy violations, there was a trend for greater over-predictions 
of fear to be associated with higher CLQ scores, but it did not reach significance, B = .56, 




 The primary aim of this study was to examine a method of overcoming one of the 
primary limitations of exposure therapy, namely that the learning of safety resulting from 
exposure to a feared situation may not adequately generalize beyond the context in which 
that learning occurs. To accomplish this aim, I conducted a randomized clinical trial 
testing the effect of mentally reinstating the memory of previous exposure training for 
claustrophobia prior to approaching a novel feared situation, specifically a mock MRI 
scanner. Building upon limitations of previous studies examining such a procedure 
(Elsesser et al., 2013; Mystkowski et al., 2006; Laborda et al., 2016), which showed 
limited effects, the mental reinstatement procedure in this study was (putatively) 
enhanced by having participants listen to an audio-recording of themselves verbalizing 
what they had learned in their prior exposure training, and then explicitly identify how 
this previous learning applied to the novel exposure context they were about to encounter.  
 This study examined the effects of such a manipulation on 45 participants 
endorsing significant fear of enclosed spaces generally and MRIs specifically, 84% of 
whom met DSM-5 criteria for specific phobia. Across conditions, results showed that the 
exposure training resulted in significant reductions in fear ratings, heart rate and 
avoidance during a behavioral approach test (BAT) in the exposure training context, as 
well as self-reported claustrophobic symptoms and MRI fear one week later and at one-
month follow-up. Fear responses one week later during a BAT in the mock MRI scanner 
(i.e. BAT 2) were significantly lower compared to baseline, but fear ratings and heart rate 
were significantly higher compared to BAT 1B, which occurred at the end of exposure 
 
54 
training in the exposure context. Therefore, a partial return of fear of fear effect was seen, 
enabling this study to meaningfully investigate the effect of EMR on generalization of 
gains following exposure training. For behavioral avoidance, however, only 7 of the 45 
participants exited BAT 2 before the maximum time elapsed, limiting investigation of 
behavioral outcomes.  
Results of the primary analyses showed that compared to SE, EMR led to 
significantly reduced heart rate reactivity during BAT 2, reflective of a medium-sized 
effect (sr2 = .14). The impact of EMR vs. SE on subjective fear was in the expected 
direction (i.e., reduced fear in EMR compared to SE), but the effect was small (sr2 = .03) 
and not significant. Furthermore, no differences were seen on behavioral avoidance, 
though low avoidance rates across conditions indicate a likely ceiling effect. With regard 
to secondary outcomes, no effect of treatment condition was seen on negative outcome 
expectancies prior to BAT 2, self-reported claustrophobia symptoms at one-month 
follow-up, or MRI fear-related outcomes (i.e. negative outcome expectancies, expected 
fear, likelihood of getting an MRI) after BAT 2 or at one-month follow-up. As with the 
fear rating outcome, results for nearly all secondary outcomes were in the expected 
direction of greater improvement in EMR, but effect sizes were small (sr2 = .01 to .05) 
and not statistically significant.  
The absence of effect on subjective fear ratings in this study is in contrast to the 
findings of Mystkowski and colleagues (2006), who found mental reinstatement to lead 
to decreased subjective fear during a BAT with spider phobics, but consistent with 
findings of Elsesser et al. (2013) in dental phobia and Laborda et al. (2016) in social 
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phobia. A notable difference between the study by Mystkowski et al. (2006) and the 
present research, beyond the type of phobia treated, is that generalization was examined 
with the same exposure stimulus (a spider) across distinct contexts, whereas in the current 
study the context and stimulus differed, potentially leading to more difficulty 
generalizing.  
With regard to heart rate outcomes, this is the first study to show effects of mental 
reinstatement on heart rate reactivity during exposure following a context change, though 
it should be noted that only one (Elsesser et al., 2013)  of the three prior mental 
reinstatement studies examined effects on heart rate. That effects were specific to heart 
rate is somewhat surprising given that the “enhanced” aspects of the procedure were in 
large part designed to target top-down reasoning processes about the relevance of prior 
learning to a new feared situation, and therefore might be more likely to impact 
subjective fear ratings and threat expectancies. In particular it was hypothesized that the 
advantage of EMR over the control condition would be mediated by superior impacts on 
negative outcome expectancies, but no difference in expectancies was found across 
conditions. Nonetheless, despite equivalent subjective ratings of fear and outcome 
expectancies, the EMR intervention led to decreased physiological reactivity compared to 
SE when entering a novel feared situation, with heart rate levels essentially equivalent to 
post-exposure training in a familiar claustrophobic context. 
The discordance between subjective and physiological outcomes in this study is 
noteworthy in that it highlights the distinct response systems of fear originally delineated 
by Lang (1968). De-synchrony between these response systems has been shown to be 
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greatest under conditions of less severe emotional arousal (Calvo & Miguel-Tobal, 1998; 
Hodgson & Rachman, 1974), which appears to have been reflected in this study in the 
relatively moderate levels of fear experienced on average during BAT 2. Although 
researchers are frequently drawn to prioritize physiological outcomes as more objective 
indicators of emotional states directly linked to underlying brain circuitry (e.g., Perusini 
& Fanselow, 2015), others have argued that the subjective, conscious report of fear 
reflects a valid and reliable measurement that is particularly important since subjective 
distress tends to be what drives people to seek treatment (LeDoux, 2014; LeDoux and 
Hofmann, 2018). In this account, physiological responses reflect defensive survival 
circuits that can contribute to the conscious experience of fear, but do not determine it. 
Thus in this study, the EMR intervention appeared to have an effect on reducing a 
measure of autonomic arousal (heart rate) reflective of underlying defensive circuitry 
(Friedman, 2007), However, this reduced autonomic arousal did not appear to impact the 
conscious experience fear enough to lead to a concordant reduction in subjective fear 
ratings.   
A number of possible explanations exist for the non-significant findings of EMR 
on self-reported variables. For one, results of the manipulation check applied after BAT 2 
showed that a sizable portion (56%) of the participants in the SE condition reported 
thinking about their prior exposure training during BAT 2 and specifically described 
thinking about what they learned or used the memory to help them feel less afraid. There 
was a trend toward more MRE participants (81%) revisiting their exposure training in 
this way, but such a pattern suggests that not everyone in the MRE condition explicitly 
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recalled the more helpful aspects of their prior exposure training while going in the mock 
MRI canner, and that numerous participants revisited their exposure training without 
going through those procedures. It should be noted that there were substantial limitations 
to this manipulation check given that it was done retrospectively, ratings did now a 
significant relationship with fear during BAT 2, and there may have been a social 
desirability bias impacting participants from both conditions. Furthermore, MRE 
procedures still could have had an effect without leading to explicit memory retrieval 
(e.g. see Shin & Newman, 2018). Nonetheless, such a pattern reflects the likelihood that 
prior learning was likely fairly salient for all participants in the study. Although BAT 2 
occurred one week after initial training and occurred in a location, the novelty of coming 
in for a research study visit on claustrophobia could made reinstatement of prior safety 
memories easily occur, as could have the SE procedure in which participants recalled a 
neutral memory from around the same time as the first study visit.  
Also potentially contributing to the high salience of prior learning for all 
participants, and consequently to the limited impact of EMR, is the creation of the audio-
recording after exposure training, in which participants reviewed what happened during 
the exposure training and what they learned about their fear. Expression of fear and 
safety memories are influenced by consolidation processes as well as retrieval (Quirk & 
Mueller, 2011), and the elaborated review of exposure training may have functioned as a 
strong extinction memory consolidation intervention, reducing possible effects of a later 
retrieval-based manipulation. In fact, Raeder and colleagues (2019) showed that 
reactivating the memory of exposure training and evaluating one’s success in facing 
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feared scenarios immediately after a single session of exposure training for height phobia 
led to reduced recovery of fear and increased self-efficacy during BATs done two to three 
days later and at one-month follow-up. After using a similar intervention across all 
participants in the present study, a large return of fear effect (d = 1.25) was still present, 
suggesting there was still substantial room for improvement from the EMR intervention. 
However, the median peak fear level across conditions was 40 out of 100, meaning that 
many participants did not experience substantial fear levels after a change in context. 
Moderator analyses did not show the effect of treatment condition to be significantly 
impacted by claustrophobia severity or state anxiety prior to the manipulation, which 
might be expected if ceiling effects were present, though such tests were limited by the 
small sample size.  
Exposure Takeaways  
 In order to better understand the role of higher-order reasoning processes on 
generalization of learning following exposure, this study examined what participants 
reported learning and remembering from their exposure training. Doing so enabled an 
investigation of the meaning participants made of their exposure experience immediately 
after the training concluded, and how this meaning related to subsequent fear outcomes. 
It also provided insight in to what participants in the EMR condition remembered prior to 
entering to entering the mock MRI scanner.  
Results showed that despite the standardized exposure training, there was 
substantial variability in the participants’ biggest takeaways. The most common theme 
immediately after exposure training was Threat Reappraisal/Safety, suggesting that the 
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realization that fears did not come true and they were actually safe in an enclosed space 
was particularly salient for participants. When recalling the exposure memory during 
EMR procedures one week later, however, almost all participants emphasized fear 
reduction, suggesting this was one of the most memorable elements of the exposure 
training. Fear tolerance takeaways, on the other hand, were described by only a small 
proportion of participants in both the post-exposure recording at Visit 1 and exposure 
recall at Visit 2, which is notable given the theoretical importance of learning to tolerate 
fear for long-term exposure outcomes (Arch & Abramowitz, 2015; Craske et al., 2008). 
Of note, fear tolerance was not emphasized during the rationale for exposure (whereas 
threat reappraisal and fear reduction were), fear tolerance beliefs were tracked through 
exposure training. Nonetheless fear tolerance did not appear to be a particularly salient 
takeaway point for participants in this study.  
 In regards to relationships with outcome, the presence of a fear reduction 
takeaway during the post-exposure recording was associated with increased heart rate 
reactivity at BAT 2. Although interaction effects should be interpreted with caution given 
the small sample size, it appears that this effect was specific to the EMR condition, 
suggesting that the impact of a fear reduction takeaway may have had more to do with 
hearing fear reduction being highlighted on the audio-recording during EMR procedures 
than it being a point of emphasis at the end of exposure. It is possible that hearing oneself 
describe how fear reduced over the course of exposure led to an expectation or hope for 
reduced fear during BAT, consequently leading to a greater physiological fear response 
when inside the mock MRI and experiencing significant fear. Alternatively, audio-
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recordings emphasizing fear reduction may have also elicited stronger memories of the 
fear initially experienced during exposure training, thereby strengthening the salience of 
the fear memory prior to BAT 2.  
 A somewhat surprising result from the analysis of exposure recording themes was 
that takeaways that included a generalized component to them were predictive of greater 
fear ratings during BAT 2. Associating safety with a specific context rather than 
abstracting a rule that can be applied across contexts is thought to be one of major 
determinants of fear renewal (Gawronski, Rydell, Vervliet, & De Houwer, 2010), so it 
was expected that a generalized element of exposure takeaway recordings would help to 
reduce return of fear. Closer inspection of the generalized statements present, however, 
shows that many of them described what occurred in a somewhat simplistic way (e.g. 
“fear is all in my head,” “exposure shows you nothing bad will happen, even if at first 
you imagine it will”), absent of specific details about why this generalized statement is 
true. Such statements may reflect a lack of memory specificity about the exposure 
experience, which could be associated with poorer outcomes given evidence that low 
autobiographical memory specificity has been shown to be associated with more 
generalized fear responding (Lenaert et al., 2012) and poor discrimination learning 
(Lenaert, Boddez, Vervliet, Schruers, & Hermans, 2015). Based on such findings,  
investigating whether memory specificity for exposure experiences or extinction training 
is helpful for the retention or generalization of safety learning would be an intriguing 




 By tracking feared expectations and outcomes at each trial of exposure training, 
this study enabled the investigation of a number of different types of expectancy 
violations as predictors of generalization outcomes. Results showed that expectancy 
violations pertaining to coping self-efficacy and expected fear levels during participants’ 
initial exposure were significantly related to self-reported fear outcomes, though in 
opposite directions. Specifically, greater surprise about coping self-efficacy outcomes 
(i.e. surprise about coping better than expected) predicted lower fear ratings at BAT 2, as 
well as self-reported claustrophobia symptoms at one-month follow-up. There was also 
some indication that likelihood-outcome discrepancies related to coping-self efficacy 
concerns predicted fear and heart rate reactivity during BAT 2, though this result was not 
consistent across analytic approaches. The finding that learning related to coping self-
efficacy, i.e. the ability to actively manage fearful thoughts, feelings and behaviors, was 
associated with outcomes is consistent with previous literature showing improvements in 
coping self-efficacy to mediate subsequent symptom reduction during exposure therapy 
(Fentz et al., 2013; Gallagher et al., 2014). Furthermore, experimentally manipulating 
self-efficacy prior to an extinction learning task has been shown to lead to reduced 
physiological responding and negative evaluations of a conditioned stimulus (Zlomuzica, 
Preusser, Schneider, & Margraf, 2015). The present study extends these findings by 
showing that a strong expectation of poor coping self-efficacy, followed by the 




 Although it was based on a small sample, there was also a non-significant trend 
(rpart = .40) toward recall of a coping self-efficacy takeaway during EMR predicting 
reduced heart rate reactivity at BAT 2, which is consistent with the idea that coping 
beliefs are central to fear outcomes. Also notable is the finding that positive affect after 
the memory recall procedure for EMR participants was associated with lower fear during 
BAT 2, as positive affect and self-efficacy are often linked (Schutte, 2014). Thus during 
exposure training, particularly at the first exposure, surprise about one’s ability to cope 
during exposure was predictive of later fear outcomes, whereas after having gone through 
exposure training, recalling that one can cope and feeling positive immediately prior to 
entering a feared situation was associated with reduced fear.   
 With regard to fear level expectancy violations, discrepancy between expected 
and actual fear (i.e. expected minus actual fear levels, or over-prediction of fear) at the 
initial exposure was significantly positively associated with greater fear ratings and heart 
rate reactivity during BAT 2. There were also positive associations between over-
prediction of fear and fear intolerance outcomes (i.e. believing fear would be more 
intolerable than it was) across all exposures and fear outcomes at BAT 2, though this 
result was not consistent across analytic approaches. Although realizing that fear was 
consistently lower and more tolerable than expected should theoretically help facilitate 
therapeutic learning (Craske, Vervliet, & Hermans, 2018), it is important to note that in 
the present study attention was not explicitly drawn to expected vs. actual fear 
discrepancies like it was for specific feared outcomes, as surprise about fear levels was 
not rated. Over-predictions of fear levels and consistent expectations that fear would be 
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intolerable may have instead reflected an inability to update expectations based on actual 
experience, suggestive of a more rigid cognitive style. The finding that expectancy 
violations related to fear tolerance and coping self-efficacy showed opposite associations 
with fear outcomes is somewhat surprising given that both belief domains reflect 
concerns about the consequences of fear. However, coping self-efficacy beliefs are 
specific to one’s ability to actively cope with or reduce fear rather than tolerate it, 
suggesting that learning one can exert control over one’s response in a feared situation is 
particularly beneficial.  Notably, fear tolerance expectancy violations were predictive 
only of BAT 2 heart rate outcomes and not fear ratings, further highlighting the 
discordance between subjective and physiological outcomes seen in the present study. 
The direction of these effects is consistent with the findings of Kircanski & Peris 
(2015), who found that over-predictions of fear early in exposure treatment predicted 
worse mid-treatment outcome. A study by Guzick et al. (2018), on the other hand, found 
that greater variability in expected vs. actual fear over the full course of treatment, which 
meant a higher proportion of over-predictions, was associated with improved outcome. 
Of note, expectancy violations in the current study were based on a massed set of 
identical exposures, in contrast to the studies mentioned above which included a full 
course of treatment with varying types of exposures. It may be that over-predictions of 
fear are related to outcome when a limited number of exposure situations have been 
encountered, but as more situations are approached this no longer is the case.  
 This is the first study to show that expectancy violations about specific feared 
outcomes (rather than expected fear levels) are predictive of subsequent fear levels. 
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However conclusions about the belief domains used in this study (coping self-efficacy, 
fear tolerance, and threat expectancies) should be considered as tentative. The categories 
of beliefs used in the CLEQ, which were subsequently used to distinguish expectancy 
violation beliefs, were based on items selected from prior measures as well as distinctions 
between theorized mechanisms of exposure. Although internal consistency within belief 
domains was strong, sample size limitations prevented full psychometric analysis. Given 
that expectancy violations related to different types of beliefs can have divergent effects 
on future outcomes, better delineating the types of beliefs related to exposure outcomes is 
an important direction for future research. It is also worth noting that the associations 
between .  
Limitations 
Results of this study should be considered within the context of a number of 
limitations. For one, administration of BATs was not blinded, making it impossible to 
rule out that knowledge of experimental condition subtly impacted experimenter 
behavior. Although a standardized script was followed for each BAT, having a separate 
experimenter conduct outcome assessment served as a stronger control. Relatedly, 
although SE procedures were designed to mimic EMR procedures in terms of memory 
reinstatement, it was not designed to be an equally plausible alternative in terms of 
helping reduce fear outcomes, so participant expectancy effects may have played a role in 
EMR.  
 Another limitation is that the results of the present study cannot speak to whether 
effects on fear outcomes during BAT 2 are specific to generalization processes, or rather 
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impacted return of fear due to the passage of time, which could only be determined if 
there was a comparison group that went through BAT 2 in the same context as BAT 1. 
Furthermore, without counterbalancing the order of contexts, it is possible that effects are 
restricted to the specific order of exposure situations that participants encountered. The 
decision to test the return of fear exclusively in a mock MRI explicitly was made with 
maximizing clinical applicability in mind, as generalization to an MRI scanner is a real-
life scenario claustrophobic individuals may need to encounter, and given the wide 
variety of situations anxious patients encounter, the failure to generalize is a more 
common limitation of treatment effects than return of fear due to passage of time. 
Nonetheless, these limitations are relevant when considering the specific mechanisms 
preventing or leading to the return of fear  
Regarding the EMR intervention itself, another limitation is that because it 
included multiple ingredients (i.e. recall of exposure memory, listening to audio 
recording, and identifying relevance of exposure memory), it is difficult to know whether 
certain elements may have been driving or impeding effects. Multiple components were 
used in order to maximize likelihood of improving outcomes given that exposure is 
already a fairly robust intervention, but it is also possible that certain elements of the 
procedure ended up increasing fear levels, particularly for certain participants like those 
who emphasized fear reduction in their exposure recordings. Unlike previous research 
examining mental reinstatement, however, we assessed and analyzed a number of 
different components of the memory recall procedures, enabling more specific 
understanding of the factors potentially influencing mental reinstatement. 
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 It should also be noted that even though the study was adequately powered to 
detect a medium-sized effect for the main outcomes, sample size is still a limitation, 
particularly for secondary analyses involving moderation. Even for main outcomes, non-
significant effects were consistently in the direction of superior outcomes for EMR, but 
may have been too small to detect in the present study. This may be especially true given 
the modest return of fear seen for the majority of the sample, and particularly for 
behavioral avoidance as an outcome, which showed a clear ceiling effect. Relatedly, the 
control procedures in the SE condition may have inadvertently elicited reinstatement of 
the exposure memory in a way that reduced differences seen between conditions. 
Specifically, vividly imagining a neutral memory that occurred close in proximity to the 
initial study visit as well as listening to an audio-recording made during that visit may 
have prompted SE participants to implicitly or explicitly recall the memory of exposure 
training more than they otherwise would have. Although the elaborated procedures of the 
EMR condition would still be expected to lead to a stronger reinstatement of prior 
learning, overlap between conditions could have reduced the magnitude of effects to a 
level not detectable given the present sample size. This idea is also supported by the 
results of the manipulation check mentioned previously, in which the difference in 
proportion of EMR vs SE participants who explicitly revisited the memory of exposure 
training prior to or during BAT 2 compared only approached significance.    
Implications and Future Directions 
Based on findings from this study and other investigations of mental 
reinstatement techniques (Elsesser et al., 2013; Laborda et al., 2016; Mystkowski et al., 
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2006), effects of revisiting a prior exposure memory in order to enhance generalization 
appear to be limited, and it is difficult to make definitive conclusions about the clinical 
utility of such an exposure augmentation strategy as it has been applied to date. 
Nonetheless, the presence of significant effects on psychophysiological reactivity, 
possible moderators (e.g. post-reinstatement positive affect) and sample size limitations 
of this study suggests that further investigation of mental reinstatement and related 
techniques could be beneficial. 
In order to better understand the processes in play in extant findings on mental 
reinstatement, one future direction would be to experimentally manipulate the manner in 
which the memory is recalled, as well as the formation of the memory itself. For instance, 
Raeder and colleagues (2019) found that immediately after exposure treatment, having 
participants reactivate the memory of the exposure experience and connect it to other 
mastery experiences led to improved fear outcomes compared to reactivating the memory 
and comparing it to other stressful experiences. An extension of this research would be to 
examine whether mental reinstatement of exposure after such a self-mastery reactivation 
exercise could amplify its effects, and potentially extend benefits to a novel situation. 
Given the challenges of experimentally manipulating complex memories like that of an 
exposure, laboratory fear conditioning and extinction paradigms also offer a way to more 
specifically influence and evaluate what is remembered. For instance, in a study using a 
contextual renewal extinction paradigm, neural reinstatement of a safe context was 
associated with reduced feelings of threat to a conditioned stimulus (Hennings, McClay, 
Lewis-Peacock, & Dunsmoor, 2020), so future research could examine memory retrieval 
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techniques (e.g., mental rehearsal; Joos et al., 2012) designed to help facilitate such 
neural reinstatement.  
 Another meaningful direction for this research would be to examine the potential 
of utilizing mental reinstatement procedures to enhance generalization of learning to a 
person’s day to day life. One of the most significant context shifts that patients 
experience during exposure therapy is going from an exposure completed during a 
treatment session in the presence of a therapist to encountering feared situations one their 
own outside of the clinic. Unlike the present study, in which the context of being a 
research participant and the presence of the experimenter likely made the memory of 
previous exposure highly salient, day to day feared situations are likely to contain fewer 
contextual cues and reminders of prior learning. Therefore there may be a stronger need 
for, and therefore benefit of, reinstatement of previous exposure success. Mobile 
technology could be particularly useful in this regard, delivering reminders of prior 
exposure success, potentially through self-generated statements capturing the most 
important learning points from earlier exposures, as well as visual or other sensory cues 
that serve as a reminder of therapeutic learning (e.g. Rosenthal & Kutlu, 2014). In doing 
so, such an approach could utilize mental reinstatement as well as retrieval cues 
strategies, both of which have shown potential for clinical utility (e.g. Shin & Newman, 
2018) but by themselves may be more limited in impact.  
 Another consideration for future research is the limitations of examining exposure 
augmentation strategies over the course of a single session. For instance, effects that are 
useful over multiple sessions of exposure may be too small to detect after a single 
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session. In addition, single session protocols like the one in the present study inherently 
limit variability in exposure contexts, and the facilitation of generalized therapeutic 
learning or beliefs about coping self-efficacy may be more limited with only a single 
context from which to learn from. Multiple sessions of exposures in different contexts 
may enable more generalized safety learning to occur, and thus more effectively be 
retrieved through reinstatement procedures. Furthermore, early in treatment it may be 
important to emphasize the creation of strong expectancy violations in order to enhance 
the formation of new learning, whereas overemphasizing safety and low fear levels 
carries risks of relapse if an exposure goes poorly (Abramowitz & Arch, 2014).  
Regarding expectancy violations, findings from this study are certainly in need of 
replication given the exploratory nature of the analyses and small sample size. However, 
they suggest that the experience of coping more effectively than one expected during an 
exposure helps to facilitate durable reductions in fear. Such a finding offers important 
evidence in a clinical context for a central tenet of inhibitory learning theory, which is 
that therapeutic learning is facilitated through maximizing of expectancy violations 
(Craske et al., 2008; Rescorla-Wagner, 1972). This is particularly notable given a number 
of recent studies that failed to find evidence in support of expected associations between 
expectancy violations and outcomes (de Kleine et al., 2017; Scheveneels, Boddez, Van 
Daele, & Hermans, 2019; Scheveneels, Boddez, Vervliet, & Hermans, 2019). This study 
also demonstrated the value of investigating the different types of expectancies that may 
be violated during exposure, as previous research has largely focused on a single 
indicator of expectancies, most frequently expected fear levels. The types of beliefs that 
 
70 
drive fear can vary widely both across and within different types of anxiety presentations, 
and the present results show that examining expectancy violations with greater specificity 
in regards to belief domains may help to clarify inconsistent findings. Further research 
investigating the types of expectancy violations that are most predictive of outcomes, 
both within and across individuals, will be important to continue refine inhibitory 
learning theory and elucidate the cognitive mechanisms driving change during exposure.  
In addition, in order to demonstrate that expectancy violations function as mechanism of 
change, future research will need to manipulate treatment in such a way that facilitates 
greater expectancy-outcome mismatches (e.g. Deacon et al., 2013), and demonstrate that 
this in turn leads to improved outcomes. 
Lastly, although the current study was not specifically designed as an intervention 
for treatment of MRI-related claustrophobia, it illustrates the utility of exposure therapy 
for decreasing MRI-related fear when access to a real scanner is limited. Specifically, 
MRI-related fear and expected likelihood of getting a medically-indicated MRI 
substantially improved as a result of two visits involving exposure to feared spaces. 
Given the major public health implications of MRI avoidance due to claustrophobia 
(Munn et al., 2015), this study could serve as the basis for future research investigating an 
efficient exposure-based intervention for fear of MRI scans.  
Conclusion 
Results of the present study showed that an intervention involving mental 
reinstatement of prior exposure training for claustrophobia led to reduced heart rate 
reactivity when entering a new feared situation, but effects on subjective fear rating or 
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feared outcome expectancies were not significant. In addition, no impact of intervention 
was seen on self-reported claustrophobia symptoms or MRI fear-related variables at one-
month follow-up. Compared to results of prior studies examining a similar manipulation, 
the elements added to the procedure, including listening to an audio-recording of what 
participants learned from prior exposure training, did not appear to meaningfully improve 
outcomes. Analysis of exposure training processes showed that expectancy violations 
related to coping self-efficacy, particularly during participants’ first exposure, led to less 
fear in a novel exposure situation one week later, as well as less self-reported 
claustrophobia symptoms at one-month follow-up. Over-predictions of fear levels, 
however, were associated with greater fear levels in the novel feared situation. More 
research is needed to understand how to most effectively facilitate the formation and 







 EMR (n = 22) SE (n = 23) p value for T, χ2 
or Fisher’s Exact 
Test 
 M (SD) or n 
(%) 
M (SD) or n 
(%) 
Age 30.8 (13.3) 27.7 (11.4) 0.40 
Participant Type   0.30 
    Student 13  (55%) 13 (57%)  
    Community 9    (45%) 10 (43%)  
Gender   0.29 
    Male 9    (41%) 6   (26%)  
    Female 12  (54%) 17 (74%)  
    Other 1    (5%) 0   (0%)  
Race/Ethnicity   0.19 
    Asian 7   (31%) 11  (48%)  
    Black 6   (27%) 2    (9%)  
    White 9   (41%)   7    (30%)  
    Latinx 0 1    (4%)  
    Multiple 0 2    (9%)  
Education   0.47 
   High school 3  (14%)        1  (4%)  
   Some college 5  (23%)  9  (39%)  
   4-yr college deg. 7  (31%) 8  (34%)  
   Postgrad deg. 7  (31%)  5  (22 %)  






Baseline Clinical Characteristics 
 EMR (n = 22) SE (n = 23) p value for T, χ2 
or Fisher’s Exact 
Test 
 M (SD) or n (%) M (SD) or n 
(%) 
Specific Phobia Diagnosis (Claustrophobia) 0.15 
   Currently meets 19  (86%) 19  (82%)  
   Past only 2    (9%) 0    (0%)  
   Does not meet 1    (5%) 4    (17%)  
Psychiatric medication 2    (9%) 4     (17%) 0.67 
    
MRI Variables    
Prior MRI Experience 13  (59%) 12   (52%) 0.64 
MRI Fear (0–100) 75.4 (19.1) 71.5 (18.9) 0.49 
MRI Likelihood (0–100) 56.5 (27.4) 67.0 (34.7) 0.27 
    
Questionnaire Scores    
CLQ-fear 58.6 (17.4) 59.4 (17.7) 0.87 
CLQ-avoidance 59.6 (19.2) 62.8 (16.8) 0.59 
STAI-T 44.0 (11.7) 42.6 (11.4) 0.68 
STAI-S 43.8 (10.7) 40.9 (11.3) 0.38 
DTS 45.1 (13.6) 44.1 (11.4) 0.78 
ASI-3 29.0 (13.0) 31.7 (14.0) 0.51 
VVIQ 44.0 (9.3) 44.7 (9.8) 0.81 
CEQ 5.5 (1.5) 5.9 (1.4) 0.35 
    
BAT 1A Variables    
Peak Fear (0–100) 76.3 (14.0) 70.9 (15.1) 0.22 
End Fear (0–100) 63.4 (22.6) 59.1 (22.9) 0.54 
Exited early  8    (36%) 3     (14%) 0.10 
CLEQ – concern  48.6 (16.1) 51.9 (20.6) 0.56 
CLEQ – likelihood 56.4 (15.7) 56.4 (24.4) 0.87 
Note: EMR = Enhanced Mental Reinstatement; SE = Standard Exposure; CLQ = 
Claustrophobia Questionnaire; STAI-T = State-Trait Anxiety Inventory – trait; STAI-S = 
State-Trait Anxiety Inventory – state; DTS = Distress Tolerance Scale; ASI-3 = Anxiety 
Sensitivity Inventory; VVIQ = Vividness of Imagery Questionnaire; CLEQ = 









Post-Exposure and EMR Audio-recording Themes, Interrater Reliabilities and Frequencies 
Theme Definition Example Interrater 
reliability (κ) 







Learns they have control over how 
they react, think or feel in a feared 
situation 
I can reduce my fear by 
staying in the situation 
and accepting it 
0.60 Total: 17  





Learns that fear can be tolerated My fear wasn’t as 
unbearable as I thought 







Learns their fears were not 
accurate and/or they were actually 
safe 
What I was anxious 
about did not happen 






Describes how their fear or distress 
level decreased 
My anxiety eventually 
reduced 




Generalized Describes what they learned in a 
general manner, rather than 
speaking just about the exposure 
training experience/ context itself 
Fear is not a reliable 
source of information 
(Yes) vs. My fears about 
















  Intra-class Correlation  
Fear Recall Indicates amount of attention 
placed on experience of fear 
 
0 – No mention of fear 
1 – Mentions fear w/o 
elaboration, or in context 
of fear not coming true 
2 – Describes fear in 
detail, multiple times, or 
mentions how fear has 
persisted/is still present 
0.59 NA (0) = 0 
(1) = 13 




Results from regression models examining effect of condition on primary outcomes 
during BAT 2 
Note: * = p < .05; ** = p < .01; BAT = Behavioral Approach Test; BAT 1A Exited 
coded; Condition coded 0 = Standard Exposure, 1 = Enhanced Mental Reinstatement; 0 = 
no, 1 = yes; STAI-S = State Trait Anxiety inventory – State, measured at the beginning of 
Visit 2; HR = Heart rate.  
 
  
Outcome Step Predictor ΔR2 B SE B β sr2 
Fear Rating 
1. BAT 1B Fear .19* 0.42 0.35 .17 .04 
 STAI-S 0.87 0.32     .38** .15 
2. Condition .03 -9.79 8.41 -.17 .03 
Heart Rate  
1. BAT 1B HR 
.01 
0.03 0.22 0.03 .00 
 STAI-S -0.02 0.11 -0.04 .00 
2. Condition .14* -6.73 2.64 -0.33* .14 
Outcome Step Predictor Δχ2 
Hazard 
Ratio 
95% CI for 
 Hazard Ratio p 
Avoidance 
(Time to exit) 
1. STAI-S 
6.62* 
1.04 0.98 to 1.10 .15 
 BAT 1A Exited 7.55* 1.52 to 37.44 .01 




Claustrophobia symptom scores and MRI fear variables across study time-points.  















EMR 118.4 (36.1) 98.4 (38.1) 72.0 (34.0) 
31.70** 0.42 SE 122.2 (34.1) 92.0 (37.0) 79.2 (46.3) 
MRI Fear 
EMR 75.5 (19.1) 52.7 (24.1) 39.6 (31.0) 
36.46** 0.46 SE 71.5 (18.9) 46.3 (30.8) 39.4 (34.4) 
MRI 
Likelihood 
EMR 56.6 (27.4) 74.1 (25.3) 84.4 (17.6) 
21.57** 0.33 SE 67.0 (34.7) 74.3 (30.6) 80.7 (28.4) 
CLEQ-MRI 
concern 
EMR - 24.5 (19.6) 15.7 (17.6) 
9.91* 0.19 SE - 23.9 (22.1) 18.1 (22.5) 
CLEQ-MRI 
likelihood 
EMR - 40.7 (25.5) 26.4 (28.2) 18.92** 0.31 
SE - 36.1 (29.8) 24.3 (21.0)   
Note: *p < .01; **p < .001;  aCLQ administered pre-BAT 2 at Visit 2, whereas other 
variables captures after BAT 2. bFollow-up paired samples t-tests (collapsed across 
condition) indicated significant differences between all Visit 1 and Visit 2 variables, and 
between Visit 2 and follow-up (all p’s < .001); EMR = Enhanced Mental Reinstatement; 
SE = Standard Exposure; CLQ = Claustrophobia Questionnaire; CLEQ-MRI – 





Table 6  
Partial correlations of EMR process variables with BAT 2 Fear and Heart Rate 
Reactivity 
 Measure Fear Rating 
(n = 22) 
Heart Rate 
(n = 21) 
Exposure Recall 
Themes 
Fear Recall .23 .20 
Coping Self-Efficacy .30 -.40+ 
Threat Reappraisal -.15 .13 
Generalized  -.18 -.09 
Post-Reinstatement 
Ratings 
Vividness .13 .13 
Perspectivea  -.01 -.05 
Positive affect -.50* -.18 
Negative affect .40+ .14 
Baseline VVIQ  .64** .21 
Note: +p < .01; *p < .05; **p < .01; Correlations with BAT 2 Fear Rating and Heart Rate 
are controlling for the respective outcome variable (i.e. fear or heart rate) at BAT1B. Fear 
tolerance theme not included due it being present for only one participant, and fear 
reduction theme not included due to it being present for all but two participants. a For 
Perspective rating, larger values indicate taking more of an observer perspective, whereas 
smaller values indicate a ‘field’ perspective (i.e. through one’s own eyes); VVIQ = 

















rpart with BAT 2 Outcomes 
Δ BAT 1A to 1B  Δ BAT 1B to 2  
Fear HR Fear HR 
Total 50.3(18.4) 6.0 (7.9) 23.6 (19.3) -.05 .14 .70** .28+ 
Threat 
Expectancies 47.5 (19.1) 5.4 (7.6) 19.6 (17.8) .03 .15 .67** .21 
Coping Self-
Efficacy 50.3 (22.4) 6.8 (9.5) 28.1 (22.8) -.07 .01 .65** .25
+ 
Fear Tolerance 58.5 (23.0) 6.7 (10.0) 30.9 (26.4) -.07 .16 .64** .30+ 
Diff. across 
subscales (F) 10.18** 1.50 15.48** - - - - 
ηp2 .19 .03 .26 - - - - 
Note: + p < .10; **p < .001; CLEQ = Claustrophobic Expectancies Questionnaire; HR = heart rate; Degrees  






















54.8 (19.5) 35.6 (23.7) 19.2 (22.1) 44.8 (32.0) 
 Fear 
Tolerance 
52.5 (21.6) 39.8 (24.2) 12.7 (25.8) 49.1 (29.0) 
 Threat 
Expectancy 
50.3 (26.0) 41.3 (27.1) 9.02 (31.9) 42.7 (35.0) 





29.2 (18.1) 17.9 (14.8) 11.3 (8.1) 27.2 (17.3) 
 Fear 
Tolerance 
27.3 (15.9) 18.4 (16.0) 8.9 (8.1) 29.7 (15.8) 
 Threat 
Expectancy 
26.3 (18.2) 19.8 (16.9) 6.4 (11.1) 27.2 (17.3) 
 Fear Level 35.1 (17.7) 21.8 (16.9) 13.4 (8.9) - 
Note: All ratings made on a scale from 0 to 100 with the following anchors: Likelihood: 0  
(will not happen) to 100 (certainly will happen); Fear: 0 (No fear) to 100 (Extreme 
fear/panic); Occurrence: 0 (not at all) to 100 (completely); Surprise: 0 (not at all 
surprised) to 100 (completely surprised). If participants were surprised because the feared 
outcome occurred more than they expected, a negative value for the rating was used. 






Figure 1. CONSORT diagram of participant screening, randomization, and study 
completion. Randomization occurred at Visit 2, following completion of exposure 
training at Visit 1. *For heart rate analysis, n = 21 for enhanced mental reinstatement and 
n = 22 for standard exposure, as data for two participants were lost due to equipment 







Figure 2. Schematic of study design and contexts for Behavioral Approach Tests (BAT). Open space in cabinet (Context 1) is 
6’ x 3’ x 1.5’, and doors were closed on top of participants. Diameter of tube in mock MRI scanner (Context 2) is 2’. 
Participants were slid in to tube headfirst until their entire upper body was enclosed, and then were moved an additional 6” 





Figure 3. Peak fear rating during Behavioral Approach Tests (BAT) across conditions. 
Error bars reflect 95% confidence intervals. SE = Standard Exposure; EMR = Enhanced 


















Figure 4. Heart rate during behavioral approach tests (BATs) across conditions. Error 
bars reflect 95% confidence intervals. Heart rate values are adjusted for baseline. SE = 





Figure 5. Percentage of Enhanced Mental Reinstatement (EMR) vs. Standard Exposure 







Figure 6. Change in Fear Rating from BAT 1B to BAT 2 across condition and presence 





Figure 7. Change in Heart Rate from BAT 1B to BAT 2 across Condition and Exposure 
Takeaway. Error bars reflect standard errors. Heart rate values reflect estimated marginal 




Appendix A: Script for Exposure Rationale  
(Delivered via video) 
 
Hi there. I’m a therapist at the anxiety clinic here at Boston University. I’m going 
to be talking to you for the next few minutes about the most effective way to overcome 
fears like claustrophobia.  To start, it can be helpful to have a basic understanding of how 
fear works, and what is happening when someone has a phobia. Fear is our body’s alarm 
system, meaning that its purpose is to alert us to possible danger. When we’re afraid, our 
nervous system kicks in to gear,  and prepares us to fight or flee. In some situations that’s 
useful, for instance when a car is coming right at you as you’re crossing the street, fear 
drives you to get out of the way. In the case of phobias, however, fear is acting as a false 
alarm, telling us there is danger when in reality there is not. In claustrophobia, for 
example, fear is sending the message that some possible harm, usually related to 
suffocation or being trapped, could occur as a result of being in an enclosed space. While 
there are a few rare situations where this danger may be a reality, most of the time it’s 
not. Nonetheless, the false alarm signal of a phobia tries to convince us otherwise by 
flooding our body and minds with fear.  
Now one of the reasons why phobias tend to persist is that people who are afraid 
of something tend to avoid it as much as they can. As someone with a fear of enclosed 
spaces, for example, you probably tend to avoid such spaces whenever possible. This 
makes a lot of sense, as feeling fear isn’t much fun. However, one result of such 
avoidance is that it prevents you from getting a chance to see that the situations you’re 
afraid of aren’t actually as dangerous as they feel. Or in other words, you don’t get the 
chance to  learn that the fear you experience in tight spaces is a false alarm. 
So what can we do instead? Well, the most effective strategy for reducing fear is 
to confront the feared situation repeatedly until the anxiety decreases. Or in other words, 
face your fears. We call this treatment strategy exposure. To see how exposure works, 
let’s look at the following graph, where we have fear level on the vertical axis, and time 
on the horizontal axis. When you enter an enclosed space, your fear probably spikes, so 
you leave the situation as quickly as you can, and then your fear comes back down. By 
itself that’s not so bad, but what happens the next time you’re in an enclosed space? The 
fear spikes right back up again. You can continue to avoid, but the fear will come back 
every time you encounter the situation. In fact, avoiding tends to make the fear get even 
worse. This is because by avoiding, you are basically telling your brain that the situation 
is in fact dangerous. You’re reinforcing the false alarm.  
Now let’s look at the alternative to avoidance on this graph, which is what 
happens in exposure. In this case, you encounter the enclosed space, and your anxiety 
goes up, but you don’t leave. What do you think will happen? Well, the anxiety will 
continue to go up, but it doesn’t go up indefinitely. Eventually it will level off, and then 
even begin to go down. By itself, this might not look that much better than avoiding. 
However, if you approach that feared situation a second time, things get better. 
Specifically, the peak of the fear is lower, and the anxiety reduces more over the course 
of the exposure. Do it repeatedly, time and time again, and eventually the fear response 
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becomes minimal and you’ll no longer feel the urge to avoid. Why does this happen? 
Well when you repeatedly confront a feared situation rather than avoiding it, you get the 
opportunity to see that the things you’re most afraid of don’t actually happen. Essentially, 
your brain realizes that the alarm system going off is a false alarm, and that you’re not 
actually in danger. In addition, you get a chance to see that the anxiety you’re 
experiencing is tolerable and harmless, rather than something to avoid at all costs. By 
experiencing these things, your automatic fear response tends to gradually subside.  
To see how this works for yourself, you’re going to be doing a series of exposures 
in the closet you entered before, with the purpose of helping you overcome fear of 
enclosed spaces. The experimenter is going to direct you to lie down in the closet with 
the doors closed as you did before, and your goal will be to try and remain in the closet 
for as long as you can. Understand that you can leave the chamber at any time if you get 
too uncomfortable, just let the experimenter know you want to exit. However, you should 
try and stay for at least five minutes. As mentioned before, it’s important to do these 
exposures multiple times to fully benefit, so you’ll be doing six separate exposures. In 
between exposures, you’ll also be answering some questions about your fears and 
expectations about being in the closet, and how the prior exposure went.  
One final note about the exposures is that when you’re in the closet, it’s important 
that you don’t engage in subtle avoidance behaviors. This includes things like trying to 
suppress anxious thoughts or feelings, closing your eyes, or pretending you’re 
somewhere else. Although these things might provide temporary relief, they get in the 
way of learning that you are safe in the situation. This is because similar to avoiding the 
situation entirely, avoiding anxious thoughts and feelings teaches your brain that the 
situation is in fact dangerous, and that you can only handle it if you avoid thinking about 
the scary parts. If you instead let yourself pay attention to whether your feared outcomes 
are occurring, you are more likely to learn that you are in fact safe, and your anxiety is 
more likely to go down.   
If you have any further questions, let your experimenter know, and they will 




Appendix B: Claustrophobia Expectancies Questionnaire (CLEQ) 
Rate how concerned you are about the following outcomes occurring for the following exposure. Use the 
scale below (using any number 0–100), and enter your ratings in the unshaded boxes. 
0         10          20          30         40         50         60         70           80         90          100 
           No Concern    Mild Concern       Moderate Concern     Strong Concern    Extreme Concern 
 A B C 
I might start to choke    
I might not be able to escape if I have to    
I might lose control    
I might not be able to reduce my fear to a tolerable level    
I might not be able to tolerate my discomfort    
I might run out of air    
I might not be able to get out    
I might be paralyzed by fear    
I might not be able to think clearly    
The feelings of fear might be unbearable to me    
I might have difficulty breathing    
I might be trapped    
I might act foolishly    
I might not be able to remain in control of my actions    
I might not be able to handle my fear    
I might not be able to get enough air    
I might not be able to move    
I might go crazy    
I might not be able to control fearful thoughts or images    
I might be so scared that I need to leave    
 
Select the highest rated concern from each column and write it below. Then rate how likely you think it is 
that this concern will occur when you are in the closet, using on the scale below (use any number 0–100) 
 
0%       10%     20%      30%      40%       50%       60%       70%       80%       90%     100% 
Will not happen                    Maybe will happen        Certainly will happen 
Column A: _____________________________________________________________  Likelihood:_____ 
Column B: _____________________________________________________________ Likelihood:_____ 
Column C: _____________________________________________________________ Likelihood:_____ 
 
Use the scale below for the final two questions (using any number 0–100): 
0         10          20          30         40         50         60         70           80         90          100 
           No Fear              Mild Fear                Moderate Fear         Strong Fear         Extreme Fear (panic) 
1. How fearful do you think you will be when you are in the closet (max fear)?_______ 
2. What is your current level of fear? ________ 
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(Appendix B continued) 
Post-Exp 1 
Use the scale below for the next two questions (using any number 0–100): 
          0         10          20          30         40         50         60         70           80         90          100 
   No Fear              Mild Fear                Moderate Fear         Strong Fear         Extreme Fear (panic) 
 
1. What was the HIGHEST level of fear you experienced while in the closet? __________ 
 
 
2. What was the level of fear you experienced IMMEDIATELY BEFORE exiting the 
closet? __________ 
 
For the next sections, copy the 3 concerns selected from the previous sheet in the first column, 
and then answer the questions in the second and third columns using the rating scales below. 
 
Rating Scale 1: How much did your concern/feared outcome happen? 
0         10          20          30         40         50         60         70           80         90          100 
      Not at all                 A little bit                  Somewhat                   Mostly                  Completely  
 
Rating Scale 2: How surprised were you about how much it happened? 
0         10          20          30         40         50         60         70           80         90          100 
     No Surprise      Mildly Surprised    Moderately Surprised      Very Surprised     Completely  
       Surprised 
 
Concern/Feared outcome 
(from previous sheet) 
How much did your 
concern happen? (rating 
scale 1) 
How surprised were you 
about how much it 
happened? (rating scale 2) 
A.    
B.   




[Not included in measure] 
Column A = Threat Expectancies 
Column B = Coping Self Efficacy 
Column C = Fear Tolerance  
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For the next section, copy the 3 concerns from the prior sheets in to the first column, and then 
answer the questions in the second and third columns with regard to the next exposure. Use the 
rating scales below. 
 
Rating Scale 1: How concerned are you about this outcome? 
0         10          20          30         40         50         60         70           80         90          100 
           No Concern    Mild Concern       Moderate Concern     Strong Concern    Extreme Concern 
 
Rating Scale 2: How likely is it that this outcome will occur? 
     0%       10%     20%      30%      40%       50%       60%       70%       80%       90% 100% 
Will not happen                    Maybe will happen                   Certainly will happen 
 
Concern/Feared outcome 
(from previous sheet) 
How concerned are you 
about the outcome?  
(rating scale 1) 
How likely is it that this 
outcome will occur? (use 
rating scale 2) 
A.   
B.   




Use the scale below for the final two questions (using any number 0–100): 
0         10          20          30         40         50         60         70           80         90          100 
No Fear              Mild Fear                Moderate Fear         Strong Fear         Extreme Fear                
                                                                                                                             (panic) 
1. How fearful do you think you will be when you are in the closet (max fear)?_______ 




Appendix C: Exposure Training Review Form 
Memory Prompt 2 
1. Over the last 45 minutes, I went through exposure training for claustrophobia. This 
involved…[describe what you did] 
 
 
















4. I was also worried that… 
 
 
By the end of the training… [how much did it happen/was it a concern?] 
 
 
5. I was also worried that… 
 
 




6. By repeatedly going in to the closet for long periods of time and facing my fears by, I learned…  
[Describe your biggest take-away from the exposure training. Or in other words, what was the 




____ of 100 
 
End Fear 
____ of 100 
Beginning 
Concern    ____ 
Likelihood____ 
End 
Concern    ____ 
Occurrence____ 
Beginning 
Concern    ____ 
Likelihood____ 
End 
Concern    ____ 
Occurrence____ 
Beginning 
Concern    ____ 
Likelihood____ 
End 




Appendix D: Post-Exposure and MRE Coding 
Post-Exposure Recording Coding 
Rate whether the participant stated a take-away from the exposure in each of the 
following categories. This take-away should come after they reviewed the changes in 
their ratings, typically starting where they said “By repeatedly going in to the closet…and 
facings my fears…” 
1. Coping Self-Efficacy – Participant identified there is something they learned they can 
do to better handle the claustrophobic situation or reduce their fear. This is something 
indicating that they have some control over how they react, think or feel in the situation. 
This is different from other categories in that the participant describes something active 
they can do to cope rather than passively being able to tolerate their fear. 
Examples: 
If I set my mind to it I can get through it 
I can control my fear 
I tolerated my fear by telling my brain that everything is fine, it’s not a big deal 
 
2. Fear Tolerance – Participant identified learning that fear is tolerable or they can cope 
with fear without mentioning anything they did/can do to make it more tolerable (if they 
did mention a strategy to tolerate it, it would be coping self-efficacy). This can also 
include learning that fear isn’t that bad, or isn’t as bad as they thought.  
 
Examples:  
I can tolerate better than I thought 
Fear is just fear, it’s not that bad 
I can get through fearful situations 
 
3. Threat Reappraisal/Safety – Participant identified that their fears were misguided/did 
not come true, or that they were actually safe (i.e. their experience helped them 
reappraise the perceived threat in the situation). Can include realizing that fears were 
irrational or unrealistic, or realizing that nothing bad was going to happen. This does not 
apply to realizing fears about fear being intolerable or not being able to cope didn’t come 
true, as those would fall under fear tolerance or coping self-efficacy. 
 
Examples 
My fears did not come true  
What I’m anxious about is unlikely to happen 




4. Fear Reduction – Participant identified that over the course of the exposure their fear, 
anxiety, distress, etc. went down. Of note, if they say they were able to do something that 
reduced their fears (e.g. not avoid), it counts as Coping Self-Efficacy, not Fear Reduction.  
 
Examples: 
I learned my fear will eventually go down 
The more I went it in, the comfortable I got 
My anxiety eventually reduced 
 
5. Generalized – Participant describes an insight that refers to more than just the specific 
exposure situation they experienced. If they are saying something in the past tense (“I 
learned that it was tolerable”) or something specific about the closet (“I know I can 
tolerate the closet”) this does not count. Rather, it’s something that could applies to other 
situations beyond what they experienced. It still needs to be a specific and meaningful 
takeaway (not vague).  
 
Examples  
Fear can’t hurt you 
I just need to face my fears 




Same categories as Post Exposure Recording, plus… 
 
Fear Recall rating – Rate how much attention they were placing on their fears during the 
exposure and/or the extent to which they persisted:  
 
0 Does not explicitly mention being afraid or having to be let out of closet early  
1 Mentions their initial fear at but does not elaborate on it (i.e. no more than a 
sentence).  
  OR  
      Describes fear I n more detail, but mentions how those fears did not come true (e.g. I  
was scared that I wouldn’t be able to breathe, but realized that I my fear was 
exaggerated). 
 
2 Describes their fear/urge to escape in some detail (i.e. more than a sentence 
describing specific thoughts, physical sensations, concerns etc.) w/o describing how 
those fears didn’t come true. 
                  OR 
       Mentions their fears on multiple instances throughout recording 
OR 
       Describes a fear that they still have/that lasted throughout the exposure. 
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Note: Take in to account the general tone of their memory. If you’re uncertain but it 








Appendix E: Expectancy violation results for simultaneously tested predictors 














Note: * p <  .05; All values reflect results of linear regression controlling for condition and  BAT 1B fear rating. Scale for 
Surprise Ratings is 0-100, though if participants described being surprised , a negative values was assigned. Likelihood and 
occurrence ratings also rated on scale from 0-100, with occurrence rating subtracted from likelihood rating (i.e. positive values 
= fears occurring less than expected) 
EV Variable Expectancy Type Mean (SD) B SE B β sr2 
Likelihood-occurrence 
discrepancy: Total 
Coping Self-Efficacy 11.30 (8.07) -0.07 0.70 -.02 .00 
Threat Expectancy 6.40 (11.08) 0.09 0.51  .03 .00 
Fear Tolerance 8.94 (8.12) 0.13 0.63 .04
 
.00 
Expected Fear 13.37 (8.90) 0.75 0.58 .23 .04 
Likelihood-occurrence 
discrepancy: Exposure 1 
Coping Self-Efficacy 19.20 (22.10) -0.53 0.20 -.42* .16 
Threat Expectancy 9.02 (31.87) 0.15 0.15 .16 .02 
Fear Tolerance 12.68 (25.81) 0.03 0.19 .03 .00 
Expected Fear 18.42 (19.89) 0.50 0.23 .36* .12 
Surprise Rating: 
Total 
Coping Self-Efficacy 27.80 (18.43) -0.03 0.53 -.02 .00 
Threat Expectancy  26.66 (17.12) -0.56 0.50 -.33 .03 
Fear Tolerance 28.80 (16.15) 0.37 0.48 .21 .01 
Surprise Rating: 
Exposure 1 
Coping Self-Efficacy 44.66 (31.63) -0.36 -0.17 -.40* .10 
Threat Expectancy  44.11 (35.04) 0.10 0.15 .12 .01 
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Note: * p <  .05; ** p < .05; All values reflect results of linear regression controlling for condition and  BAT 1B heart rate. 
Heart rate values are adjusted for baseline. Scale for Surprise Ratings is 0-100, though if participants described being surprised 
, a negative values was assigned. Likelihood and occurrence ratings also rated on scale from 0-100, with occurrence rating 
subtracted from likelihood rating (i.e. positive values = fears occurring less than expected)  
  
EV Variable Expectancy Type Mean (SD) B SE B β sr2 
Likelihood-occurrence 
discrepancy: Total 
Coping Self-Efficacy 11.30 (8.07) -0.54 0.16 -.52** .25 
Threat Expectancy 6.40 (11.08) -0.16 0.12 -.17 .04 
Fear Tolerance 8.94 (8.12) 0.60 0.18 .52** .25 
Expected Fear 13.37 (8.90) 0.27 0.13 .22* .10 
Likelihood-occurrence 
discrepancy: Exposure 1 
Coping Self-Efficacy 19.20 (22.10) -0.10 0.06 -.27 .08 
Threat Expectancy 9.02 (31.87) -0.03 0.05 -.11 .01 
Fear Tolerance 12.68 (25.81) 0.05 0.05 .19 .03 
Expected Fear 18.42 (19.89) 0.16 0.07 .37* .15 
Surprise Rating: Total Coping Self-Efficacy 27.80 (18.43) -0.03 0.15 -.13 .00 
Threat Expectancy  26.66 (17.12) -0.03 0.15 -.16 .00 
Fear Tolerance 28.80 (16.15) 0.04 0.15 .29 .00 
Surprise Rating: Exposure 1 Coping Self-Efficacy 44.66 (31.63) 0.05 0.05 .06 .03 
Threat Expectancy  44.11 (35.04) -0.05 0.06 .08 .02 
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Background: Reductions in fear following exposure therapy for anxiety often do not 
generalize well outside the context in which they took place. This study tested a strategy 
for increasing generalization that involved revisiting the memory of a prior exposure 
experience in order to enhance the retrieval of the learning that occurred.  
Methods: Forty-five participants with claustrophobia received exposure training 
consisting of repeated 5-minute trials lying inside a narrow cabinet laid on the ground. 
One week later, they were randomly assigned to either enhanced mental reinstatement 
(EMR) or control procedures. Prior to entering a mock MRI scanner, participants in the 
EMR condition recalled the memory of exposure training and listened to an audio 
recording of themselves describing what they learned, while control participants recalled 
and then listened to an audio recording of themselves describing a neutral memory.  
Results: Compared to the control condition, the EMR intervention led to significantly 
reduced heart rate reactivity in the mock MRI scanner, but not self-reported fear or 
avoidance of the mock scanner, nor were there any differences between conditions at 
one-month follow-up. Across conditions, greater expectancy violations related to coping 
self-efficacy during exposure training predicted lower fear ratings and heart rate one 
week later in the mock MRI. Conversely, greater over-predictions of fear levels 
throughout exposure training predicted greater fear in the mock MRI.  
Conclusions: Results suggest relatively limited benefits of mental reinstatement of 
exposure training for improving generalization of learning in claustrophobia, with 





Exposure-based cognitive-behavioral therapy has been shown to be the gold-
standard treatment for anxiety disorders, yet treatment outcomes remain suboptimal 
(Carpenter et al., 2018; Hofmann & Smits, 2008). One hypothesized reason for this is that 
the learning that occurs during exposure therapy often does not completely generalize to 
new situations (Mineka, Mystkowski, Hladek, & Rodriguez, 1999; Dibbets, Moor, & 
Voncken, 2013; Mystkowski, Craske, & Echiverri, 2002; Vervliet, Vansteenwegen, 
Baeyens, Hermans, & Eelen, 2005; Vervliet, Vansteenwegen, & Eelen, 2006; Rowe & 
Craske, 1998). The consequences of such a failure to generalize safety learning can be 
significant for exposure therapy outcomes, as successful exposures conducted with a 
therapist may not translate to reduced anxiety outside of the treatment context, or 
improvements may be restricted to the specific feared situation confronted in the 
exposure. Enhancing generalization, on the other hand, could lead to reduced 
vulnerability to return of fear and more efficient treatment as a result of fewer in-session 
exposures.  
One commonly experienced feared situation in which improving generalization 
may be particularly relevant is MRI scans, which involve spending extended periods of 
time in an enclosed space, frequently leading to claustrophobic fear. Claustrophobia is 
one of the more common specific phobias, with prevalence rates around 4% (Curtis, 
Magee, Eaton, Wittchen, & Kessler, 1998), and approximately 1% of patients in need of 
an MRI refuse or prematurely terminate a scan due to claustrophobia, posing a significant 




Ritano & Murphy, 2015). Although exposure therapy has major potential for helping to 
alleviate this problem, poor generalization from exposure training in a separate context to 
an actual MRI could limit its utility. Accordingly, MRI-related claustrophobia offers a 
target for investigating generalization that both has ecologically validity and relates to an 
important public health issue.    
One technique for enhancing generalization after exposure treatment is called 
mental reinstatement, which involves mentally revisiting what happened during exposure 
treatment and the context in which it occurred prior to approaching a new feared 
situation. Mental reinstatement of the context in which information was encoded has been 
shown to reduce the decrement in memory seen after a context change (Smith & Vela, 
2001), and could plausibly bolster the retrievability of memories formed during 
extinction learning after a context change as well. Applications of this technique have 
shown promise for enhancing generalization, but effects are somewhat inconsistent and 
are limited to particular outcomes. In the most successful application to date, 
Mystkowski, Craske, Echiverri, and Labus (2006) showed that in spider phobics, mental 
reinstatement of exposure treatment led to reduced recovery of subjective fear after a 
context change compared to reinstatement of a neutral memory, though they elected not 
to test effects on heart rate or behavioral avoidance given that no return of fear was seen 
in those measures. Elsesser and colleagues (2013) found that mental reinstatement led to 
shorter approach latencies to one of three phobic stimuli a week after exposure treatment 
for dental phobia, but no effects on subjective fear or heart rate to the phobic stimuli, or 




Jöhren, & Sartory, 2013). Finally, in a study by Laborda and colleagues (2016) on public 
speaking anxiety, there was no effect of mental reinstatement on renewal of subjective 
fear ratings.  
 One limitation of the way mental reinstatement has been implemented is these 
studies is that they have provided minimal guidance for what exactly participants should 
recall. The instructions in Mystkowski et al., (2006) and Laborda et al., (2016) stated that 
participants should remember what happened in the prior exposure, including what they 
learned and where it took place, and Elsesser et al., (2013) described only that 
participants were told to mentally retrieve the previous treatment session. Given such 
instructions, it is possible that participants widely varied in what exactly they recalled (no 
such information was reported in the studies), ranging from how anxious they were 
during the exposures to how accomplished they felt afterward for overcoming their fear. 
Such varying responses could have led to dramatically different expectations, anxiety 
levels, and avoidance behavior in the subsequent exposure, thereby altering effects of the 
manipulation. In addition, participants were not explicitly encouraged to reflect on or 
articulate the extent to which the learning they recalled applies to the exposure situation 
they are about to encounter. If participants were to reason about or focus their attention 
on similarities between the new and old exposure contexts, that may influence their level 
of fear and willingness to approach the new exposure situation.  
The present study sought to test an enhanced version of mental reinstatement 
procedures, which involved the following modifications. First, while recalling their 




feared levels changed and feared outcomes did not occur during the course of exposure 
training. This was done to more tightly control what participants were recalling, and 
specifically to have them identify the aspects of prior learning that are theorized to be 
most important for long-term gains resulting from exposure therapy. Inhibitory learning 
theory posits that a mismatch between expectancies and outcome drives the development 
and retention of new non-fearful associations during exposure therapy (Craske et al., 
2008; Craske, Treanor, Conway, Zbozinek, & Verlivet, 2014), and evidence suggests that 
altering the delivery of treatment to maximize such expectancy violations leads to 
improved outcomes (Deacon et al., 2013). Therefore, highlighting the extent to which 
expectancies were violated in a prior exposure could help to more effectively recall the 
non-threat associations previously developed, thereby decreasing expectations of danger 
and increasing confidence in coping ability in a new exposure situation. In support of 
this, a study by Raeder and colleagues (2019) showed that reactivating the memory of 
how one overcame their fears immediately after exposure training led to reduced return 
of fear and increased self-efficacy in the same exposure situation several days later.  
A second modification was to have participants revisit the memory of their 
exposure training while listening to an audio recording of themselves (created 
immediately after training) articulating what happened during the exposure and what they 
learned. This was done firstly to further control what participants were recalling from 
exposure and to ensure they would recall the memory in an accurate and detailed manner. 
Furthermore, the audio-recording was used to enhance the believability of what 




what they took away from the training and how they felt about it, while simultaneously 
replaying that experience in their imagination, could help to more effectively reinstate the 
emotional learning associated with the training, thereby enhancing the extent to which the 
intervention targets both bottom-up and top-down processes.  
The final modification was to have participants articulate how the learning 
recalled from the prior exposure is relevant to a subsequent exposure. This was done to 
more effectively harness top-down cognitive processes by fostering the generation of 
propositional beliefs about the likelihood of safety and one’s ability to cope. Threat 
expectancies and coping beliefs have been shown to impact acute anxiety levels during 
singular exposures (Valentiner, Telch, Petruzzi, Bolte, 1996) and throughout exposure-
based therapy (Fentz et al., 2013; Gallagher et al., 2013). Therefore, being encouraged to 
reason how prior learning about the absence of expected danger applies to a novel feared 
situation was expected to help participants to realize that feared consequences related to 
the new exposure situation are unlikely to occur.  
The primary aim of the this study was to conduct a randomized control trial 
comparing  the effect of an enhanced mental reinstatement (EMR) procedure with 
standard exposure (SE) on recovery of subjective, behavioral and physiological indices of 
claustrophobic fear during exposure to a mock MRI one week after exposure training for 
claustrophobia in a different context. In addition, the effect of EMR vs SE was examined 
on several secondary outcomes, including and negative outcome expectancies prior to 
entering the mock MRI, self-reported claustrophobia symptoms at one-month follow-up, 




occurrence of feared outcomes in the EMR intervention, it was hypothesized that superior 
reductions in negative outcome expectancies resulting from  the EMR manipulation 
would mediate intervention effects.  
A final aim of this study was to examine whether the strength of expectancy 
violations (i.e. prediction error; Rescorla & Wagner, 1972) during exposure training 
predicts fear-related outcomes in novel and familiar exposure contexts one week post-
training, as well as self-reported outcomes at one-month follow-up. Although changes in 
threat expectancies are widely thought to be a fundamental mechanism of learning during 
exposure (Craske et al., 2008; Hofmann, 2008), and modifying treatment to maximize 
expectancy violations has been shown to fruitful (Deacon et al., 2013), explicit tests of 
the impact of expectancy violation strength on subsequent outcomes have only begun to 
emerge and have not consistently shown predicted effects. Specifically, a study by de 
Kleine and colleagues (2017) found no effect of harm expectancy violations on outcomes 
during exposure therapy for PTSD, whereas two studies in pediatric OCD showed 
divergent effects of fear level expectancy violations on exposure outcomes (Guzick, 
Reid, Balkhi, Geffken & McNamara., 2018; Kircanski & Peris, 2015). To help further 
clarify the role of expectancy violations in exposure outcomes, the present study 
measured expected vs. actual fear, discrepancy between likelihood of greatest feared 
outcomes and their occurrence, and surprise about feared outcome occurrence throughout 
exposure training, and these variable were examined as predictors of fear-related 







 A schematic of the experimental design can be seen in Figure 2. During the initial 
visit participants in both conditions completed a pre-training behavioral approach test 
(BAT; which also served as the final assessment of eligibility), exposure training, and a 
post-training BAT all in context 1 (a horizontal metal cabinet). Prior to the pre-training 
BAT (BAT 1A), baseline heart rate data and state anxiety were measured. Following 
BAT 1A, participants completed a battery of self-report questionnaires and audio 
recorded a neutral memory. After exposure training, an audio recording was made of 
participants orally reviewing their change in fear and feared outcomes and verbalizing 
their biggest “takeaway” from the training. At Visit 2, one week after exposure training, 
baseline heart rate, state anxiety and self-reported claustrophobia symptoms were 
measured again. Participants were then block-randomized to either Standard Exposure 
(SE) or Enhanced Mental Reinstatement (EMR), and underwent condition-specific 
procedures prior to a BAT conducted in a mock MRI scanner (BAT 2) in a different 
location from Visit 1. Randomization was done in blocks of 4 and 6 and stratified by 
participant type (university student vs. community) using the web-based service Sealed 
Envelope, with condition revealed only when participants arrived at Visit 2.  
Participants 
Participants consisted of adults (n = 45) recruited through postings on university 
student job sites, Craigslist and email list-serves of local hospitals. In addition, patients at 




indicating clinical levels of claustrophobia and reported interest in research were 
contacted about the study. Participants received $75 for their participation. The 
CONSORT diagram outline participant screening, randomization and study completion 
can be seen in Figure 1.  
Inclusion criteria included: 1) being 18-75 years of age; 2) self-reported fear of 
enclosed spaces at a moderate or greater level (≥2 on a 0-4 Likert scale); 3) expected fear 
of being in an MRI machine at a moderate or greater level (≥2 on a 0-4 Likert scale); 4) 
peak self-reported fear during a behavioral approach test (BAT) in a claustrophobia 
chamber (i.e. a horizontal metal cabinet) of ≥50 of 100. Participants with peak fear <50 
who exited the cabinet before for the end of the two-minute BAT for fear-related reasons 
were also deemed eligible. See the Procedure section for further details on the screening 
process.  
Exclusion criteria included: 1) presence of a medical condition (i.e., pregnancy, 
cerebrovascular disease, cardiovascular disease) that contraindicated participation in 
claustrophobia exposures; 2) physical condition preventing individuals from being able to 
safely enter the claustrophobia chamber, including individuals weighing >350 lbs (the 
weight limit for the mock MRI used in this study), and 6’4” (the length of the inside of 
the claustrophobia chamber); 3) prior exposure therapy for claustrophobia-related 
concerns; 4) presence of bipolar disorder, psychotic disorder, or cognitive dysfunction 
likely to impair participation in study activities; 5) refusal to enter the claustrophobia 
chamber during the initial BAT. In addition, participants who took as-needed medication 




medication the day of the study visit until after study procedures had been completed.  
The sample was racially/ethnically diverse, with 40% identifying as Asian, 36% 
White/Caucasian, 18% Black/African-American, 4% Latinx and 2 % multiracial. Females 
made up 64% of the sample, mean age was 29.2 (SD = 12.3), and 58% of participants 
were students (graduates or undergraduates). Demographics for each study condition can 
be seen in Table 1, and baseline clinical variables are in Table 2. Thirteen percent of the 
sample was taking psychiatric medication and 84% met DSM-5 diagnostic criteria for 
Specific Phobia with claustrophobia at the time of the study.  
Procedures 
Screening Process. The screening procedure in this study was based on that of 
previous studies examining exposure training for claustrophobia (Kamphuis & Telch, 
2000; Powers et al., 2008; Sloan & Telch, 2002; Telch et al., 2004; Telch et al., 2014). 
Potential participants were first screened on the phone for eligibility, which included 
being asked to rate on their overall fear of enclosed spaces on a 5-point Likert scale (0 = 
no fear, 1 = mild fear, 2 = moderate fear, 3 = severe fear, 4 = extreme fear). They also 
were provided a description of the mock MRI scanner used during BAT 2 and asked how 
much fear they would experience if they were to enter the scanner using the same scale. 
Those who reported a 2 or above on both questions and did not meet any exclusion 
criteria were invited in to the laboratory. Following the consent process, state anxiety was 
measured so ratings would not be affected by having entered the cabinet during BAT 1. 
Next, participants were outfitted with a heart rate monitor and baseline heart rate data 




then instructed to complete BAT 1. Those who experienced a peak fear level of 50 or 
greater (out of 100) were eligible to participate in the rest of the study. In addition, 
participants who requested to leave the cabinet prior to the 2-minute time limit for any 
fear-related reason (e.g., couldn’t tolerate their anxiety, felt like they couldn’t breathe, 
etc.) were also deemed eligible.  
Behavioral Approach Test 1 (BAT 1). For BAT 1, participants were first shown 
the claustrophobia chamber, which consists of a metal cabinet with internal dimensions 
of 6’ x 3’ x 1.5’ laid on the ground (see Figure 2). Participants were told they would be 
asked to lie down inside the cabinet on their backs, at which point the experimenter 
would shut the cabinet doors. They were also instructed that the goal of the task was to 
remain inside the cabinet for as long as they could, but if they wanted to leave they could 
tell the experimenter, who would remain in the room, and would be let out immediately. 
Participants were made aware that when the task was over the experimenter would open 
the doors and let them out, but were not told the maximum length of the task, which was 
2 minutes. After these instructions were given, participants completed a series of 
questions about their fears and expectations for the task, and then instructions were 
reiterated prior to entering the cabinet. BAT 1 was conducted prior to exposure training 
(BAT 1A) and after the training was completed (BAT 1B).  
Pre-Exposure Procedures. Following BAT 1A, participants underwent a 
diagnostic interview assessing DSM-5 criteria for specific phobia of claustrophobia, and 
completed the remainder of the self-report questionnaires, and then created an audio 




the first 30 minutes when they got out of bed that morning, and rate the degree of 
negative and positive emotion associated with this memory on a 5-point Likert scale (0 = 
none, 4 = extreme). Participants with a rating of 0 or 1 for both emotions were then asked 
to recount the memory out loud step by step while being audio-recorded. Participants 
whose memory elicited a rating of  >1 for either negative or positive emotion were then 
instructed to identify a different memory from the previous 24 hours that met the positive 
and negative emotion criteria, and was also something they did on a daily basis (e.g. what 
they did before going to bed). An audio-recording was made while they recited the detail 
of this memory.  
Exposure Training. Participants first viewed an eight-minute video of a clinician 
who was not an experimenter for the study describing the rationale for exposure as a 
method for overcoming claustrophobia. The video began with psychoeducation about the 
role of avoidance in the maintenance of claustrophobia, and then explained how 
repeatedly remaining in a feared situation for an extended period of time provides the 
opportunity to see that the situation is safe and tolerable. The video also explained the 
procedures of exposure training conducted in this study.   
Following the procedures by Telch and colleagues (Kamphuis & Telch, 2000; 
Powers et al., 2008; Sloan & Telch, 2002; Telch et al., 2004; Telch et al., 2014), the 
exposure training itself consisted of six 5-minute exposure trials. During these trials, 
participants lay on their backs in the cabinet with the doors closed in the same manner as 
during BAT 1, except they were asked to stay in the cabinet for 5-minute intervals. They 




pretending they were somewhere else, and instead try to simply observe the situation 
around them and attend to whether their feared outcomes were actually occurring. If 
participants were unwilling to stay in the cabinet for the full 5-minute period initially, the 
time during later exposures when participants were more comfortable was increased so 
that each participant spent a full 30 minutes in the closet. This occurred for just three 
participants.  
Prior to each trial, participants rated their degree of concern about various feared 
outcomes, as well as the predicted likelihood that their three greatest feared outcomes 
will occur (see details in Measures section). They also rated their current and expected 
fear levels. After each trial, participants rated their peak and end fear levels, as well as the 
extent to which their feared outcomes occurred and how surprised they were about each 
outcome. The experimenter also checked in about any avoidance behaviors the 
participant may have been engaging in, and provided coaching on how to act counter to 
such urges to avoid. Participants then rated their feared outcomes and expected fear levels 
for the next exposure trial.  
Post-Exposure Training. After the final exposure trial, the experimenter helped 
the participant to review 1) what happened during the exposure training, including how 
their fear levels and concern and expectancy ratings for their three most feared outcomes 
changed, and 2) their biggest “take-away” from the training (i.e. the most important thing 
they learned). Then, participants made an audio recording of themselves verbalizing what 
they had just reviewed on the form. After this exercise, participants entered the cabinet 




 Visit 2 Procedures. Visit 2 occurred one week after the first visit, plus or minus 
one day, at the Boston University Medical Campus’s Center for Biomedical Imaging, 
which was in a different campus compared to Visit 1. Participants completed measures of 
state anxiety and claustrophobia symptoms, and baseline heartrate data were recorded 
while seated over the same 5-minute period as Visit 1. The experimenter then showed 
participants the mock MRI scanner they would be entering, explained the nature of BAT 
2, and then took participants to a separate room for condition-specific procedures. After 
BAT 2, participants answered a final set of questionnaires.  
 Enhanced Mental Reinstatement (EMR). Following the introduction of the 
BAT 2, EMR participants were be taken to another room and asked to close their eyes 
and re-imagine what took place during their exposure training one week before. 
Specifically they were told to recall out loud 1) where they were, 2) how their fear levels 
and feared outcomes changed and why, and 3) what they learned from the training. Next, 
participants were instructed to continue to keep their eyes closed and keep the memory of 
the training in mind while listening to the audio recording they made the prior week 
about what happened and what they learned through exposure training at the first visit. 
Following this, participants completed vividness, perspective, affect ratings. Finally, the 
experimenter assisted participants in completing a worksheet in which they write down 
all the ways in which the situation they just recalled in their memory was similar to the 
mock MRI scanner they were about to enter, including similarities about the space itself 
as well as the types of fears elicited. They were explicitly instructed to focus only 




prior exposure training was relevant to the situation they were about to enter. They then 
spoke out loud what they had written on the worksheet. All participant responses during 
this time were audio-recorded for further analysis.  
Standard Exposure (SE). The pre-BAT 2 procedures of the SE group were 
designed to mimic those of the EMR group as much as possible. After the introduction of 
the BAT 2 procedures, participants in the SE condition were taken to another room and 
reminded of the neutral memory they recorded at Visit 1. They were asked to close their 
eyes and imagine what took place during that memory in as much detail as possible, 
saying out loud exactly what they remembered. Next, they listened to the audio recording 
made the week before of them recalling this event while continuing to hold their memory 
in mind, and afterward completed the same vividness and affect questions as the EMR 
group. Following this, participants wrote down and then verbalized all the ways in which 
what happened the morning of the experiment (or whatever neutral memory had been 
recalled) was similar to what had happened the morning of Visit 2 (or equivalent, if a 
different memory). As in EMR, participant responses during SE procedures were audio-
recorded.  
Behavioral Approach Test 2 (BAT 2). BAT 2 took place in a decommissioned 
3T MRI scanner used to accustom individuals to an MRI machine prior to a real scan (see 
Figure 2). Participants lay on a stretcher with their head held in place by plastic siding, 
and the experimenter slid the stretcher in to the tube of the mock scanner until the 
participant’s entire upper body was inside enclosed. The opening of the scanner had a 




coming in to the tube was from the direction of the participants’ feet. Following the same 
procedures as BAT 1, participants answered questions about their feared outcomes and 
current fear levels prior to entering the scanner. They were given the same instructions as 
BAT 1A and BAT 1B about remaining in the tube for as long as they were willing, but if 
they became too uncomfortable, the experimenter would remove them from the scanner 
immediately. In order to reduce the likelihood of ceiling effects for time spent in the 
mock scanner, the maximum time before participants were removed was increased to 10 
minutes (compared to two minutes during BAT 1). In addition, every two minutes 
participants were asked their current fear level, and then told that if they remained in the 
willing to stay they will be moved another 6 inches in to the scanner. After participants 
exited the tube, they completed a rating of their maximum and end fear levels.  
One-month Follow-up. One month after visit 2, participants were sent a series of 
questionnaires via email that assessed claustrophobia symptoms, severity of feared 
outcomes if they were to undergo an MRI scan, and likelihood and expected fear of 
receiving an MRI scan.  
Outcome Measures 
Subjective Fear. Participants rated their subjective fear on a scale from 0 to 100, 
with anchors of 0 (no fear), 25 (mild fear), 50 (moderate fear), 75 (strong fear), and 100 
(extreme fear/panic). Immediately upon exiting the claustrophobia chamber during BATs 
and exposure trials, participants rated their maximum level of fear while in the chamber, 
and their fear at the end of the trial (before knowing they were about to exit). Peak and 




separately were consistently similar, so analyses focused on peak fear. Prior to each BAT 
and exposure trial, participants also rated their current fear and expected fear for entering 
the enclosed space. 
Behavioral Avoidance. Time until each participant requested to exit each of the 
BAT tasks, if relevant, was also recorded an indicator of behavioral avoidance.  
Heart Rate Reactivity. Heart rate was measured continuously throughout the 
experiment via the Zephyr BioModuleTM (Zephyr Technology Corp, Annapolis, MD, 
US), an ambulatory heart rate monitor that attaches to the chest via skin conductive 
electrodes. The device measures heart rate via electrocardiography (ECG) and has been 
shown to produce reliable and valid measurements of heart rate across a variety of 
contexts (Nazari et al., 2018). Sampling rate for ECG data was 1000 Hz. Artifact 
detection was conducted automatically using Kubios Version 3.1 Premium (Tarvainen, 
Niskanen, Lipponen, Ranta-Aho, & Karjalainen, 2014), and then was inspected manually 
and any additional corrections necessary were made. Mean heart rate data were extracted 
for baseline and BAT periods from Visits 1 and 2. Heart rate during BATs was adjusted 
for baseline by calculating the difference between mean heart rate during each BAT and 
the corresponding baseline period, and then adding that value to the mean baseline heart 
rate for the sample. This baseline-adjusted heart rate variable was used in analyses.  
The Claustrophobia Questionnaire (CLQ). The CLQ (Radomsky, Rachman, 
Thordarson, McIsaac, & Teachman,, 2001) is a 26-item assessment of claustrophobia 
symptoms. Participants are asked to rate how anxious they would feel on a 5-point Likert 




suffocation (e.g. “Using an oxygen mask”) and restriction (e.g. “Locked in a small dark 
room without windows for 15 minutes”), the two components of fear thought to underlie 
claustrophobia (Rachman & Taylor, 1993). The CLQ has demonstrated strong predictive 
and discriminant validity, along with good internal consistency and test-retest reliability 
(Radomsky et al., 2001). Given the importance of avoidance of feared situations in 
anxiety psychopathology, participants were also asked how much they would want to 
avoid each of the 26 situations listed in the CLQ from 0 (no desire to avoid) to 4 (avoid at 
all costs). The CLQ was administered at after eligibility screening, the beginning of Visit 
2 prior to randomization, and at one-month follow-up. Internal consistency in the present 
study was excellent at all three time points, both for fear and avoidance subscales 
separately and combined (α = .92 - .96). 
Claustrophobic Expectancies Questionnaire (CLEQ). The CLEQ (see 
Appendix B) is a measure adapted for this study assessing respondents concern about 20 
possible feared outcomes for a claustrophobic situation. It consisted of four items 
regarding concerns about suffocation (e.g. “I might start to choke”), four items regarding 
entrapment concerns (e.g. “I might not be able to escape if I had to”), and four items 
regarding coping self-efficacy (e.g. “I won’t be able to tolerate to my fear”), all of which 
were adapted from the Claustrophobic Concerns Questionnaire (Valentiner, Telch, 
Petruzzie, & Bolte, 1996). Also included were four items regarding loss of control (e.g. “I 
might lose control”) adapted from the Claustrophobia General Cognitions Questionnaire 
(Febbraro & Clum, 1995), and four items regarding fear tolerance (e.g. “The feelings of 




Gaher, 2005). The intent in creating this questionnaire was to generate a wide variety of 
possible feared outcomes for individuals with claustrophobia in order to increase the 
likelihood of accurately capturing participants’ greatest specific concerns, and enable 
them to be tracked throughout the exposure training. From this scale, three subscale 
scores were created based on item averages: 1) threat expectancies (based on suffocation, 
entrapment, and loss of control items), 2) coping self-efficacy, and 3) fear tolerance.  
Items were rated on a scale from 0 (no concern) to 100 (extreme concern). In 
addition, the highest-rated feared outcome from each CLEQ subscale was selected, and 
participants indicated how likely they believed each outcome was to occur (0% to 100% 
likelihood). The CLEQ was administered prior to all BATs and prior to the first and last 
trials of exposure training. Also before exposure trials 2 through 5, participants tracked 
their top-rated feared outcomes from the initial exposure by continuing to complete 
concern and likelihood ratings with regards to the next exposure. Internal consistency for 
the full scale was excellent across time points (α = .92 - .96), with subscale reliability 
being strong as well: Threat Expectancies: (α = .86 - .91), Coping Self-Efficacy, (α = .78 - 
.90), and Fear Tolerance (α = .83 - .94). 
MRI Expectancies, Fear and Likelihood. After BAT 2 and at one-month 
follow-up, participants were asked how likely they would be to get a medically indicated 
MRI from 0 (definitely would NOT get it) to 100 (definitely WOULD get it). They were 
then asked to imagine they were to undergo a real MRI scan. They were told this would 
involve being in the same type of scanner they were in during the study, but that it would 




press a button to tell the MRI technician they wanted to leave. Participants then rated 
their maximum expected fear while in the scanner with the same 0-100 scale used during 
BATs, as well as the feared outcome items from the CLEQ (CLEQ-MRI). Participants 
also rated fear and likelihood of getting a medically indicated MRI scan at baseline.  
Claustrophobic Expectancy Violations. After each exposure, participants rated 
the extent to which their top feared outcomes occurred on a scale from 0 (not at all) to 
100 (completely), and how surprised they were at the extent to which it occurred from 0 
(not at all surprised) to 100 (completely surprised). For surprise ratings, the experimenter 
asked participants whether they were surprised that their feared outcome occurred more 
or less than expected, and if participants reported it happened more than expected, ratings 
were given a negative value. Surprise ratings, the difference between likelihood and 
occurrence scores, and the difference between concern and occurrence scores (see De 
Kleine, et al., 2017) were initially investigated as indicators of expectancy violations. In 
addition, the difference between expected and actual fear was examined as an additional 
possible indicator, as has been done in previous literature (Guzick et al., 2018; Kircanski 
& Paris, 2015). Because correlations between likelihood and concern rating at each 
exposure were quite high (r > .60), however, concern-occurrence discrepancies were not 
included in the analysis. Values for each feared outcome from the CLEQ (Threat 
Expectancies, Coping Self-Efficacy, and Fear Tolerance) over the course of six exposure 
trials were averaged in an attempt to capture the total  expectancy violation throughout 
training. Because the exposure scenarios were identical throughout training and the 




expectancy violations during the first exposure were also examined. Expectancy 
violations for each type of feared outcome were not combined for analysis in order to 
comparatively examine violation of different beliefs, and also because internal 
consistency for discrepancy scores was in the questionable range (α = .62-.63)  
Additional Measures  
Composite International Diagnostic Interview (CIDI). The CIDI is a structured 
clinical interview commonly used in clinical and research settings to efficiently assess 
diagnostic criteria of psychological disorders (World Health Organization, 1997). The 
experimenter administered only the specific phobia module in this study to assess 
claustrophobia. Although designed for assessment of DSM-IV criteria, criteria for 
specific phobia in DSM-5 were essentially unchanged, and responses were evaluated with 
regard to DSM-5 criteria. The anxiety disorder module of the CIDI has demonstrated 
good psychometric properties, including good sensitivity (.86) and acceptable specificity 
(.52) (World Health Organizaiton, 1997). 
State-Trait Anxiety Inventory (STAI). The 6-item version of the STAI-state 
(Marteau & Bekker, 1992) was used as a brief measure of state anxiety at the beginning 
of Visits 1 and 2, whereas the 20-item version of the STAI-trait (Spielberger, Gorsuch, & 
Lushene, 1970) was used to characterize the degree of trait anxiety present in the sample. 
Internal consistency in this study was strong for the STAI-trait (α = 0.92), as well as for 
the STAI-state at Visit 1 (α = 0.83) and Visit 2 (α = 0.86).  
Exposure Training Thinking. After participants completed BAT 2, they 




approaching the mock MRI and when inside on a scale from 0 (not at all) to 100 (the 
entire time). If they answered a response other than 0, they were prompted to write a 
sentence or two about what specifically they thought about. Responses were coded yes/no 
for whether the participant described either something they learned from the exposure 
training or reported using the memory to help them feel less anxious.   
Data Analytic Approach 
 Data were analyzed using SPSS 26.0. Prior to running the primary analyses, EMR 
and SE groups were compared on baseline clinical and demographic variables using Chi-
Square for categorical variables and independent-samples t-test for continuous measures. 
A series of 2 x 2 mixed effects ANOVAs with time as a within-subject factor and 
condition as a between-subject factor were then used to examine equivalence of treatment 
effects across condition (pre-randomization) on subjective fear, behavioral avoidance, 
and heart rate during pre- and post-exposure training BATs, as well as Visit 1 and Visit 2 
CLQ scores. One-way ANOVAs were also used to test for differences in main outcome 
variables between BATs (collapsing across condition), in order to test for return of fear 
after exposure training.  
 To analyze the effect of condition (EMR vs. SE) on primary fear outcome 
variables, hierarchical linear regression was used, entering each at outcome at BAT 1B 
and Visit 2 STAI-S as predictors in the first step, and condition at the second step (SE 
coded as 0, EMR coded as 1). For behavioral avoidance, a survival analysis was 
performed using Cox regression to predict the relatively likelihood of exit from the mock 




minutes of the BAT, while controlling for relevant covariates. Because no participants 
exited early from BAT 1B, a categorical variable was created to indicate whether a 
participant exited early from BAT 1A, and was used to control for baseline behavioral 
avoidance. For secondary outcomes linear regression was used to examine the effect of 
condition on CLQ scores at one-month follow-up, controlling for CLQ at Visit 2 (pre-
randomization). The effect of condition was also examined on Visit 2 (post-BAT 2) and 
one-month follow-up CLEQ-MRI scores, controlling for CLEQ at BAT 1B (as CLEQ-
MRI was not administered pre-randomization), and MRI fear and likelihood ratings, 
controlling for at baseline (as these ratings were not made post-exposure training). 
Furthermore, the effect of EMR vs. SE was investigated on CLEQ scores prior to BAT 2, 
controlling for CLEQ at BAT 1B. When examining the impact of as expectancy violation 
variables, predictors were entered in to a stepwise linear regression set to retain all 
predictors at p < .05 and exclude predictors at p > .10.  
Throughout analysis assumptions of linear regression were tested, including 
normality, homoscedasticity and independence of residuals, absence of multicollinearity, 
and the presence of outliers. Data were consistently suitable for linear regression. The 
squared semi-partial correlation coefficient (sr2), which represents the unique portion of 
variance explained by the predictor, was used as an indicator of effect size for regression 
analyses. 
Missing data. No data were missing for self-report or behavioral variables. Due 
to equipment failure, heart rate data was not collected for two participants (one SE, one 




resulting from a poor-quality ECG signal. Across participants with any heart rate data, 
9.7% of values were missing. To address this, first Little’s missing completely at random 
test (Little, 1988) was used to determine whether missingness of data was related to any 
variables being examined in the study. Although this test was not significant, χ2 (24) = 
23.65, p = .48, indicating that were missing completely at random, multiple imputation 
was used to generate plausible values for the missing heart rate data and preserve power. 
The model used to generate such values included the mean, maximum and standard 
deviation of heart rate at each BAT and baseline period, as well as several additional 
periods of heart rate data not directly analyzed in this study, specifically the first and last 
exposure in the closet and a two-minute period for and after each BAT. In addition, fear 
ratings and duration of BATs, state anxiety and experimental condition were included as 
predictors given their potential relationships with heart rate during a BAT. Fully 
conditional specification (van Buunen, 2007) was used to handle instances of multiple 
missing variables, and twenty iterations of complete data sets were generated and 
analyzed, with effects pooled to create a single set of results. As recommended by Sterne 
et al., (2009), we conducted sensitivity analyses to compare results of the imputed data 
set with the original data, and report results in a footnote below.  
 Power Analyses: The mental reinstatement procedure by Mystkowski and 
colleagues (2006), which led to significantly reduced subjective fear levels after a context 
change compared to a control condition, resulted in a partial eta squared of 0.15, 
indicative of a large effect (Cohen, 1988). Conservatively assuming a medium-to-large 




indicated that a sample size of 34 would be sufficient to detect a significant effect. A 
minimum sample size of 40 was planned for in order to increase power to detect a smaller 
effect and investigate potential moderators, and data collection was continued until no 
longer feasible. A post-hoc sensitivity analysis indicated that with the current sample 
size, controlling for an additional covariate (STAI-S), the study had power = .80 to detect 
a medium effect size of f2 = 0.18.  
Results 
Baseline Characteristics and Overall Response to Exposure Training 
 Demographics across condition can be seen in Table 1, with baseline clinical 
characteristics seen in Table 2. No baseline differences were found for any demographic 
or clinical variables.  
With regard to effects of exposure training, means and standard errors of BAT 
Fear across time-points and condition can be seen in Figure 3. A 2 x 2 mixed-effects 
ANOVA showed a main effect of time-point on BAT Fear during Visit 1, F(1,43) = 
598.78, p < .001, ηp2 = .93, such that fear at BAT 1B (M = 8.18, SE = 1.78) was 
significantly reduced compared to BAT 1A (M = 73.59, SE = 2.18), with no significant 
effect of condition, F(1,43) = 2.94, p = 0.10, ηp2 = .06, or time by condition interaction, 
F(1,43) = 0.35, p = 0.85, ηp2 = .00. Similarly, there was a significant main effect of time-
point on heart rate, F(1,41) = 55.23, p < .001, ηp2 = .57, showing a decrease from BAT 
1A (M = 77.01, SE = 1.36) to BAT 1B (M = 68.80, SE = 1.29), but no significant effect of 
condition, F(1,41) = 1.17, p = .29, ηp2 = .02, or time by condition interaction, F(1,41) = 




for the full two minutes at BAT 1B, in contrast to BAT 1A in which eight SE participants 
(35%) and three EMR participants (14%) exited early (not significantly different, χ2 = 
2.72, p = 0.10). There was a significant main effect of time-point on BAT duration, 
F(1,43) = 8.72, p = .005, ηp2 = .17, but again no effect of condition, F(1,43) = 0.21, p = 
.89, ηp2 = .00, or time by condition interaction, F(1,43) = 0.21, p = .89, ηp2 = .00. In sum, 
exposure training led to significant and large improvements in subjective fear, heart rate 
and behavioral avoidance, with no differences in response to exposure across conditions.  
 At Visit 2, CLQ scores (M = 95.18, SE = 5.60) from prior to randomization 
showed a similarly large and significant reduction compared to scores pre-exposure 
training from Visit 1 (M = 120.33, SE = 5.23; F[1,43] = 23.06, p < .001, ηp2 = .35). No 
main effect of condition, F(1,43) = 0.02, p = .89, ηp2 = .00, or time by condition 
interaction, F(1,43) = 0.93, p = .34, ηp2 = .02, was found. However, there was a 
significant difference in state on the STAI-S at the beginning of Visit 2, t(43) = -2.11, p = 
.04, d = 0.63, indicating that at the beginning of Visit 2 (prior to all other Visit 2 
procedures other than baseline heart rate measurement), EMR participants (M = 42.58, 
SE = 2.75) endorsed greater levels of state anxiety than SE participants (M = 34.93, SE = 
2.36). Accordingly, STAI-S was controlled for in subsequent analyses examining the 
effect of condition. There was no significant difference in baseline heart rate at visit 2, 
t(41) = 1.82, p = .55, d = 0.05. 
 Return of Fear. To examine the extent to which the change in context from BAT 
1 to BAT 2 led to a return of fear across conditions, one-way ANOVAs were conducted 




differences across time-points in fear, F(1.54, 67.78) = 140.69, p = <.001, ηp2 = .76, and 
heart rate F(1.51, 66.20) = 27.68, p = <.001, ηp2 = .40. Paired-samples t-tests indicated 
fear rating at BAT 2 (M = 44.04, SE = 4.29) was significantly greater than at BAT 1B, 
t(44) = 8.35, p < .001, d = 1.25, and significantly lesser than at BAT 1A, t(44) = 8.35, p < 
.001, d = 0.98. Similarly, heart rate at BAT 2 (M =72.21, SE = 1.27) was significantly 
greater than BAT 1B (M = 68.80, SE = 0.92; t(42) = 2.21, p = .03, d = 0.34), and 
significantly lower than BAT 1A (M = 77.01, SE =0.97; t(42) = 3.96, p < .001, d = 0.61).  
Primary Aim: Effects of Treatment Condition on Fear Outcomes at BAT 2 
 Results of the full regression models predicting fear rating and heart rate can be 
seen in Table 4. Controlling for BAT 1B Fear and STAI-S, the effect of treatment 
condition (EMR vs. SE) on Fear at BAT 2 was not significant, B = -9.79, SE = 8.41, p = 
.25, sr2 = .03. 
For heart rate data, after controlling for STAI-S and heart rate at BAT 1B, the 
effect of condition was significant, B = -6.73, SE = 2.64, p = .01, sr2 = .14, indicating that 
EMR participants had a lower heart rate during BAT 2 relative to baseline than 
participants in SE. To ensure that such an effect was not confounded by the variable 
length of time participants spent in BAT 2, heart rate data during the first minute of BAT 
2 was compared to the full duration of the BAT (among participants who stayed more 
than one minute, 95% of the sample), and a paired t-test showed no significant difference, 
t(40) = -0.44, p = .66, d = .07. Nonetheless, the effect of condition was also examined on 
heart rate during the first minute of BAT 2. Results again show a significant effect of 




baseline in EMR vs. SE.7  
Regarding behavioral avoidance, Figure 5 graphically depicts the portion of 
participants in EMR vs. SE groups exiting early across the 10 minutes of BAT 2, 
including when they exited. One participant asked to exit the scanner before entering 
entirely, so time was recorded as 0. When entered together in a Cox regression, exiting 
BAT 1A early was a significant predictor of exiting early during BAT 2, Hazard Ratio 
(HR) = 5.79, 95% CI [1.45, 37.10],  p = .02, but treatment condition, HR = 0.60, 95% CI 
[0.12, 3.38], p = .60, and STAI-S, HR = 1.05, 95% CI [0.99, 1.12], p = .13) were not. 
Given that only seven of 45 participants (16%) exited the MRI scanner early (n = 4 in SE, 
n = 3 in EMR), results should be interpreted in the context of possible ceiling effects. 
Accordingly, BAT 2 duration was not used as a dependent variable in subsequent 
analyses.  
Exposure Thinking Manipulation Check. When asked after BAT 2, all but 3 
participants endorsed thinking about the prior exposure training while in the mock MRI 
scanner. EMR participants’ ratings of how much they thought about the prior exposure 
training while in the scanner (M = 63.73, SD = 27.17) were not significantly different 
from SE participants (M = 50.91, SD = 30.52; t(43) = 1.49, p = .15, d = 0.44), though 
means were in the expected direction. When comparing the portion of participants from 
each group who described thinking about what they learned from exposure training or 
 
7 Following recommendations by Sterne et al., (2009), a sensitivity analysis was conducted examining 
only participants with complete data and compared to the analysis using multiple imputation. The 
significant effect of condition remained, and effect sizes were slightly larger when examining heart 
rate during the full duration of BAT 2, B = -8.89, SE = 3.30, p = .01, sr2 = .20, and the first minute 




used the memory to help them feel less anxious (i.e. safety retrieval), the difference 
approached significance, (EMR = 81%; SE = 56%; χ2 = 3.02, p = 0.08). After controlling 
for BAT 1B outcomes and STAI-S, safety retrieval did not significantly predict BAT 2 
fear, B = -9.04, SE = 9.66, p = .36, sr2 = .02, or heart rate, B = -1.38, SE = 2.99, p = .65, 
sr2 = .01, nor did it its interaction with treatment condition, (fear: B = 13.74, SE = 21.66, 
p = .53, sr2 = .01; heart rate: B = 5.49, SE = 5.72, p = .34, sr2 = .02).  
When asked at the conclusion of Visit 2 whether they thought revisiting the 
memory of prior training was helpful, 14 of 18 (78%) EMR participants (4 missing 
responses) responded affirmatively, with 2 participants being unsure and 2 participants 
saying it was not. A partial point bi-serial correlation with BAT 2 fear outcomes, 
controlling for outcomes at BAT 1B, showed responding yes was associated with lower 
fear ratings (r = -.43, p = .07) and heart rate (r = -.54, p = .04). 
Effects of Treatment Condition on Secondary Outcomes 
 Visit 2. There was no significant effect of condition on pre-BAT 2 outcome 
expectancies (i.e. CLEQ scores), B = -3.06, SE = 5.79, p = .60, sr2 = .01, or expected 
fear, B = -8.84, SE = 7.21, p = .23, sr2 = .04, controlling for each variable at BAT 1B as 
well as STAI-S at the beginning of Visit 2. Accordingly, planned analyses of 
claustrophobic expectancies as a mediator of the effect of EMR vs. SE were not 
conducted. There was also no significant difference between conditions on MRI-related 
variables at the end of Visit 2, including outcome expectancies (i.e. CLEQ-MRI score), B 
= -2.00, SE = 5.92, p = .74, sr2 = .003, expected fear, B = 5.21, SE = 8.23, p = .53, sr2 = 




sr2 = .05, controlling for baseline ratings, or in the case of the CLEQ-MRI, controlling for 
BAT 1B CLEQ scores. 
Follow-up. Effects at follow-up mirrored those at Visit 2. Controlling for CLQ 
scores at Visit 2 (pre-randomization), there was no significant effect of treatment 
condition on CLQ at one-month follow-up, B = -11.71, SE = 9.25, p = .21, ηp2 = .04. 
Similarly, there was no significant effect of condition on MRI fear, B = -2.20, SE = 9.25, 
p = .81, ηp2 = .001, MRI likelihood, B = 8.75, SE = 5.63, p = .13, ηp2 = .05, or CLEQ-
MRI, B = -3.86, SE = 6.05, p = .53, ηp2 = .01, controlling for baseline ratings, or for 
CLEQ-MRI controlling for BAT1B CLEQ. 
Table 5 shows means of the CLQ and MRI-related variables across study time-
points, along with the results of one-way ANOVAs examining differences in each 
variable across time when collapsing across condition. Significant decreases in CLQ 
scores, MRI fear, and MRI outcome expectancies were seen between all time-points, as 
were significant increases in likelihood of getting an MRI (all ps < .001).  
Expectancy Violations 
Expectancy violation variables were grouped according to time-point (initial 
exposure vs. mean across all six exposures), and then each type of expectancy violation 
(threat expectancy, coping self-efficacy, fear tolerance, and fear level) as measured by 
both surprise ratings and likelihood-occurrence discrepancy was entered in a stepwise 
regression model predicting BAT 2 fear and heart rate reactivity, controlling for 




Prediction of BAT 2 Fear. When examining initial exposure predictors of fear at 
BAT 2, surprise ratings regarding coping self-efficacy, B = -0.33, SE = 0.14, p = .02, sr2 
= .10, and discrepancy between expected vs. actual fear levels, B = 0.45, SE = 0.21, p = 
.04, sr2 = .10, emerged as significant, though effects were in opposite directions. Whereas 
greater coping self-efficacy surprise predicted lower fear, expecting greater fear than 
actually occurred (i.e over-predicting fear) during the first exposure was associated with 
higher fear ratings at BAT 2. Of note, likelihood-occurrence discrepancy for coping self-
efficacy approached significance, B = -0.38, SE = 0.20, p = .06, sr2 = .09, with its effect 
in same direction as coping self-efficacy surprise (i.e., greater expectancy violation 
predicting reduced fear). Expectancy violations related to threat expectancies and fear 
tolerance from the initial exposure were not significant predictors of BAT 2 fear, 
regardless of whether they were measured by surprise ratings or likelihood-occurrence 
discrepancies (all ps > .22). When examining expectancy violation variables averaged 
across all exposure trials, no individual predictor showed significant effects on BAT 2 
fear (all ps > .11). 
 Prediction of BAT 2 Heart Rate. When examining heart rate at BAT 2, the only 
initial exposure predictor that emerged as significant in the stepwise regression was fear 
level expectancy violations, with greater over-predictions of fear associated with greater 
BAT 2 heart rate, B = -0.38, SE = 0.20, p = .06, sr2 = .09 (all other ps > .15). No 
expectancy violation measure averaged across all exposures significantly predicted BAT 




Prediction of Claustrophobia Symptoms. Based on results from the stepwise 
approach, a separate regression model was then tested that included just the significant 
predictors from the previous analyses, coping self-efficacy surprise and fear level 
expectancy violation during the initial exposure, and examined effects on CLQ scores at 
Visit 2 and follow-up, controlling for Visit 1 CLQ scores and treatment condition. No 
significant effects were seen for CLQ at Visit 2 (coping self-efficacy: B = -0.23, SE = 
0.16, p = .17, sr2 = .05; fear level: B = 0.34, SE = 0.17, p = .22, sr2 = .03), but coping 
self-efficacy surprise significantly predicted CLQ scores at follow-up, B = -0.38, SE = 
0.20, p = .06, sr2 = .09, with greater surprise about coping self-efficacy during the initial 
exposure being associated with reduced claustrophobia symptoms on the CLQ. For initial 
exposure fear level expectancy violations, there was a trend for greater over-predictions 
of fear to be associated with higher CLQ scores, but it did not reach significance, B = .56, 
SE = 0.32, p = .09, sr2 = .10. 
Discussion 
This study sought to examine whether mentally reinstating the memory of 
previous exposure training for claustrophobia would enhance the generalization of gains 
from exposure to a new context, specifically a mock MRI scanner. Results showed that 
exposure training successfully lead to reductions in fear ratings, heart rate and avoidance 
during a behavioral approach test (BAT) in the exposure training context. One week later, 
a partial return of fear of fear effect was seen for subjective fear and heart rate reactivity 
in the mock MRI, enabling this study to meaningfully investigate the effect of EMR on 




showed that compared to SE, EMR led to significantly reduced heart rate reactivity 
during BAT 2, reflective of a medium-sized effect (sr2 = .14). The impact of EMR vs. SE 
on subjective fear was in the expected direction (i.e., reduced fear in EMR compared to 
SE), but the effect was small (sr2 = .03) and not significant. Furthermore, no significant 
differences were seen between conditions on negative outcome expectancies, self-
reported claustrophobia symptoms at one-month follow-up, or behavioral avoidance in 
the mock MRI, though there appeared to be a ceiling effect for avoidance since few 
participants exited the mock MRI in either condition.  
The absence of effect on subjective fear ratings is in contrast to the findings of 
Mystkowski and colleagues (2006), who found mental reinstatement to lead to decreased 
subjective fear during a BAT with spider phobics, but consistent with findings of Elsesser 
et al. (2013) in dental phobia and Laborda et al. (2016) in social phobia. A notable 
difference between the study by Mystkowski et al. (2006) and the present research, 
beyond the type of phobia treated, is that generalization was examined with the same 
exposure stimulus (a spider) across distinct contexts, whereas in the current study the 
context and stimulus differed, potentially leading to more difficulty generalizing.  
With regard to heart rate outcomes, this is the first study to show effects of mental 
reinstatement on heart rate reactivity during exposure following a context change, though 
it should be noted that only one (Elsesser et al., 2013) of the three prior mental 
reinstatement studies examined effects on heart rate. That effects were specific to heart 
rate is somewhat surprising given that the “enhanced” aspects of the procedure were in 




learning to a new feared situation, and therefore might be more likely to impact 
subjective fear ratings and threat expectancies. In particular it was hypothesized that the 
advantage of EMR over the control condition would be mediated by superior impacts on 
negative outcome expectancies, but no difference in expectancies was found across 
conditions. Nonetheless, despite equivalent subjective ratings of fear and outcome 
expectancies, the EMR intervention led to decreased physiological reactivity compared to 
SE when entering a novel feared situation in the mock MRI scanner, with heart rate levels 
essentially equivalent to post-exposure training in a familiar claustrophobic context.  
The discordance between subjective and physiological outcomes in this study is 
noteworthy in that it highlights the distinct response systems of fear originally delineated 
by Lang (1968). De-synchrony between these response systems has been shown to be 
greatest under conditions of less severe emotional arousal (Calvo & Miguel-Tobal, 1998; 
Hodgson & Rachman, 1974), which appears to have been reflected in this study in the 
relatively moderate levels of fear experienced on average during BAT 2. Although 
researchers are frequently drawn to prioritize physiological outcomes as more objective 
indicators of emotional states directly linked to underlying brain circuitry (e.g., Perusini 
& Fanselow, 2015), others have argued that the subjective, conscious report of fear 
reflects a valid and reliable measurement that is particularly important since subjective 
distress tends to be what drives people to seek treatment (LeDoux, 2014; LeDoux and 
Hofmann, 2018). In this account, physiological responses reflect defensive survival 
circuits that can contribute to the conscious experience of fear, but do not determine it. 




measure of autonomic arousal (heart rate) reflective of underlying defensive circuitry 
(Friedman, 2007), However, this reduced autonomic arousal did not appear to impact the 
conscious experience fear enough to lead to a concordant reduction in subjective fear 
ratings. 
A number of possible explanations exist for the non-significant findings of EMR 
on self-reported variables. For one, results of the manipulation check applied after BAT 2 
showed that a sizable portion (56%) of the participants in the SE condition reported 
thinking about their prior exposure training during BAT 2 and specifically described 
thinking about what they learned or used the memory to help them feel less afraid. There 
was a trend toward more MRE participants (81%) revisiting their exposure training in 
this way, but such a pattern suggests that not everyone in the MRE condition explicitly 
recalled the more helpful aspects of their prior exposure training while going in the mock 
MRI canner, and that numerous participants revisited their exposure training without 
going through those procedures. It should be noted that there were substantial limitations 
to this manipulation check given that it was done retrospectively, ratings did now a 
significant relationship with fear during BAT 2, and there may have been a social 
desirability bias impacting participants from both conditions. Furthermore, MRE 
procedures still could have had an effect without leading to explicit memory retrieval 
(e.g. see Shin & Newman, 2018). Nonetheless, such a pattern reflects the likelihood that 
prior learning was likely fairly salient for all participants in the study. Although BAT 2 
occurred one week after initial training and occurred in a location, the novelty of coming 




memories easily occur, as could have the SE procedure in which participants recalled a 
neutral memory from around the same time as the first study visit.  
Also potentially contributing to the high salience of prior learning for all 
participants, and consequently to the limited impact of EMR, is the creation of the audio-
recording after exposure training, in which participants reviewed what happened during 
the exposure training and what they learned about their fear. Expression of fear and 
safety memories are influenced by consolidation processes as well as retrieval (Quirk & 
Mueller, 2011), and the elaborated review of exposure training may have functioned as a 
strong extinction memory consolidation intervention, reducing possible effects of a later 
retrieval-based manipulation. In fact, Raeder and colleagues (2019) showed that 
reactivating the memory of exposure training and evaluating one’s success in facing 
feared scenarios immediately after a single session of exposure training for height phobia 
led to reduced recovery of fear and increased self-efficacy during BATs done two to three 
days later and at one-month follow-up. After using a similar intervention for all 
participants in the present study, a sizeable return of fear effect (large effect size, d = 
1.25) was still present, suggesting there was still substantial room for improvement from 
the EMR intervention. However, the median peak fear level across conditions was 40 out 
of 100, meaning that many participants did not experience substantial fear levels after a 
change in context. Moderator analyses did not show the effect of treatment condition to 
be significantly impacted by claustrophobia severity or state anxiety prior to the 
manipulation, which might be expected if ceiling effects were present, though such tests 





 By tracking feared expectations and outcomes at each trial of exposure training, 
this study enabled the investigation of a number of different types of expectancy 
violations as a predictor of outcomes. Results showed that expectancy violations 
pertaining to coping self-efficacy and expected fear levels during participant’s initial 
exposure were significantly related to self-reported fear outcomes, though in opposite 
directions. Specifically, greater surprise about coping self-efficacy outcomes (i.e. surprise 
about coping better than expected) predicted lower fear ratings at BAT 2, as well as self-
reported claustrophobia symptoms at one-month follow-up. There was also some 
indication that likelihood-outcome discrepancies related to coping-self efficacy fears 
predicted fear and heart rate reactivity during BAT 2, though this result was not 
consistent across analytic approaches. The finding that learning related to coping self-
efficacy, i.e. the ability to actively manage fearful thoughts, feelings and behaviors, was 
associated with outcomes is consistent with previous literature showing improvements in 
coping self-efficacy to mediate subsequent symptom reduction during exposure therapy 
(Fentz et al., 2013; Gallagher et al., 2014). Furthermore, experimentally manipulating 
self-efficacy prior to an extinction learning task has been shown to lead to reduced 
physiological responding and negative evaluations of a conditioned stimulus (Zlomuzica, 
Preusser, Schneider, & Margraf, 2015). The present study extends these findings by 
showing that a strong expectation of poor coping self-efficacy, followed by the 





 With regard to fear level expectancy violations, discrepancy between expected 
and actual fear (i.e. expected minus actual fear levels, or over-prediction of fear) at the 
initial exposure was significantly positively associated with greater fear ratings and heart 
rate reactivity during BAT 2. There were also positive associations between over-
prediction of fear across all exposures and fear outcomes at BAT 2, though this result was 
not consistent across analytic approaches. Although realizing that fear was consistently 
lower than expected should theoretically help facilitate therapeutic learning (Craske, 
Vervliet, & Hermans, 2018), it is important to note that in the present study attention was 
not explicitly drawn to expected vs. actual fear discrepancies like it was for specific 
feared outcomes, as surprise about fear levels was not rated. Over-prediction of fear may 
have instead reflected or an inability to update expectations about fear levels based on 
actual experience suggestive of a more rigid cognitive style. The direction of this effect is 
also consistent with the findings of Kircanski & Peris (2015), who found that over-
predictions of fear early in exposure treatment predicted worse mid-treatment outcome. A 
study by Guzick et al. (2018), on the other hand, found that greater variability in expected 
vs. actual fear over the full course of treatment, which meant a higher proportion of over-
predictions, was associated with improved outcome. Of note, expectancy violations in the 
current study were based on a massed set of identical exposures, in contrast to a full 
course of treatment with varying types of exposures in the above-mentioned studies. It 
may be that over-predictions of fear are related to outcome when a limited number of 
exposure situations have been encountered, but as more situations are approached this 




 This is the first study to show that expectancy violations about specific feared 
outcomes (rather than expected fear levels) is predictive of subsequent fear levels. 
However it should be noted that conclusions about the belief domains used in this study 
(coping self-efficacy, fear tolerance, and threat expectancies) should be considered very 
much tentative. The categories of beliefs used in the CLEQ, which were subsequently 
used to distinguish expectancy violation beliefs, were based on items selected from prior 
measures as well as distinctions between theorized mechanisms of exposure. Although 
internal consistency within belief domains was strong, sample size limitations prevented 
full psychometric analysis. Given that expectancy violations related to different types of 
beliefs can have divergent effects on future outcomes, better delineating the types of 
beliefs related to exposure outcomes is an important direction for future research.  
Limitations 
Results of this study should be considered within the context of a number of 
limitations. For one, administration of BATs was not blinded, making it impossible to 
rule out that knowledge of experimental condition subtly impacted experimenter 
behavior. Although a standardized script was followed for each BAT, having a separate 
experimenter conduct outcome assessment served as a stronger control. Relatedly, 
although SE procedures were designed to mimic EMR procedures in terms of memory 
reinstatement, it was not designed to be an equally plausible alternative in terms of 
helping reduce fear outcomes, so participant expectancy effects may have played a role in 
EMR.  




included multiple ingredients (i.e. recall of exposure memory, listening to audio 
recording, and identifying relevance of exposure memory), it is difficult to know whether 
certain elements may have been driving or impeding effects. Multiple components were 
used in order to maximize likelihood of improving outcomes given that exposure is 
already a fairly robust intervention, but it is also possible that certain elements of the 
procedure ended up increasing fear levels, particularly for certain participants like those 
who emphasized fear reduction in their exposure recordings. Unlike previous research 
examining mental reinstatement, however, we assessed and analyzed a number of 
different components of the memory recall procedures, enabling more specific 
understanding of the factors potentially influencing mental reinstatement. 
 It should also be noted that even though the study was adequately powered to 
detect a medium-sized effect for the main outcomes, sample size is still a limitation, 
particularly for secondary analyses involving moderation. Even for main outcomes, non-
significant effects were consistently in the direction of superior outcomes for EMR, but 
may have been too small to detect in the present study. This may be especially true given 
the modest return of fear seen for a large portion of the sample, and particularly for 
behavioral avoidance as an outcome, which showed a clear ceiling effect. Relatedly, the 
control procedures in the SE condition may have inadvertently elicited reinstatement of 
the exposure memory in a way that reduced differences seen between conditions. 
Specifically, vividly imagining a neutral memory that occurred close in proximity to the 
initial study visit as well as listening to an audio-recording made during that visit may 




training more than they otherwise would have. Although the elaborated procedures of the 
EMR condition would still be expected to lead to a stronger reinstatement of prior 
learning, overlap between conditions could have reduced the magnitude of effects to a 
level not detectable given the present sample size. This idea is also supported by the 
results of the manipulation check mentioned previously, in which the difference in 
proportion of EMR vs SE participants who explicitly revisited the memory of exposure 
training prior to or during BAT 2 compared only approached significance.    
Implications and Future Directions 
Within this study and across other investigations of mental reinstatement 
techniques (Elsesser et al., 2013; Laborda et al., 2016; Mystkowski et al., 2006), effects 
of revisiting a prior exposure memory in order to enhance generalization appear to be 
limited, and it is difficult to make definitive conclusions about the clinical utility of such 
an exposure augmentation strategy as it has been applied to date. Nonetheless, the 
presence of significant effects on psychophysiological reactivity, possible moderators 
(e.g. post-reinstatement positive affect) and limitations of this study related to sample size 
suggests that further investigation of mental reinstatement and related techniques could 
be beneficial. 
In order to better understand the processes in play in extant findings on mental 
reinstatement, one future direction would be to experimentally manipulate the manner in 
which the memory is recalled, as well as the formation of the memory itself. For instance, 
Raeder and colleagues (2019) found that immediately after exposure treatment, having 




mastery experiences led to improved fear outcomes compared to reactivating the memory 
and comparing it to other stressful experiences. An extension of this research would be to 
examine whether mental reinstatement of exposure after such a self-mastery reactivation 
exercise could amplify its effects, and potentially extend benefits to a novel situation, 
which Raeder et al. (2019) did not test.  
Regarding expectancy violations, findings from this study are certainly in need of 
replication given the exploratory nature of the analyses and small sample size. However, 
they suggest that the experience of coping more effectively than one expected during an 
exposure helps to facilitate durable reductions in fear. Such a finding offers important 
evidence in a clinical context for a central tenet of inhibitory learning theory, which is 
that therapeutic learning is facilitated through maximizing of expectancy violations 
(Craske et al., 2008; Rescorla-Wagner, 1972). This is particularly notable given a number 
of recent studies that failed to find evidence in support of expected associations between 
expectancy violations and outcomes (de Kleine et al., 2017; Scheveneels, Boddez, Van 
Daele, & Hermans, 2019; Scheveneels, Boddez, Vervliet, & Hermans, 2019). This study 
also demonstrated the value of investigating the different types of expectancies that may 
be violated during exposure, as previous research has largely focused on a single 
indicator of expectancies, most frequently expected fear levels. The types of beliefs that 
drive fear can vary widely both across and within different types of anxiety presentations, 
and the present results show that examining expectancy violations with greater specificity 
in regards to belief domains may help to clarify inconsistent findings. Further research 




both within and across individuals, will be important to continue refine inhibitory 
learning theory and elucidate the cognitive mechanisms driving change during exposure.  
In addition, in order to demonstrate that expectancy violations function as mechanism of 
change, future research will need to manipulate treatment in such a way that facilitates 
greater expectancy-outcome mismatches (e.g. Deacon et al., 2013), and demonstrate that 
this in turn leads to improved outcomes.  
Lastly, although the current study was not specifically designed as an intervention 
for treatment of MRI-related claustrophobia, it illustrates the utility of exposure therapy 
for decreasing MRI-related fear when access to a real scanner is limited. Specifically, 
MRI-related fear and expected likelihood of getting a medically-indicated MRI 
substantially improved as a result of two visits involving exposure to feared spaces. 
Given the major public health implications of MRI avoidance due to claustrophobia 
(Munn et al., 2015), this study could serve as the basis for future research investigating an 
efficient exposure-based intervention for fear of MRI scans.  
Conclusion 
Results of the present study showed that an intervention involving mental 
reinstatement of prior exposure training for claustrophobia led to reduced heart rate 
reactivity when entering a new feared situation, but effects on subjective fear rating or 
feared outcome expectancies were not significant. In addition, no impact of intervention 
was seen on self-reported claustrophobia symptoms or MRI fear-related variables at one-
month follow-up. Compared to results of prior studies examining a similar manipulation, 




participants learned from prior exposure training, did not appear to meaningfully improve 
outcomes. Analysis of exposure training processes showed that expectancy violations 
related to coping self-efficacy, particularly during participants’ first exposure, led to less 
fear in a novel exposure situation one week later, as well as less self-reported 
claustrophobia symptoms at one-month follow-up. Under-predictions of fear levels, 
however, were associated with greater fear levels in the novel feared situation. More 
research is needed to understand how to most effectively facilitate the formation and 







Baseline Clinical Characteristics 
 EMR (n = 22) SE (n = 23) p value for T, χ2 
or Fisher’s Exact 
Test 
 M (SD) or n (%) M (SD) or n 
(%) 
Specific Phobia Diagnosis 
(Claustrophobia) 
 0.15 
   Currently meets 19  (86%) 19  (82%)  
   Past only 2    (9%) 0    (0%)  
   Does not meet 1    (5%) 4    (17%)  
Psychiatric 
medication 
2    (9%) 4     (17%) 0.67 
    
MRI Variables    
Prior MRI Experience 13  (59%) 12   (52%) 0.64 
MRI Fear (0-100) 75.4 (19.1) 71.5 (18.9) 0.49 
MRI Likelihood (0-
100) 
56.5 (27.4) 67.0 (34.7) 0.27 
    
Questionnaire Scores    
CLQ-fear 58.6 (17.4) 59.4 (17.7) 0.87 
CLQ-avoidance 59.6 (19.2) 62.8 (16.8) 0.59 
STAI-T 44.0 (11.7) 42.6 (11.4) 0.68 
STAI-S 43.8 (10.7) 40.9 (11.3) 0.38 
    
BAT 1A Variables    
Peak Fear (0-100) 76.3 (14.0) 70.9 (15.1) 0.22 
End Fear (0-100) 63.4 (22.6) 59.1 (22.9) 0.54 
Exited early  8    (36%) 3     (14%) 0.10 
CLEQ  48.6 (16.1) 51.9 (20.6) 0.56 
Note: EMR = Enhanced Mental Reinstatement; SE = Standard Exposure; CLQ = 
Claustrophobia Questionnaire; STAI-T = State-Trait Anxiety Inventory – trait; STAI-S = 







Results from regression models examining effect of condition on primary outcomes 
during BAT 2 
Note: * = p < .05; ** = p < .01; BAT = Behavioral Approach Test; STAI-S = State Trait 
Anxiety inventory – State, measured at the beginning of Visit 2; HR = Heart rate.  
  
Outcome Step Predictor ΔR2 B SE B β sr2 
Fear Rating 
1. BAT 1B Fear .19* 0.42 0.35 .17 .04 
 STAI-S 0.87 0.32     .38** .15 
2. Condition .03 -9.79 8.41 -.17 .03 
Heart Rate  
1. BAT 1B HR 
.01 
0.03 0.22 0.03 .00 
 STAI-S -0.02 0.11 -0.04 .00 
2. Condition .14* -6.73 2.64 -0.33* .14 
Outcome Step Predictor Δχ2 
Hazard 
Ratio 
95% CI for 
 Hazard Ratio p 
Avoidance 
(Time to exit) 
1. STAI-S 
6.62* 
1.04 0.98 to 1.10 .15 
 BAT 1A Exited 7.55* 1.52 to 37.44 .01 





Claustrophobia symptom scores and MRI fear variables across study time-points.  















EMR 118.4 (36.1) 98.4 (38.1) 72.0 (34.0) 
31.70** 0.42 SE 122.2 (34.1) 92.0 (37.0) 79.2 (46.3) 
MRI Fear 
EMR 75.5 (19.1) 52.7 (24.1) 39.6 (31.0) 
36.46** 0.46 SE 71.5 (18.9) 46.3 (30.8) 39.4 (34.4) 
MRI 
Likelihood 
EMR 56.6 (27.4) 74.1 (25.3) 84.4 (17.6) 
21.57** 0.33 SE 67.0 (34.7) 74.3 (30.6) 80.7 (28.4) 
CLEQ-MRI 
concern 
EMR - 24.5 (19.6) 15.7 (17.6) 
9.91* 0.19 SE - 23.9 (22.1) 18.1 (22.5) 
CLEQ-MRI 
likelihood 
EMR - 40.7 (25.5) 26.4 (28.2) 18.92** 0.31 
SE - 36.1 (29.8) 24.3 (21.0)   
Note: *p < .01; **p < .001;  aCLQ administered pre-BAT 2 at Visit 2, whereas other 
variables captures after BAT 2. bFollow-up paired samples t-tests (collapsed across 
condition) indicated significant differences between all Visit 1 and Visit 2 variables, and 
between Visit 2 and follow-up (all p’s < .001); EMR = Enhanced Mental Reinstatement; 
SE = Standard Exposure; CLQ = Claustrophobia Questionnaire; CLEQ-MRI – 






Figure 1. CONSORT diagram of participant screening, randomization, and study 
completion. Randomization occurred at Visit 2, following completion of exposure 
training at Visit 1. *For heart rate analysis, n = 21 for enhanced mental reinstatement and 







Figure 2. Schematic of study design and contexts for Behavioral Approach Tests (BAT). Open space in cabinet (Context 1) is 
6’ x 3’ x 1.5’, and doors were closed on top of participants. Diameter of tube in mock MRI scanner (Context 2) is 2’. 
Participants were slid in to tube headfirst until their entire upper body was enclosed, and then were moved an additional 6” 





Figure 3. Peak fear rating during Behavioral Approach Tests (BAT) across conditions. 



















Figure 4. Heart rate during behavioral approach tests (BATs) across conditions. Error 
bars reflect 95% confidence intervals. Heart rate values are adjusted for baseline. SE = 





Figure 5. Percentage of Enhanced Mental Reinstatement (EMR) vs. Standard Exposure 
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